id	sid	tid	token	lemma	pos
aesr-151	1	1	agriculture	agriculture	NOUN
aesr-151	1	2	and	and	CCONJ
aesr-151	1	3	food	food	NOUN
aesr-151	1	4	sciences	sciences	PROPN
aesr-151	1	5	research	research	NOUN
aesr-151	1	6	vol	vol	NOUN
aesr-151	1	7	.	.	PROPN
aesr-151	2	1	4	4	NUM
aesr-151	2	2	,	,	PUNCT
aesr-151	2	3	no	no	INTJ
aesr-151	2	4	.	.	NOUN
aesr-151	2	5	1	1	NUM
aesr-151	2	6	,	,	PUNCT
aesr-151	2	7	24	24	NUM
aesr-151	2	8	-	-	SYM
aesr-151	2	9	29	29	NUM
aesr-151	2	10	,	,	PUNCT
aesr-151	2	11	2017	2017	NUM
aesr-151	2	12	issn(e	issn(e	NOUN
aesr-151	2	13	)	)	PUNCT
aesr-151	2	14	2411	2411	NUM
aesr-151	2	15	-	-	SYM
aesr-151	2	16	6653	6653	NUM
aesr-151	2	17	/	/	SYM
aesr-151	2	18	issn(p	issn(p	PROPN
aesr-151	2	19	)	)	PUNCT
aesr-151	2	20	2518	2518	NUM
aesr-151	2	21	-	-	SYM
aesr-151	2	22	0193	0193	NUM
aesr-151	2	23	doi	doi	NOUN
aesr-151	2	24	:	:	PUNCT
aesr-151	2	25	10.20448	10.20448	NUM
aesr-151	2	26	/	/	SYM
aesr-151	2	27	journal.512.2017.41.24.29	journal.512.2017.41.24.29	PROPN
aesr-151	2	28	24	24	NUM
aesr-151	2	29	assessment	assessment	NOUN
aesr-151	2	30	of	of	ADP
aesr-151	2	31	the	the	DET
aesr-151	2	32	secondary	secondary	ADJ
aesr-151	2	33	metabolite	metabolite	NOUN
aesr-151	2	34	patulin	patulin	ADJ
aesr-151	2	35	and	and	CCONJ
aesr-151	2	36	lycium	lycium	NOUN
aesr-151	2	37	barbarum	barbarum	NOUN
aesr-151	2	38	fruit	fruit	NOUN
aesr-151	2	39	on	on	ADP
aesr-151	2	40	ins-1	ins-1	NUM
aesr-151	2	41	rat	rat	NOUN
aesr-151	2	42	pancreatic	pancreatic	ADJ
aesr-151	2	43	β	β	NOUN
aesr-151	2	44	-	-	NOUN
aesr-151	2	45	cells	cell	NOUN
aesr-151	2	46	madeha	madeha	NOUN
aesr-151	2	47	n.al	n.al	PROPN
aesr-151	2	48	-	-	ADJ
aesr-151	2	49	seeni1	seeni1	PROPN
aesr-151	2	50	ahmed	ahmed	PROPN
aesr-151	2	51	m.ali2	m.ali2	PROPN
aesr-151	2	52	nagwa	nagwa	PROPN
aesr-151	2	53	m.	m.	PROPN
aesr-151	2	54	elsawi3	elsawi3	PROPN
aesr-151	3	1	asma	asma	PROPN
aesr-151	3	2	s.abdo4	s.abdo4	VERB
aesr-151	3	3			PROPN
aesr-151	3	4	(	(	PUNCT
aesr-151	3	5			PROPN
aesr-151	3	6	corresponding	correspond	VERB
aesr-151	3	7	author	author	NOUN
aesr-151	3	8	)	)	PUNCT
aesr-151	3	9	1biochemistry	1biochemistry	PROPN
aesr-151	3	10	department	department	NOUN
aesr-151	3	11	,	,	PUNCT
aesr-151	3	12	faculty	faculty	NOUN
aesr-151	3	13	of	of	ADP
aesr-151	3	14	science	science	NOUN
aesr-151	3	15	,	,	PUNCT
aesr-151	3	16	king	king	NOUN
aesr-151	3	17	abdel	abdel	PROPN
aesr-151	3	18	-	-	PUNCT
aesr-151	3	19	aziz	aziz	PROPN
aesr-151	3	20	university	university	PROPN
aesr-151	3	21	,	,	PUNCT
aesr-151	3	22	jaddah	jaddah	PROPN
aesr-151	3	23	,	,	PUNCT
aesr-151	3	24	saudi	saudi	PROPN
aesr-151	3	25	arabia	arabia	PROPN
aesr-151	3	26	.	.	PUNCT
aesr-151	4	1	2chemistry	2chemistry	NUM
aesr-151	4	2	department	department	NOUN
aesr-151	4	3	,	,	PUNCT
aesr-151	4	4	faculty	faculty	NOUN
aesr-151	4	5	of	of	ADP
aesr-151	4	6	science	science	NOUN
aesr-151	4	7	,	,	PUNCT
aesr-151	4	8	al	al	PROPN
aesr-151	4	9	–	–	PUNCT
aesr-151	4	10	azhar	azhar	PROPN
aesr-151	4	11	university	university	PROPN
aesr-151	4	12	,	,	PUNCT
aesr-151	4	13	assiut	assiut	NOUN
aesr-151	4	14	branch	branch	NOUN
aesr-151	4	15	,	,	PUNCT
aesr-151	4	16	egypt	egypt	PROPN
aesr-151	4	17	3,4chemistry	3,4chemistry	NUM
aesr-151	4	18	department	department	NOUN
aesr-151	4	19	,	,	PUNCT
aesr-151	4	20	faculty	faculty	NOUN
aesr-151	4	21	of	of	ADP
aesr-151	4	22	science	science	NOUN
aesr-151	4	23	,	,	PUNCT
aesr-151	4	24	sohag	sohag	NOUN
aesr-151	4	25	university	university	NOUN
aesr-151	4	26	,	,	PUNCT
aesr-151	4	27	sohag	sohag	NOUN
aesr-151	4	28	,	,	PUNCT
aesr-151	4	29	egypt	egypt	PROPN
aesr-151	4	30	abstract	abstract	PROPN
aesr-151	4	31	patulin	patulin	PROPN
aesr-151	4	32	has	have	AUX
aesr-151	4	33	been	be	AUX
aesr-151	4	34	shown	show	VERB
aesr-151	4	35	to	to	PART
aesr-151	4	36	have	have	VERB
aesr-151	4	37	diabetogenic	diabetogenic	ADJ
aesr-151	4	38	effects	effect	NOUN
aesr-151	4	39	in	in	ADP
aesr-151	4	40	mice	mouse	NOUN
aesr-151	4	41	.	.	PUNCT
aesr-151	5	1	the	the	DET
aesr-151	5	2	effects	effect	NOUN
aesr-151	5	3	on	on	ADP
aesr-151	5	4	pancreatic	pancreatic	ADJ
aesr-151	5	5	β	β	NOUN
aesr-151	5	6	-	-	NOUN
aesr-151	5	7	cell	cell	NOUN
aesr-151	5	8	viability	viability	NOUN
aesr-151	5	9	and	and	CCONJ
aesr-151	5	10	function	function	NOUN
aesr-151	5	11	of	of	ADP
aesr-151	5	12	secondary	secondary	ADJ
aesr-151	5	13	metabolite	metabolite	NOUN
aesr-151	5	14	patulin	patulin	NOUN
aesr-151	5	15	were	be	AUX
aesr-151	5	16	investigated	investigate	VERB
aesr-151	5	17	.	.	PUNCT
aesr-151	6	1	using	use	VERB
aesr-151	6	2	forty	forty	NUM
aesr-151	6	3	adult	adult	NOUN
aesr-151	6	4	albino	albino	NOUN
aesr-151	6	5	male	male	NOUN
aesr-151	6	6	rats	rat	NOUN
aesr-151	6	7	which	which	PRON
aesr-151	6	8	divided	divide	VERB
aesr-151	6	9	into	into	ADP
aesr-151	6	10	4	4	NUM
aesr-151	6	11	groups	group	NOUN
aesr-151	6	12	.	.	PUNCT
aesr-151	7	1	control	control	NOUN
aesr-151	7	2	group	group	PROPN
aesr-151	7	3	was	be	AUX
aesr-151	7	4	injected	inject	VERB
aesr-151	7	5	subcutaneously	subcutaneously	ADV
aesr-151	7	6	daily	daily	ADV
aesr-151	7	7	with	with	ADP
aesr-151	7	8	distilled	distil	VERB
aesr-151	7	9	water	water	NOUN
aesr-151	7	10	for	for	ADP
aesr-151	7	11	one	one	NUM
aesr-151	7	12	week	week	NOUN
aesr-151	7	13	;	;	PUNCT
aesr-151	7	14	group	group	NOUN
aesr-151	7	15	i	i	PRON
aesr-151	7	16	was	be	AUX
aesr-151	7	17	injected	inject	VERB
aesr-151	7	18	subcutaneously	subcutaneously	ADV
aesr-151	7	19	daily	daily	ADV
aesr-151	7	20	with	with	ADP
aesr-151	7	21	patulin	patulin	NOUN
aesr-151	7	22	(	(	PUNCT
aesr-151	7	23	0.2	0.2	NUM
aesr-151	7	24	mg	mg	PROPN
aesr-151	7	25	/	/	SYM
aesr-151	7	26	kg	kg	PROPN
aesr-151	7	27	/	/	SYM
aesr-151	7	28	day	day	NOUN
aesr-151	7	29	)	)	PUNCT
aesr-151	7	30	for	for	ADP
aesr-151	7	31	two	two	NUM
aesr-151	7	32	weeks	week	NOUN
aesr-151	7	33	.	.	PUNCT
aesr-151	8	1	group	group	PROPN
aesr-151	8	2	ii	ii	PROPN
aesr-151	8	3	was	be	AUX
aesr-151	8	4	injected	inject	VERB
aesr-151	8	5	with	with	ADP
aesr-151	8	6	the	the	DET
aesr-151	8	7	same	same	ADJ
aesr-151	8	8	toxin	toxin	NOUN
aesr-151	8	9	and	and	CCONJ
aesr-151	8	10	dose	dose	VERB
aesr-151	8	11	for	for	ADP
aesr-151	8	12	two	two	NUM
aesr-151	8	13	weeks	week	NOUN
aesr-151	8	14	after	after	SCONJ
aesr-151	8	15	that	that	SCONJ
aesr-151	8	16	they	they	PRON
aesr-151	8	17	were	be	AUX
aesr-151	8	18	treated	treat	VERB
aesr-151	8	19	by	by	ADP
aesr-151	8	20	goji	goji	NOUN
aesr-151	8	21	extract	extract	NOUN
aesr-151	8	22	(	(	PUNCT
aesr-151	8	23	2	2	NUM
aesr-151	8	24	ml	ml	NOUN
aesr-151	8	25	/	/	SYM
aesr-151	8	26	kg	kg	NOUN
aesr-151	8	27	/day	/day	PROPN
aesr-151	8	28	.	.	PUNCT
aesr-151	8	29	)	)	PUNCT
aesr-151	9	1	for	for	ADP
aesr-151	9	2	two	two	NUM
aesr-151	9	3	weeks	week	NOUN
aesr-151	9	4	.	.	PUNCT
aesr-151	10	1	group	group	PROPN
aesr-151	10	2	iii	iii	PROPN
aesr-151	10	3	was	be	AUX
aesr-151	10	4	treated	treat	VERB
aesr-151	10	5	by	by	ADP
aesr-151	10	6	goji	goji	NOUN
aesr-151	10	7	for	for	ADP
aesr-151	10	8	two	two	NUM
aesr-151	10	9	weeks	week	NOUN
aesr-151	10	10	after	after	SCONJ
aesr-151	10	11	that	that	SCONJ
aesr-151	10	12	they	they	PRON
aesr-151	10	13	were	be	AUX
aesr-151	10	14	injected	inject	VERB
aesr-151	10	15	with	with	ADP
aesr-151	10	16	patulin	patulin	NOUN
aesr-151	10	17	for	for	ADP
aesr-151	10	18	two	two	NUM
aesr-151	10	19	weeks	week	NOUN
aesr-151	10	20	.	.	PUNCT
aesr-151	11	1	some	some	DET
aesr-151	11	2	biochemical	biochemical	ADJ
aesr-151	11	3	parameters	parameter	NOUN
aesr-151	11	4	of	of	ADP
aesr-151	11	5	blood	blood	NOUN
aesr-151	11	6	samples	sample	NOUN
aesr-151	11	7	for	for	ADP
aesr-151	11	8	experimental	experimental	ADJ
aesr-151	11	9	rodents	rodent	NOUN
aesr-151	11	10	were	be	AUX
aesr-151	11	11	evaluated	evaluate	VERB
aesr-151	11	12	.	.	PUNCT
aesr-151	12	1	patulin	patulin	ADJ
aesr-151	12	2	group	group	NOUN
aesr-151	12	3	shows	show	VERB
aesr-151	12	4	significant	significant	ADJ
aesr-151	12	5	increase	increase	NOUN
aesr-151	12	6	in	in	ADP
aesr-151	12	7	amylase	amylase	NOUN
aesr-151	12	8	and	and	CCONJ
aesr-151	12	9	glucose	glucose	NOUN
aesr-151	12	10	levels	level	NOUN
aesr-151	12	11	.	.	PUNCT
aesr-151	13	1	but	but	CCONJ
aesr-151	13	2	level	level	NOUN
aesr-151	13	3	of	of	ADP
aesr-151	13	4	c	c	NOUN
aesr-151	13	5	-	-	PUNCT
aesr-151	13	6	peptide	peptide	NOUN
aesr-151	13	7	and	and	CCONJ
aesr-151	13	8	insulin	insulin	NOUN
aesr-151	13	9	decreased	decrease	VERB
aesr-151	13	10	significantly	significantly	ADV
aesr-151	13	11	in	in	ADP
aesr-151	13	12	this	this	DET
aesr-151	13	13	group	group	NOUN
aesr-151	13	14	.	.	PUNCT
aesr-151	14	1	however	however	ADV
aesr-151	14	2	,	,	PUNCT
aesr-151	14	3	there	there	PRON
aesr-151	14	4	is	be	VERB
aesr-151	14	5	no	no	DET
aesr-151	14	6	significant	significant	ADJ
aesr-151	14	7	alteration	alteration	NOUN
aesr-151	14	8	in	in	ADP
aesr-151	14	9	lipase	lipase	NOUN
aesr-151	14	10	level	level	NOUN
aesr-151	14	11	between	between	ADP
aesr-151	14	12	patulin	patulin	ADJ
aesr-151	14	13	group	group	NOUN
aesr-151	14	14	and	and	CCONJ
aesr-151	14	15	control	control	NOUN
aesr-151	14	16	.	.	PUNCT
aesr-151	15	1	groups	group	NOUN
aesr-151	15	2	treated	treat	VERB
aesr-151	15	3	with	with	ADP
aesr-151	15	4	goji	goji	NOUN
aesr-151	15	5	extract	extract	NOUN
aesr-151	15	6	in	in	ADP
aesr-151	15	7	groups	group	NOUN
aesr-151	15	8	two	two	NUM
aesr-151	15	9	and	and	CCONJ
aesr-151	15	10	three	three	NUM
aesr-151	15	11	(	(	PUNCT
aesr-151	15	12	therapeutic	therapeutic	ADJ
aesr-151	15	13	and	and	CCONJ
aesr-151	15	14	prophylactic	prophylactic	ADJ
aesr-151	15	15	)	)	PUNCT
aesr-151	15	16	illustrated	illustrate	VERB
aesr-151	15	17	non	non	PRON
aesr-151	15	18	significant	significant	ADJ
aesr-151	15	19	alteration	alteration	NOUN
aesr-151	15	20	in	in	ADP
aesr-151	15	21	biochemical	biochemical	ADJ
aesr-151	15	22	parameters	parameter	NOUN
aesr-151	15	23	compared	compare	VERB
aesr-151	15	24	to	to	ADP
aesr-151	15	25	control	control	NOUN
aesr-151	15	26	.	.	PUNCT
aesr-151	16	1	keywords	keyword	NOUN
aesr-151	16	2	:	:	PUNCT
aesr-151	16	3	patulin	patulin	ADJ
aesr-151	16	4	,	,	PUNCT
aesr-151	16	5	pancreas	pancrea	NOUN
aesr-151	16	6	,	,	PUNCT
aesr-151	16	7	goji	goji	NOUN
aesr-151	16	8	extract	extract	NOUN
aesr-151	16	9	,	,	PUNCT
aesr-151	16	10	insulin	insulin	NOUN
aesr-151	16	11	.	.	PUNCT
aesr-151	17	1	citation	citation	NOUN
aesr-151	18	1	|	|	ADV
aesr-151	18	2	madeha	madeha	PROPN
aesr-151	18	3	n.al	n.al	PROPN
aesr-151	18	4	-	-	NOUN
aesr-151	18	5	seeni	seeni	NOUN
aesr-151	18	6	;	;	PUNCT
aesr-151	18	7	ahmed	ahmed	PROPN
aesr-151	18	8	m.ali	m.ali	PROPN
aesr-151	18	9	;	;	PUNCT
aesr-151	18	10	nagwa	nagwa	NOUN
aesr-151	18	11	m.	m.	NOUN
aesr-151	18	12	elsawi	elsawi	PROPN
aesr-151	18	13	;	;	PUNCT
aesr-151	18	14	asma	asma	PROPN
aesr-151	18	15	s.abdo	s.abdo	ADV
aesr-151	18	16	(	(	PUNCT
aesr-151	18	17	2017	2017	NUM
aesr-151	18	18	)	)	PUNCT
aesr-151	18	19	.	.	PUNCT
aesr-151	19	1	assessment	assessment	NOUN
aesr-151	19	2	of	of	ADP
aesr-151	19	3	the	the	DET
aesr-151	19	4	secondary	secondary	ADJ
aesr-151	19	5	metabolite	metabolite	NOUN
aesr-151	19	6	patulin	patulin	ADJ
aesr-151	19	7	and	and	CCONJ
aesr-151	19	8	lycium	lycium	NOUN
aesr-151	19	9	barbarum	barbarum	NOUN
aesr-151	19	10	fruit	fruit	NOUN
aesr-151	19	11	on	on	ADP
aesr-151	19	12	ins-1	ins-1	NUM
aesr-151	19	13	rat	rat	NOUN
aesr-151	19	14	pancreatic	pancreatic	ADJ
aesr-151	19	15	βcells	βcell	NOUN
aesr-151	19	16	.	.	PUNCT
aesr-151	20	1	agriculture	agriculture	NOUN
aesr-151	20	2	and	and	CCONJ
aesr-151	20	3	food	food	NOUN
aesr-151	20	4	sciences	sciences	PROPN
aesr-151	20	5	research	research	NOUN
aesr-151	20	6	,	,	PUNCT
aesr-151	20	7	4(1	4(1	NOUN
aesr-151	20	8	):	):	PUNCT
aesr-151	20	9	24	24	NUM
aesr-151	20	10	-	-	SYM
aesr-151	20	11	29	29	NUM
aesr-151	20	12	.	.	PUNCT
aesr-151	21	1	history	history	NOUN
aesr-151	21	2	:	:	PUNCT
aesr-151	21	3	received	receive	VERB
aesr-151	21	4	:	:	PUNCT
aesr-151	21	5	4	4	NUM
aesr-151	21	6	april	april	PROPN
aesr-151	21	7	2017	2017	NUM
aesr-151	21	8	revised	revise	VERB
aesr-151	21	9	:	:	PUNCT
aesr-151	21	10	3	3	NUM
aesr-151	21	11	july	july	PROPN
aesr-151	21	12	2017	2017	NUM
aesr-151	21	13	accepted	accept	VERB
aesr-151	21	14	:	:	PUNCT
aesr-151	21	15	6	6	NUM
aesr-151	21	16	july	july	PROPN
aesr-151	21	17	2017	2017	NUM
aesr-151	21	18	published	publish	VERB
aesr-151	21	19	:	:	PUNCT
aesr-151	21	20	11	11	NUM
aesr-151	21	21	october	october	PROPN
aesr-151	21	22	2017	2017	NUM
aesr-151	21	23	licensed	license	VERB
aesr-151	21	24	:	:	PUNCT
aesr-151	21	25	this	this	DET
aesr-151	21	26	work	work	NOUN
aesr-151	21	27	is	be	AUX
aesr-151	21	28	licensed	license	VERB
aesr-151	21	29	under	under	ADP
aesr-151	21	30	a	a	DET
aesr-151	21	31	creative	creative	ADJ
aesr-151	21	32	commons	common	NOUN
aesr-151	21	33	attribution	attribution	NOUN
aesr-151	21	34	3.0	3.0	NUM
aesr-151	21	35	license	license	NOUN
aesr-151	21	36	publisher	publisher	NOUN
aesr-151	21	37	:	:	PUNCT
aesr-151	21	38	asian	asian	ADJ
aesr-151	21	39	online	online	PROPN
aesr-151	21	40	journal	journal	PROPN
aesr-151	21	41	publishing	publishing	NOUN
aesr-151	21	42	group	group	NOUN
aesr-151	21	43	contribution	contribution	NOUN
aesr-151	21	44	/	/	SYM
aesr-151	21	45	acknowledgement	acknowledgement	NOUN
aesr-151	21	46	:	:	PUNCT
aesr-151	21	47	all	all	DET
aesr-151	21	48	authors	author	NOUN
aesr-151	21	49	contributed	contribute	VERB
aesr-151	21	50	to	to	ADP
aesr-151	21	51	the	the	DET
aesr-151	21	52	conception	conception	NOUN
aesr-151	21	53	and	and	CCONJ
aesr-151	21	54	design	design	NOUN
aesr-151	21	55	of	of	ADP
aesr-151	21	56	the	the	DET
aesr-151	21	57	study	study	NOUN
aesr-151	21	58	.	.	PUNCT
aesr-151	22	1	funding	funding	NOUN
aesr-151	22	2	:	:	PUNCT
aesr-151	22	3	this	this	DET
aesr-151	22	4	study	study	NOUN
aesr-151	22	5	received	receive	VERB
aesr-151	22	6	no	no	DET
aesr-151	22	7	specific	specific	ADJ
aesr-151	22	8	financial	financial	ADJ
aesr-151	22	9	support	support	NOUN
aesr-151	22	10	.	.	PUNCT
aesr-151	23	1	competing	compete	VERB
aesr-151	23	2	interests	interest	NOUN
aesr-151	23	3	:	:	PUNCT
aesr-151	23	4	the	the	DET
aesr-151	23	5	authors	author	NOUN
aesr-151	23	6	declare	declare	VERB
aesr-151	23	7	that	that	SCONJ
aesr-151	23	8	they	they	PRON
aesr-151	23	9	have	have	VERB
aesr-151	23	10	no	no	DET
aesr-151	23	11	conflict	conflict	NOUN
aesr-151	23	12	of	of	ADP
aesr-151	23	13	interests	interest	NOUN
aesr-151	23	14	.	.	PUNCT
aesr-151	24	1	transparency	transparency	NOUN
aesr-151	24	2	:	:	PUNCT
aesr-151	24	3	the	the	DET
aesr-151	24	4	authors	author	NOUN
aesr-151	24	5	confirm	confirm	VERB
aesr-151	24	6	that	that	SCONJ
aesr-151	24	7	the	the	DET
aesr-151	24	8	manuscript	manuscript	NOUN
aesr-151	24	9	is	be	AUX
aesr-151	24	10	an	an	DET
aesr-151	24	11	honest	honest	ADJ
aesr-151	24	12	,	,	PUNCT
aesr-151	24	13	accurate	accurate	ADJ
aesr-151	24	14	,	,	PUNCT
aesr-151	24	15	and	and	CCONJ
aesr-151	24	16	transparent	transparent	ADJ
aesr-151	24	17	account	account	NOUN
aesr-151	24	18	of	of	ADP
aesr-151	24	19	the	the	DET
aesr-151	24	20	study	study	NOUN
aesr-151	24	21	was	be	AUX
aesr-151	24	22	reported	report	VERB
aesr-151	24	23	;	;	PUNCT
aesr-151	24	24	that	that	SCONJ
aesr-151	24	25	no	no	DET
aesr-151	24	26	vital	vital	ADJ
aesr-151	24	27	features	feature	NOUN
aesr-151	24	28	of	of	ADP
aesr-151	24	29	the	the	DET
aesr-151	24	30	study	study	NOUN
aesr-151	24	31	have	have	AUX
aesr-151	24	32	been	be	AUX
aesr-151	24	33	omitted	omit	VERB
aesr-151	24	34	;	;	PUNCT
aesr-151	24	35	and	and	CCONJ
aesr-151	24	36	that	that	SCONJ
aesr-151	24	37	any	any	DET
aesr-151	24	38	discrepancies	discrepancy	NOUN
aesr-151	24	39	from	from	ADP
aesr-151	24	40	the	the	DET
aesr-151	24	41	study	study	NOUN
aesr-151	24	42	as	as	SCONJ
aesr-151	24	43	planned	plan	VERB
aesr-151	24	44	have	have	AUX
aesr-151	24	45	been	be	AUX
aesr-151	24	46	explained	explain	VERB
aesr-151	24	47	.	.	PUNCT
aesr-151	25	1	ethical	ethical	ADJ
aesr-151	25	2	:	:	PUNCT
aesr-151	25	3	this	this	DET
aesr-151	25	4	study	study	NOUN
aesr-151	25	5	follows	follow	VERB
aesr-151	25	6	all	all	DET
aesr-151	25	7	ethical	ethical	ADJ
aesr-151	25	8	practices	practice	NOUN
aesr-151	25	9	during	during	ADP
aesr-151	25	10	writing	writing	NOUN
aesr-151	25	11	.	.	PUNCT
aesr-151	26	1	contents	content	NOUN
aesr-151	26	2	1	1	NUM
aesr-151	26	3	.	.	PUNCT
aesr-151	27	1	introduction	introduction	NOUN
aesr-151	27	2	......................................................................................................................................................................................	......................................................................................................................................................................................	PUNCT
aesr-151	28	1	25	25	NUM
aesr-151	28	2	2	2	NUM
aesr-151	28	3	.	.	PUNCT
aesr-151	28	4	materials	material	NOUN
aesr-151	28	5	and	and	CCONJ
aesr-151	28	6	methods	method	NOUN
aesr-151	28	7	...................................................................................................................................................................	...................................................................................................................................................................	PUNCT
aesr-151	29	1	25	25	NUM
aesr-151	29	2	3	3	NUM
aesr-151	29	3	.	.	PUNCT
aesr-151	29	4	results	result	NOUN
aesr-151	29	5	................................................................................................................................................................................................	................................................................................................................................................................................................	VERB
aesr-151	29	6	26	26	NUM
aesr-151	29	7	4	4	NUM
aesr-151	29	8	.	.	PUNCT
aesr-151	30	1	discussion	discussion	NOUN
aesr-151	30	2	..........................................................................................................................................................................................	..........................................................................................................................................................................................	PUNCT
aesr-151	31	1	27	27	NUM
aesr-151	31	2	references	reference	NOUN
aesr-151	31	3	..............................................................................................................................................................................................	..............................................................................................................................................................................................	PROPN
aesr-151	32	1	28	28	NUM
aesr-151	32	2	http://crossmark.crossref.org/dialog/?doi=10.20448/journal.512.2017.41.24.29&domain=pdf&date_stamp=2017-01-14	http://crossmark.crossref.org/dialog/?doi=10.20448/journal.512.2017.41.24.29&domain=pdf&date_stamp=2017-01-14	NOUN
aesr-151	32	3	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
aesr-151	32	4	http://creativecommons.org/licenses/by/3.0/	http://creativecommons.org/licenses/by/3.0/	PROPN
aesr-151	32	5	https://orcid.org/orcid-search/quick-search?searchquery=madeha%20n.al-seeni	https://orcid.org/orcid-search/quick-search?searchquery=madeha%20n.al-seeni	PROPN
aesr-151	32	6	https://orcid.org/orcid-search/quick-search?searchquery=ahmed%20m.ali	https://orcid.org/orcid-search/quick-search?searchquery=ahmed%20m.ali	VERB
aesr-151	32	7	https://orcid.org/orcid-search/quick-search?searchquery=nagwa%20m.%20elsawi	https://orcid.org/orcid-search/quick-search?searchquery=nagwa%20m.%20elsawi	PROPN
aesr-151	32	8	https://orcid.org/orcid-search/quick-search?searchquery=asma%20s.abdo	https://orcid.org/orcid-search/quick-search?searchquery=asma%20s.abdo	NOUN
aesr-151	32	9	agriculture	agriculture	NOUN
aesr-151	32	10	and	and	CCONJ
aesr-151	32	11	food	food	NOUN
aesr-151	32	12	sciences	sciences	PROPN
aesr-151	32	13	research	research	NOUN
aesr-151	32	14	,	,	PUNCT
aesr-151	32	15	2017	2017	NUM
aesr-151	32	16	,	,	PUNCT
aesr-151	32	17	4(1	4(1	NOUN
aesr-151	32	18	):	):	PUNCT
aesr-151	32	19	24	24	NUM
aesr-151	32	20	-	-	SYM
aesr-151	32	21	29	29	NUM
aesr-151	32	22	25	25	NUM
aesr-151	32	23	1	1	NUM
aesr-151	32	24	.	.	PUNCT
aesr-151	33	1	introduction	introduction	NOUN
aesr-151	33	2	mycotoxins	mycotoxin	NOUN
aesr-151	33	3	are	be	AUX
aesr-151	33	4	reported	report	VERB
aesr-151	33	5	to	to	PART
aesr-151	33	6	be	be	AUX
aesr-151	33	7	important	important	ADJ
aesr-151	33	8	for	for	ADP
aesr-151	33	9	infection	infection	NOUN
aesr-151	33	10	and	and	CCONJ
aesr-151	33	11	possibly	possibly	ADV
aesr-151	33	12	growth	growth	VERB
aesr-151	33	13	under	under	ADP
aesr-151	33	14	natural	natural	ADJ
aesr-151	33	15	environmental	environmental	ADJ
aesr-151	33	16	conditions	condition	NOUN
aesr-151	33	17	.	.	PUNCT
aesr-151	34	1	a	a	DET
aesr-151	34	2	known	know	VERB
aesr-151	34	3	example	example	NOUN
aesr-151	34	4	of	of	ADP
aesr-151	34	5	mycotoxins	mycotoxin	NOUN
aesr-151	34	6	is	be	AUX
aesr-151	34	7	patulin	patulin	ADJ
aesr-151	34	8	[	[	X
aesr-151	34	9	1	1	NUM
aesr-151	34	10	]	]	PUNCT
aesr-151	34	11	.	.	PUNCT
aesr-151	35	1	patulin	patulin	PROPN
aesr-151	35	2	has	have	AUX
aesr-151	35	3	been	be	AUX
aesr-151	35	4	used	use	VERB
aesr-151	35	5	as	as	ADP
aesr-151	35	6	a	a	DET
aesr-151	35	7	model	model	NOUN
aesr-151	35	8	for	for	ADP
aesr-151	35	9	exposure	exposure	NOUN
aesr-151	35	10	to	to	ADP
aesr-151	35	11	secondary	secondary	ADJ
aesr-151	35	12	metabolites	metabolite	NOUN
aesr-151	35	13	via	via	ADP
aesr-151	35	14	contaminated	contaminate	VERB
aesr-151	35	15	food	food	NOUN
aesr-151	35	16	;	;	PUNCT
aesr-151	35	17	it	it	PRON
aesr-151	35	18	is	be	AUX
aesr-151	35	19	produced	produce	VERB
aesr-151	35	20	by	by	ADP
aesr-151	35	21	fungi	fungus	NOUN
aesr-151	35	22	,	,	PUNCT
aesr-151	35	23	in	in	ADP
aesr-151	35	24	particular	particular	ADJ
aesr-151	35	25	penicillium	penicillium	NOUN
aesr-151	35	26	and	and	CCONJ
aesr-151	35	27	aspergillus	aspergillus	NOUN
aesr-151	35	28	,	,	PUNCT
aesr-151	35	29	which	which	PRON
aesr-151	35	30	may	may	AUX
aesr-151	35	31	contaminate	contaminate	VERB
aesr-151	35	32	food	food	NOUN
aesr-151	35	33	products	product	NOUN
aesr-151	35	34	like	like	ADP
aesr-151	35	35	apples	apple	NOUN
aesr-151	35	36	and	and	CCONJ
aesr-151	35	37	apple	apple	NOUN
aesr-151	35	38	juice	juice	NOUN
aesr-151	35	39	.	.	PUNCT
aesr-151	36	1	the	the	DET
aesr-151	36	2	effects	effect	NOUN
aesr-151	36	3	of	of	ADP
aesr-151	36	4	patulin	patulin	NOUN
aesr-151	36	5	have	have	AUX
aesr-151	36	6	been	be	AUX
aesr-151	36	7	studied	study	VERB
aesr-151	36	8	extensively	extensively	ADV
aesr-151	36	9	,	,	PUNCT
aesr-151	36	10	where	where	SCONJ
aesr-151	36	11	it	it	PRON
aesr-151	36	12	has	have	AUX
aesr-151	36	13	been	be	AUX
aesr-151	36	14	shown	show	VERB
aesr-151	36	15	to	to	PART
aesr-151	36	16	be	be	AUX
aesr-151	36	17	both	both	CCONJ
aesr-151	36	18	genotoxic	genotoxic	ADJ
aesr-151	36	19	and	and	CCONJ
aesr-151	36	20	neurotoxic	neurotoxic	ADJ
aesr-151	36	21	through	through	ADP
aesr-151	36	22	its	its	PRON
aesr-151	36	23	covalent	covalent	NOUN
aesr-151	36	24	binding	bind	VERB
aesr-151	36	25	to	to	ADP
aesr-151	36	26	essential	essential	ADJ
aesr-151	36	27	sulphydryl	sulphydryl	NOUN
aesr-151	36	28	groups	group	NOUN
aesr-151	36	29	in	in	ADP
aesr-151	36	30	proteins	protein	NOUN
aesr-151	36	31	and	and	CCONJ
aesr-151	36	32	peptides	peptide	NOUN
aesr-151	36	33	.	.	PUNCT
aesr-151	37	1	this	this	DET
aesr-151	37	2	toxicity	toxicity	NOUN
aesr-151	37	3	of	of	ADP
aesr-151	37	4	patulin	patulin	NOUN
aesr-151	37	5	has	have	AUX
aesr-151	37	6	already	already	ADV
aesr-151	37	7	been	be	AUX
aesr-151	37	8	demonstrated	demonstrate	VERB
aesr-151	37	9	against	against	ADP
aesr-151	37	10	various	various	ADJ
aesr-151	37	11	mammalian	mammalian	ADJ
aesr-151	37	12	cells	cell	NOUN
aesr-151	37	13	and	and	CCONJ
aesr-151	37	14	has	have	AUX
aesr-151	37	15	been	be	AUX
aesr-151	37	16	attributed	attribute	VERB
aesr-151	37	17	to	to	ADP
aesr-151	37	18	its	its	PRON
aesr-151	37	19	ability	ability	NOUN
aesr-151	37	20	to	to	PART
aesr-151	37	21	inhibit	inhibit	VERB
aesr-151	37	22	rna	rna	NOUN
aesr-151	37	23	and	and	CCONJ
aesr-151	37	24	protein	protein	NOUN
aesr-151	37	25	synthesis	synthesis	NOUN
aesr-151	37	26	.	.	PUNCT
aesr-151	38	1	it	it	PRON
aesr-151	38	2	is	be	AUX
aesr-151	38	3	also	also	ADV
aesr-151	38	4	interfere	interfere	ADJ
aesr-151	38	5	with	with	ADP
aesr-151	38	6	the	the	DET
aesr-151	38	7	activity	activity	NOUN
aesr-151	38	8	of	of	ADP
aesr-151	38	9	many	many	ADJ
aesr-151	38	10	enzymes	enzyme	NOUN
aesr-151	38	11	such	such	ADJ
aesr-151	38	12	as	as	ADP
aesr-151	38	13	glycogen	glycogen	NOUN
aesr-151	38	14	phosphorylase	phosphorylase	NOUN
aesr-151	38	15	,	,	PUNCT
aesr-151	38	16	glucose6	glucose6	NOUN
aesr-151	38	17	-	-	PUNCT
aesr-151	38	18	phosphatase	phosphatase	NOUN
aesr-151	38	19	,	,	PUNCT
aesr-151	38	20	hexokinase	hexokinase	NOUN
aesr-151	38	21	and	and	CCONJ
aesr-151	38	22	aldolase	aldolase	NOUN
aesr-151	38	23	that	that	PRON
aesr-151	38	24	are	be	AUX
aesr-151	38	25	considered	consider	VERB
aesr-151	38	26	crucial	crucial	ADJ
aesr-151	38	27	for	for	ADP
aesr-151	38	28	cell	cell	NOUN
aesr-151	38	29	survival	survival	NOUN
aesr-151	38	30	[	[	X
aesr-151	38	31	2	2	NUM
aesr-151	38	32	]	]	PUNCT
aesr-151	38	33	.	.	PUNCT
aesr-151	39	1	o	o	X
aesr-151	40	1	oh	oh	INTJ
aesr-151	40	2	o	o	X
aesr-151	40	3	o	o	NOUN
aesr-151	40	4	fig-1	fig-1	NOUN
aesr-151	40	5	.	.	PUNCT
aesr-151	41	1	chemical	chemical	ADJ
aesr-151	41	2	structure	structure	NOUN
aesr-151	41	3	of	of	ADP
aesr-151	41	4	patulin(pat	patulin(pat	NOUN
aesr-151	41	5	)	)	PUNCT
aesr-151	42	1	[	[	X
aesr-151	42	2	ref	ref	X
aesr-151	42	3	]	]	PUNCT
aesr-151	42	4	lycium	lycium	NOUN
aesr-151	42	5	barbarum	barbarum	PROPN
aesr-151	42	6	fruit	fruit	NOUN
aesr-151	42	7	,	,	PUNCT
aesr-151	42	8	generally	generally	ADV
aesr-151	42	9	called	call	VERB
aesr-151	42	10	goji	goji	NOUN
aesr-151	42	11	berry	berry	NOUN
aesr-151	42	12	or	or	CCONJ
aesr-151	42	13	wolfberry	wolfberry	VERB
aesr-151	42	14	,	,	PUNCT
aesr-151	42	15	is	be	AUX
aesr-151	42	16	a	a	DET
aesr-151	42	17	well	well	ADV
aesr-151	42	18	-	-	PUNCT
aesr-151	42	19	known	know	VERB
aesr-151	42	20	traditional	traditional	ADJ
aesr-151	42	21	chinese	chinese	ADJ
aesr-151	42	22	medicine	medicine	NOUN
aesr-151	42	23	.	.	PUNCT
aesr-151	43	1	goji	goji	PROPN
aesr-151	43	2	berry	berry	NOUN
aesr-151	43	3	has	have	AUX
aesr-151	43	4	shown	show	VERB
aesr-151	43	5	a	a	DET
aesr-151	43	6	wide	wide	ADJ
aesr-151	43	7	range	range	NOUN
aesr-151	43	8	of	of	ADP
aesr-151	43	9	health	health	NOUN
aesr-151	43	10	benefits	benefit	NOUN
aesr-151	43	11	such	such	ADJ
aesr-151	43	12	as	as	ADP
aesr-151	43	13	the	the	DET
aesr-151	43	14	functions	function	NOUN
aesr-151	43	15	and	and	CCONJ
aesr-151	43	16	activities	activity	NOUN
aesr-151	43	17	associated	associate	VERB
aesr-151	43	18	with	with	ADP
aesr-151	43	19	the	the	DET
aesr-151	43	20	liver	liver	NOUN
aesr-151	43	21	,	,	PUNCT
aesr-151	43	22	kidney	kidney	NOUN
aesr-151	43	23	,	,	PUNCT
aesr-151	43	24	eyesight	eyesight	ADJ
aesr-151	43	25	,	,	PUNCT
aesr-151	43	26	sex	sex	NOUN
aesr-151	43	27	,	,	PUNCT
aesr-151	43	28	immune	immune	ADJ
aesr-151	43	29	system	system	NOUN
aesr-151	43	30	,	,	PUNCT
aesr-151	43	31	and	and	CCONJ
aesr-151	43	32	longevity	longevity	NOUN
aesr-151	43	33	[	[	X
aesr-151	43	34	3	3	NUM
aesr-151	43	35	]	]	PUNCT
aesr-151	43	36	.	.	PUNCT
aesr-151	44	1	also	also	ADV
aesr-151	44	2	,	,	PUNCT
aesr-151	44	3	it	it	PRON
aesr-151	44	4	improves	improve	VERB
aesr-151	44	5	the	the	DET
aesr-151	44	6	insulin	insulin	NOUN
aesr-151	44	7	resistance	resistance	NOUN
aesr-151	44	8	of	of	ADP
aesr-151	44	9	the	the	DET
aesr-151	44	10	cells	cell	NOUN
aesr-151	44	11	and	and	CCONJ
aesr-151	44	12	prevents	prevent	VERB
aesr-151	44	13	damage	damage	NOUN
aesr-151	44	14	from	from	ADP
aesr-151	44	15	diabetes	diabetes	NOUN
aesr-151	44	16	[	[	X
aesr-151	44	17	4	4	NUM
aesr-151	44	18	]	]	PUNCT
aesr-151	44	19	.	.	PUNCT
aesr-151	45	1	in	in	ADP
aesr-151	45	2	addition	addition	NOUN
aesr-151	45	3	,	,	PUNCT
aesr-151	45	4	lycium	lycium	NOUN
aesr-151	45	5	barbarum	barbarum	NOUN
aesr-151	45	6	may	may	AUX
aesr-151	45	7	help	help	VERB
aesr-151	45	8	in	in	ADP
aesr-151	45	9	lowering	lower	VERB
aesr-151	45	10	glucose	glucose	NOUN
aesr-151	45	11	level	level	NOUN
aesr-151	45	12	in	in	ADP
aesr-151	45	13	diabetic	diabetic	ADJ
aesr-151	45	14	person	person	NOUN
aesr-151	45	15	.	.	PUNCT
aesr-151	46	1	in	in	ADP
aesr-151	46	2	vitro	vitro	X
aesr-151	46	3	hypoglycaemic	hypoglycaemic	ADJ
aesr-151	46	4	effect	effect	NOUN
aesr-151	46	5	assay	assay	NOUN
aesr-151	46	6	indicated	indicate	VERB
aesr-151	46	7	that	that	SCONJ
aesr-151	46	8	lbp	lbp	PROPN
aesr-151	46	9	may	may	AUX
aesr-151	46	10	decrease	decrease	VERB
aesr-151	46	11	high	high	ADJ
aesr-151	46	12	glucose	glucose	NOUN
aesr-151	46	13	level	level	NOUN
aesr-151	46	14	by	by	ADP
aesr-151	46	15	protecting	protect	VERB
aesr-151	46	16	pancreatic	pancreatic	ADJ
aesr-151	46	17	β	β	NOUN
aesr-151	46	18	-	-	NOUN
aesr-151	46	19	cells	cell	NOUN
aesr-151	46	20	from	from	ADP
aesr-151	46	21	oxidative	oxidative	ADJ
aesr-151	46	22	damages	damage	NOUN
aesr-151	46	23	and	and	CCONJ
aesr-151	46	24	alleviating	alleviate	VERB
aesr-151	46	25	the	the	DET
aesr-151	46	26	insulin	insulin	NOUN
aesr-151	46	27	resistance	resistance	NOUN
aesr-151	46	28	in	in	ADP
aesr-151	46	29	liver	liver	NOUN
aesr-151	46	30	cells	cell	NOUN
aesr-151	46	31	.	.	PUNCT
aesr-151	47	1	hypoglycaemic	hypoglycaemic	ADJ
aesr-151	47	2	activity	activity	NOUN
aesr-151	47	3	of	of	ADP
aesr-151	47	4	lycium	lycium	NOUN
aesr-151	47	5	barbarum	barbarum	PROPN
aesr-151	47	6	fruit	fruit	NOUN
aesr-151	47	7	may	may	AUX
aesr-151	47	8	be	be	AUX
aesr-151	47	9	correlative	correlative	ADJ
aesr-151	47	10	with	with	ADP
aesr-151	47	11	polysaccharides	polysaccharide	NOUN
aesr-151	47	12	,	,	PUNCT
aesr-151	47	13	a	a	DET
aesr-151	47	14	mainly	mainly	ADV
aesr-151	47	15	functional	functional	ADJ
aesr-151	47	16	composition	composition	NOUN
aesr-151	47	17	,	,	PUNCT
aesr-151	47	18	considered	consider	VERB
aesr-151	47	19	as	as	ADP
aesr-151	47	20	potential	potential	ADJ
aesr-151	47	21	candidate	candidate	NOUN
aesr-151	47	22	for	for	ADP
aesr-151	47	23	developing	develop	VERB
aesr-151	47	24	a	a	DET
aesr-151	47	25	new	new	ADJ
aesr-151	47	26	beneficial	beneficial	ADJ
aesr-151	47	27	food	food	NOUN
aesr-151	47	28	or	or	CCONJ
aesr-151	47	29	new	new	ADJ
aesr-151	47	30	anti	anti	ADJ
aesr-151	47	31	-	-	ADJ
aesr-151	47	32	diabetic	diabetic	ADJ
aesr-151	47	33	agent	agent	NOUN
aesr-151	47	34	[	[	X
aesr-151	47	35	5	5	NUM
aesr-151	47	36	]	]	PUNCT
aesr-151	47	37	.	.	PUNCT
aesr-151	48	1	it	it	PRON
aesr-151	48	2	has	have	AUX
aesr-151	48	3	long	long	ADV
aesr-151	48	4	been	be	AUX
aesr-151	48	5	used	use	VERB
aesr-151	48	6	to	to	PART
aesr-151	48	7	treat	treat	VERB
aesr-151	48	8	diabetes	diabetes	NOUN
aesr-151	48	9	mellitus	mellitus	NOUN
aesr-151	48	10	and	and	CCONJ
aesr-151	48	11	related	related	ADJ
aesr-151	48	12	hyperlipidemia	hyperlipidemia	NOUN
aesr-151	48	13	[	[	X
aesr-151	48	14	6	6	NUM
aesr-151	48	15	]	]	PUNCT
aesr-151	48	16	.	.	PUNCT
aesr-151	49	1	fig-2	fig-2	VERB
aesr-151	49	2	.	.	PUNCT
aesr-151	50	1	lyciumbarbarum	lyciumbarbarum	PROPN
aesr-151	50	2	(	(	PUNCT
aesr-151	50	3	goji	goji	NOUN
aesr-151	50	4	berry	berry	NOUN
aesr-151	50	5	)	)	PUNCT
aesr-151	51	1	[	[	X
aesr-151	51	2	7	7	X
aesr-151	51	3	]	]	PUNCT
aesr-151	51	4	in	in	ADP
aesr-151	51	5	this	this	DET
aesr-151	51	6	study	study	NOUN
aesr-151	51	7	,	,	PUNCT
aesr-151	51	8	the	the	DET
aesr-151	51	9	biochemical	biochemical	ADJ
aesr-151	51	10	profile	profile	NOUN
aesr-151	51	11	of	of	ADP
aesr-151	51	12	fungal	fungal	ADJ
aesr-151	51	13	secondary	secondary	ADJ
aesr-151	51	14	metabolite	metabolite	NOUN
aesr-151	51	15	,	,	PUNCT
aesr-151	51	16	patulin	patulin	ADJ
aesr-151	51	17	,	,	PUNCT
aesr-151	51	18	on	on	ADP
aesr-151	51	19	the	the	PRON
aesr-151	51	20	ins-1	ins-1	X
aesr-151	51	21	rat	rat	NOUN
aesr-151	51	22	β	β	NOUN
aesr-151	51	23	-	-	NOUN
aesr-151	51	24	cell	cell	NOUN
aesr-151	51	25	was	be	AUX
aesr-151	51	26	examined	examine	VERB
aesr-151	51	27	,	,	PUNCT
aesr-151	51	28	in	in	ADP
aesr-151	51	29	order	order	NOUN
aesr-151	51	30	to	to	PART
aesr-151	51	31	evaluate	evaluate	VERB
aesr-151	51	32	the	the	DET
aesr-151	51	33	possible	possible	ADJ
aesr-151	51	34	role	role	NOUN
aesr-151	51	35	of	of	ADP
aesr-151	51	36	goji	goji	NOUN
aesr-151	51	37	extract	extract	NOUN
aesr-151	51	38	in	in	ADP
aesr-151	51	39	reversing	reverse	VERB
aesr-151	51	40	patulin	patulin	ADJ
aesr-151	51	41	toxicity	toxicity	NOUN
aesr-151	51	42	.	.	PUNCT
aesr-151	52	1	2	2	X
aesr-151	52	2	.	.	X
aesr-151	52	3	materials	material	NOUN
aesr-151	52	4	and	and	CCONJ
aesr-151	52	5	methods	method	NOUN
aesr-151	52	6	2.1	2.1	NUM
aesr-151	52	7	.	.	PUNCT
aesr-151	53	1	chemicals	chemical	NOUN
aesr-151	53	2	patulin	patulin	NOUN
aesr-151	53	3	(	(	PUNCT
aesr-151	53	4	4	4	NUM
aesr-151	53	5	-	-	NUM
aesr-151	53	6	hydroxy-4h	hydroxy-4h	NOUN
aesr-151	53	7	-	-	PUNCT
aesr-151	53	8	furo[3	furo[3	PROPN
aesr-151	53	9	,	,	PUNCT
aesr-151	53	10	2	2	NUM
aesr-151	53	11	-	-	SYM
aesr-151	53	12	c]pyran-2	c]pyran-2	PUNCT
aesr-151	53	13	(	(	PUNCT
aesr-151	53	14	6h)one	6h)one	NOUN
aesr-151	53	15	)	)	PUNCT
aesr-151	53	16	was	be	AUX
aesr-151	53	17	obtained	obtain	VERB
aesr-151	53	18	from	from	ADP
aesr-151	53	19	sigma	sigma	PROPN
aesr-151	53	20	chemical	chemical	NOUN
aesr-151	53	21	company	company	NOUN
aesr-151	53	22	.	.	PUNCT
aesr-151	54	1	2.2	2.2	NUM
aesr-151	54	2	.	.	PUNCT
aesr-151	54	3	extraction	extraction	NOUN
aesr-151	54	4	of	of	ADP
aesr-151	54	5	goji	goji	NOUN
aesr-151	54	6	wine	wine	NOUN
aesr-151	54	7	goji	goji	NOUN
aesr-151	54	8	berry	berry	NOUN
aesr-151	54	9	was	be	AUX
aesr-151	54	10	extracted	extract	VERB
aesr-151	54	11	according	accord	VERB
aesr-151	54	12	to	to	ADP
aesr-151	54	13	method	method	NOUN
aesr-151	54	14	described	describe	VERB
aesr-151	54	15	by	by	ADP
aesr-151	54	16	yang	yang	PROPN
aesr-151	54	17	and	and	CCONJ
aesr-151	54	18	baojun	baojun	PROPN
aesr-151	55	1	[	[	X
aesr-151	55	2	8]where	8]where	ADV
aesr-151	55	3	,	,	PUNCT
aesr-151	55	4	5	5	NUM
aesr-151	55	5	g	g	NOUN
aesr-151	55	6	of	of	ADP
aesr-151	55	7	goji	goji	NOUN
aesr-151	55	8	fruits	fruit	NOUN
aesr-151	55	9	,	,	PUNCT
aesr-151	55	10	25	25	NUM
aesr-151	55	11	ml	ml	NOUN
aesr-151	55	12	alcohol	alcohol	NOUN
aesr-151	55	13	and	and	CCONJ
aesr-151	55	14	75	75	NUM
aesr-151	55	15	ml	ml	ADV
aesr-151	55	16	distilled	distil	VERB
aesr-151	55	17	water	water	NOUN
aesr-151	55	18	were	be	AUX
aesr-151	55	19	put	put	VERB
aesr-151	55	20	into	into	ADP
aesr-151	55	21	erlenmeyer	erlenmeyer	PROPN
aesr-151	55	22	flask	flask	PROPN
aesr-151	55	23	(	(	PUNCT
aesr-151	55	24	the	the	DET
aesr-151	55	25	ratio	ratio	NOUN
aesr-151	55	26	of	of	ADP
aesr-151	55	27	goji	goji	NOUN
aesr-151	55	28	berry	berry	NOUN
aesr-151	55	29	and	and	CCONJ
aesr-151	55	30	alcohol	alcohol	NOUN
aesr-151	55	31	is	be	AUX
aesr-151	55	32	referred	refer	VERB
aesr-151	55	33	to	to	ADP
aesr-151	55	34	the	the	DET
aesr-151	55	35	ratio	ratio	NOUN
aesr-151	55	36	of	of	ADP
aesr-151	55	37	making	make	VERB
aesr-151	55	38	commercial	commercial	ADJ
aesr-151	55	39	goji	goji	NOUN
aesr-151	55	40	wine	wine	NOUN
aesr-151	55	41	)	)	PUNCT
aesr-151	55	42	.	.	PUNCT
aesr-151	56	1	the	the	DET
aesr-151	56	2	erlenmeyer	erlenmeyer	PROPN
aesr-151	56	3	flask	flask	PROPN
aesr-151	56	4	was	be	AUX
aesr-151	56	5	sealed	seal	VERB
aesr-151	56	6	with	with	ADP
aesr-151	56	7	parafilm	parafilm	NOUN
aesr-151	56	8	and	and	CCONJ
aesr-151	56	9	tinfoil	tinfoil	NOUN
aesr-151	56	10	and	and	CCONJ
aesr-151	56	11	put	put	VERB
aesr-151	56	12	in	in	ADP
aesr-151	56	13	refrigerator	refrigerator	NOUN
aesr-151	56	14	for	for	ADP
aesr-151	56	15	5	5	NUM
aesr-151	56	16	days	day	NOUN
aesr-151	56	17	.	.	PUNCT
aesr-151	57	1	filtration	filtration	NOUN
aesr-151	57	2	was	be	AUX
aesr-151	57	3	made	make	VERB
aesr-151	57	4	to	to	PART
aesr-151	57	5	separate	separate	VERB
aesr-151	57	6	the	the	DET
aesr-151	57	7	solid	solid	ADJ
aesr-151	57	8	and	and	CCONJ
aesr-151	57	9	liquid	liquid	ADJ
aesr-151	57	10	phases	phase	NOUN
aesr-151	57	11	after	after	ADP
aesr-151	57	12	finishing	finish	VERB
aesr-151	57	13	steeping	steeping	NOUN
aesr-151	57	14	process	process	NOUN
aesr-151	57	15	,	,	PUNCT
aesr-151	57	16	solvent	solvent	PROPN
aesr-151	57	17	is	be	AUX
aesr-151	57	18	removed	remove	VERB
aesr-151	57	19	from	from	ADP
aesr-151	57	20	filtrate	filtrate	NOUN
aesr-151	57	21	by	by	ADP
aesr-151	57	22	rotatory	rotatory	ADJ
aesr-151	57	23	evaporator	evaporator	NOUN
aesr-151	57	24	to	to	PART
aesr-151	57	25	obtain	obtain	VERB
aesr-151	57	26	crude	crude	ADJ
aesr-151	57	27	goji	goji	NOUN
aesr-151	57	28	extract	extract	NOUN
aesr-151	57	29	.	.	PUNCT
aesr-151	58	1	2.3	2.3	NUM
aesr-151	58	2	.	.	PUNCT
aesr-151	58	3	animals	animal	NOUN
aesr-151	58	4	and	and	CCONJ
aesr-151	58	5	experimental	experimental	ADJ
aesr-151	58	6	design	design	NOUN
aesr-151	58	7	2.3.1	2.3.1	NUM
aesr-151	58	8	.	.	PUNCT
aesr-151	58	9	animals	animal	NOUN
aesr-151	58	10	forty	forty	NUM
aesr-151	58	11	male	male	NOUN
aesr-151	58	12	adult	adult	NOUN
aesr-151	58	13	albino	albino	NOUN
aesr-151	58	14	rats	rat	NOUN
aesr-151	58	15	weighing	weigh	VERB
aesr-151	58	16	240	240	NUM
aesr-151	58	17	-	-	SYM
aesr-151	58	18	300	300	NUM
aesr-151	58	19	g	g	NOUN
aesr-151	58	20	at	at	ADP
aesr-151	58	21	the	the	DET
aesr-151	58	22	age	age	NOUN
aesr-151	58	23	of	of	ADP
aesr-151	58	24	3.0	3.0	NUM
aesr-151	58	25	-	-	SYM
aesr-151	58	26	4.0	4.0	NUM
aesr-151	58	27	months	month	NOUN
aesr-151	58	28	were	be	AUX
aesr-151	58	29	obtained	obtain	VERB
aesr-151	58	30	from	from	ADP
aesr-151	58	31	the	the	DET
aesr-151	58	32	animal	animal	NOUN
aesr-151	58	33	house	house	NOUN
aesr-151	58	34	,	,	PUNCT
aesr-151	58	35	faculty	faculty	NOUN
aesr-151	58	36	of	of	ADP
aesr-151	58	37	medicine	medicine	NOUN
aesr-151	58	38	,	,	PUNCT
aesr-151	58	39	assiut	assiut	NOUN
aesr-151	58	40	university	university	NOUN
aesr-151	58	41	.	.	PUNCT
aesr-151	59	1	they	they	PRON
aesr-151	59	2	were	be	AUX
aesr-151	59	3	housed	house	VERB
aesr-151	59	4	in	in	ADP
aesr-151	59	5	standard	standard	ADJ
aesr-151	59	6	environmental	environmental	ADJ
aesr-151	59	7	conditions	condition	NOUN
aesr-151	59	8	(	(	PUNCT
aesr-151	59	9	22±	22±	NUM
aesr-151	59	10	3	3	NUM
aesr-151	59	11	°	°	NOUN
aesr-151	59	12	c	c	NOUN
aesr-151	59	13	,	,	PUNCT
aesr-151	59	14	and	and	CCONJ
aesr-151	59	15	a	a	DET
aesr-151	59	16	12	12	NUM
aesr-151	59	17	h	h	NOUN
aesr-151	59	18	light/	light/	NUM
aesr-151	59	19	dark	dark	ADJ
aesr-151	59	20	cycle	cycle	NOUN
aesr-151	59	21	as	as	ADP
aesr-151	59	22	percpcsea	percpcsea	NOUN
aesr-151	59	23	guidelines	guideline	NOUN
aesr-151	59	24	)	)	PUNCT
aesr-151	59	25	and	and	CCONJ
aesr-151	59	26	fed	feed	VERB
aesr-151	59	27	with	with	ADP
aesr-151	59	28	standard	standard	ADJ
aesr-151	59	29	rodent	rodent	ADJ
aesr-151	59	30	diet	diet	NOUN
aesr-151	59	31	.	.	PUNCT
aesr-151	60	1	the	the	DET
aesr-151	60	2	rats	rat	NOUN
aesr-151	60	3	were	be	AUX
aesr-151	60	4	randomly	randomly	ADV
aesr-151	60	5	assigned	assign	VERB
aesr-151	60	6	to	to	ADP
aesr-151	60	7	four	four	NUM
aesr-151	60	8	groups	group	NOUN
aesr-151	60	9	of	of	ADP
aesr-151	60	10	10	10	NUM
aesr-151	60	11	rats	rat	NOUN
aesr-151	60	12	each	each	PRON
aesr-151	60	13	(	(	PUNCT
aesr-151	60	14	5	5	NUM
aesr-151	60	15	rats	rat	NOUN
aesr-151	60	16	in	in	ADP
aesr-151	60	17	each	each	DET
aesr-151	60	18	cage	cage	NOUN
aesr-151	60	19	)	)	PUNCT
aesr-151	60	20	and	and	CCONJ
aesr-151	60	21	treated	treat	VERB
aesr-151	60	22	as	as	SCONJ
aesr-151	60	23	follows	follow	VERB
aesr-151	60	24	:	:	PUNCT
aesr-151	60	25	control	control	NOUN
aesr-151	60	26	group	group	NOUN
aesr-151	60	27	:	:	PUNCT
aesr-151	60	28	injected	inject	VERB
aesr-151	60	29	subcutaneously	subcutaneously	ADV
aesr-151	60	30	daily	daily	ADV
aesr-151	60	31	with	with	ADP
aesr-151	60	32	distilled	distil	VERB
aesr-151	60	33	water	water	NOUN
aesr-151	60	34	;	;	PUNCT
aesr-151	60	35	group	group	NOUN
aesr-151	60	36	i	i	PRON
aesr-151	60	37	:	:	PUNCT
aesr-151	60	38	injected	inject	VERB
aesr-151	60	39	subcutaneously	subcutaneously	ADV
aesr-151	60	40	daily	daily	ADV
aesr-151	60	41	with	with	ADP
aesr-151	60	42	patulin	patulin	NOUN
aesr-151	60	43	(	(	PUNCT
aesr-151	60	44	0.2	0.2	NUM
aesr-151	60	45	mg	mg	PROPN
aesr-151	60	46	/	/	SYM
aesr-151	60	47	kg	kg	PROPN
aesr-151	60	48	/	/	SYM
aesr-151	60	49	day	day	NOUN
aesr-151	60	50	)	)	PUNCT
aesr-151	60	51	for	for	ADP
aesr-151	60	52	two	two	NUM
aesr-151	60	53	weeks	week	NOUN
aesr-151	60	54	respectively	respectively	ADV
aesr-151	60	55	.	.	PUNCT
aesr-151	61	1	agriculture	agriculture	NOUN
aesr-151	61	2	and	and	CCONJ
aesr-151	61	3	food	food	NOUN
aesr-151	61	4	sciences	sciences	PROPN
aesr-151	61	5	research	research	NOUN
aesr-151	61	6	,	,	PUNCT
aesr-151	61	7	2017	2017	NUM
aesr-151	61	8	,	,	PUNCT
aesr-151	61	9	4(1	4(1	NOUN
aesr-151	61	10	):	):	PUNCT
aesr-151	61	11	24	24	NUM
aesr-151	61	12	-	-	SYM
aesr-151	61	13	29	29	NUM
aesr-151	61	14	26	26	NUM
aesr-151	61	15	group	group	NOUN
aesr-151	61	16	ii	ii	PROPN
aesr-151	61	17	:	:	PUNCT
aesr-151	61	18	injected	inject	VERB
aesr-151	61	19	by	by	ADP
aesr-151	61	20	patulin	patulin	NOUN
aesr-151	61	21	as	as	ADP
aesr-151	61	22	a	a	DET
aesr-151	61	23	previous	previous	ADJ
aesr-151	61	24	dose	dose	NOUN
aesr-151	61	25	for	for	ADP
aesr-151	61	26	two	two	NUM
aesr-151	61	27	weeks	week	NOUN
aesr-151	61	28	after	after	SCONJ
aesr-151	61	29	that	that	SCONJ
aesr-151	61	30	they	they	PRON
aesr-151	61	31	were	be	AUX
aesr-151	61	32	treated	treat	VERB
aesr-151	61	33	with	with	ADP
aesr-151	61	34	goji	goji	NOUN
aesr-151	61	35	extract	extract	NOUN
aesr-151	61	36	(	(	PUNCT
aesr-151	61	37	2	2	NUM
aesr-151	61	38	ml	ml	NOUN
aesr-151	61	39	/	/	SYM
aesr-151	61	40	kg	kg	PROPN
aesr-151	61	41	/	/	SYM
aesr-151	61	42	day	day	NOUN
aesr-151	61	43	)	)	PUNCT
aesr-151	61	44	for	for	ADP
aesr-151	61	45	another	another	DET
aesr-151	61	46	two	two	NUM
aesr-151	61	47	weeks	week	NOUN
aesr-151	61	48	.	.	PUNCT
aesr-151	62	1	group	group	PROPN
aesr-151	62	2	iii	iii	PROPN
aesr-151	62	3	:	:	PUNCT
aesr-151	62	4	treated	treat	VERB
aesr-151	62	5	by	by	ADP
aesr-151	62	6	goji	goji	NOUN
aesr-151	62	7	extract	extract	NOUN
aesr-151	62	8	for	for	ADP
aesr-151	62	9	two	two	NUM
aesr-151	62	10	weeks	week	NOUN
aesr-151	62	11	then	then	ADV
aesr-151	62	12	,	,	PUNCT
aesr-151	62	13	they	they	PRON
aesr-151	62	14	were	be	AUX
aesr-151	62	15	injected	inject	VERB
aesr-151	62	16	subcutaneously	subcutaneously	ADV
aesr-151	62	17	with	with	ADP
aesr-151	62	18	the	the	DET
aesr-151	62	19	same	same	ADJ
aesr-151	62	20	dose	dose	NOUN
aesr-151	62	21	of	of	ADP
aesr-151	62	22	the	the	DET
aesr-151	62	23	toxin	toxin	NOUN
aesr-151	62	24	also	also	ADV
aesr-151	62	25	for	for	ADP
aesr-151	62	26	another	another	DET
aesr-151	62	27	two	two	NUM
aesr-151	62	28	weeks	week	NOUN
aesr-151	62	29	.	.	PUNCT
aesr-151	63	1	2.4	2.4	NUM
aesr-151	63	2	.	.	PUNCT
aesr-151	64	1	biochemical	biochemical	ADJ
aesr-151	64	2	studies	study	NOUN
aesr-151	64	3	animals	animal	NOUN
aesr-151	64	4	were	be	AUX
aesr-151	64	5	anesthetized	anesthetize	VERB
aesr-151	64	6	under	under	ADP
aesr-151	64	7	light	light	ADJ
aesr-151	64	8	diethyl	diethyl	NOUN
aesr-151	64	9	ether	ether	NOUN
aesr-151	64	10	and	and	CCONJ
aesr-151	64	11	blood	blood	NOUN
aesr-151	64	12	samples	sample	NOUN
aesr-151	64	13	were	be	AUX
aesr-151	64	14	collected	collect	VERB
aesr-151	64	15	from	from	ADP
aesr-151	64	16	the	the	DET
aesr-151	64	17	heart	heart	NOUN
aesr-151	64	18	into	into	ADP
aesr-151	64	19	plain	plain	ADJ
aesr-151	64	20	tubes	tube	NOUN
aesr-151	64	21	and	and	CCONJ
aesr-151	64	22	stored	store	VERB
aesr-151	64	23	at	at	ADP
aesr-151	64	24	-20	-20	NUM
aesr-151	64	25	°	°	NOUN
aesr-151	64	26	c	c	NOUN
aesr-151	64	27	until	until	SCONJ
aesr-151	64	28	analyses	analysis	NOUN
aesr-151	64	29	were	be	AUX
aesr-151	64	30	performed	perform	VERB
aesr-151	64	31	.	.	PUNCT
aesr-151	65	1	sera	sera	NOUN
aesr-151	65	2	were	be	AUX
aesr-151	65	3	used	use	VERB
aesr-151	65	4	for	for	ADP
aesr-151	65	5	the	the	DET
aesr-151	65	6	measurement	measurement	NOUN
aesr-151	65	7	of	of	ADP
aesr-151	65	8	amylase	amylase	NOUN
aesr-151	65	9	,	,	PUNCT
aesr-151	65	10	lipase	lipase	NOUN
aesr-151	65	11	,	,	PUNCT
aesr-151	65	12	glucose	glucose	NOUN
aesr-151	65	13	,	,	PUNCT
aesr-151	65	14	c	c	NOUN
aesr-151	65	15	-	-	PUNCT
aesr-151	65	16	peptide	peptide	NOUN
aesr-151	65	17	and	and	CCONJ
aesr-151	65	18	insulin	insulin	NOUN
aesr-151	65	19	.	.	PUNCT
aesr-151	66	1	level	level	NOUN
aesr-151	66	2	of	of	ADP
aesr-151	66	3	amylase	amylase	NOUN
aesr-151	66	4	was	be	AUX
aesr-151	66	5	measured	measure	VERB
aesr-151	66	6	according	accord	VERB
aesr-151	66	7	to	to	ADP
aesr-151	66	8	ranson	ranson	PROPN
aesr-151	66	9	[	[	X
aesr-151	66	10	9	9	NUM
aesr-151	66	11	]	]	SYM
aesr-151	66	12	level	level	NOUN
aesr-151	66	13	of	of	ADP
aesr-151	66	14	lipase	lipase	NOUN
aesr-151	66	15	was	be	AUX
aesr-151	66	16	measured	measure	VERB
aesr-151	66	17	according	accord	VERB
aesr-151	66	18	to	to	ADP
aesr-151	66	19	rick	rick	PROPN
aesr-151	67	1	[	[	X
aesr-151	67	2	10	10	NUM
aesr-151	67	3	]	]	SYM
aesr-151	67	4	level	level	NOUN
aesr-151	67	5	of	of	ADP
aesr-151	67	6	glucose	glucose	NOUN
aesr-151	67	7	was	be	AUX
aesr-151	67	8	measured	measure	VERB
aesr-151	67	9	according	accord	VERB
aesr-151	67	10	to	to	ADP
aesr-151	67	11	trinder	trinder	NOUN
aesr-151	67	12	[	[	X
aesr-151	67	13	11	11	NUM
aesr-151	67	14	]	]	SYM
aesr-151	67	15	level	level	NOUN
aesr-151	67	16	of	of	ADP
aesr-151	67	17	c	c	NOUN
aesr-151	67	18	-	-	PUNCT
aesr-151	67	19	peptide	peptide	NOUN
aesr-151	67	20	was	be	AUX
aesr-151	67	21	measured	measure	VERB
aesr-151	67	22	by	by	ADP
aesr-151	67	23	elisa	elisa	PROPN
aesr-151	67	24	kit	kit	NOUN
aesr-151	67	25	that	that	PRON
aesr-151	67	26	was	be	AUX
aesr-151	67	27	purchased	purchase	VERB
aesr-151	67	28	from	from	ADP
aesr-151	67	29	immunospec	immunospec	ADJ
aesr-151	67	30	company	company	NOUN
aesr-151	67	31	and	and	CCONJ
aesr-151	67	32	level	level	NOUN
aesr-151	67	33	of	of	ADP
aesr-151	67	34	insulin	insulin	NOUN
aesr-151	67	35	was	be	AUX
aesr-151	67	36	measured	measure	VERB
aesr-151	67	37	by	by	ADP
aesr-151	67	38	elisa	elisa	PROPN
aesr-151	67	39	kit	kit	NOUN
aesr-151	67	40	that	that	PRON
aesr-151	67	41	was	be	AUX
aesr-151	67	42	purchased	purchase	VERB
aesr-151	67	43	from	from	ADP
aesr-151	67	44	demeditec	demeditec	NOUN
aesr-151	67	45	.	.	PUNCT
aesr-151	68	1	2.5	2.5	NUM
aesr-151	68	2	.	.	PUNCT
aesr-151	69	1	statistical	statistical	ADJ
aesr-151	69	2	analysis	analysis	NOUN
aesr-151	69	3	the	the	DET
aesr-151	69	4	data	datum	NOUN
aesr-151	69	5	were	be	AUX
aesr-151	69	6	presented	present	VERB
aesr-151	69	7	as	as	SCONJ
aesr-151	69	8	mean	mean	PROPN
aesr-151	69	9	±	±	NUM
aesr-151	69	10	sem	sem	NOUN
aesr-151	69	11	and	and	CCONJ
aesr-151	69	12	the	the	DET
aesr-151	69	13	level	level	NOUN
aesr-151	69	14	of	of	ADP
aesr-151	69	15	significance	significance	NOUN
aesr-151	69	16	between	between	ADP
aesr-151	69	17	groups	group	NOUN
aesr-151	69	18	were	be	AUX
aesr-151	69	19	*	*	PUNCT
aesr-151	69	20	p<0.05	p<0.05	PROPN
aesr-151	69	21	,	,	PUNCT
aesr-151	69	22	*	*	PUNCT
aesr-151	69	23	*	*	PUNCT
aesr-151	69	24	p<0.01	p<0.01	PROPN
aesr-151	69	25	,	,	PUNCT
aesr-151	69	26	*	*	PUNCT
aesr-151	69	27	*	*	PUNCT
aesr-151	69	28	*	*	PUNCT
aesr-151	69	29	p<0.0001	p<0.0001	NOUN
aesr-151	69	30	.	.	PUNCT
aesr-151	70	1	they	they	PRON
aesr-151	70	2	were	be	AUX
aesr-151	70	3	analysed	analyse	VERB
aesr-151	70	4	using	use	VERB
aesr-151	70	5	one	one	NUM
aesr-151	70	6	-	-	PUNCT
aesr-151	70	7	way	way	NOUN
aesr-151	70	8	anova	anova	PROPN
aesr-151	70	9	followed	follow	VERB
aesr-151	70	10	by	by	ADP
aesr-151	70	11	newman	newman	PROPN
aesr-151	70	12	-	-	PUNCT
aesr-151	70	13	keuls	keuls	PROPN
aesr-151	70	14	test	test	NOUN
aesr-151	70	15	.	.	PUNCT
aesr-151	71	1	statistical	statistical	ADJ
aesr-151	71	2	graph	graph	NOUN
aesr-151	71	3	pad	pad	NOUN
aesr-151	71	4	prism	prism	NOUN
aesr-151	71	5	5	5	NUM
aesr-151	71	6	was	be	AUX
aesr-151	71	7	used	use	VERB
aesr-151	71	8	for	for	ADP
aesr-151	71	9	the	the	DET
aesr-151	71	10	analysis	analysis	NOUN
aesr-151	71	11	of	of	ADP
aesr-151	71	12	the	the	DET
aesr-151	71	13	data	datum	NOUN
aesr-151	71	14	.	.	PUNCT
aesr-151	72	1	3	3	X
aesr-151	72	2	.	.	NOUN
aesr-151	72	3	results	result	VERB
aesr-151	72	4	the	the	DET
aesr-151	72	5	biochemical	biochemical	ADJ
aesr-151	72	6	changes	change	NOUN
aesr-151	72	7	were	be	AUX
aesr-151	72	8	studied	study	VERB
aesr-151	72	9	in	in	ADP
aesr-151	72	10	blood	blood	NOUN
aesr-151	72	11	of	of	ADP
aesr-151	72	12	male	male	ADJ
aesr-151	72	13	albino	albino	NOUN
aesr-151	72	14	rats	rat	NOUN
aesr-151	72	15	as	as	ADP
aesr-151	72	16	a	a	DET
aesr-151	72	17	result	result	NOUN
aesr-151	72	18	of	of	ADP
aesr-151	72	19	administration	administration	NOUN
aesr-151	72	20	of	of	ADP
aesr-151	72	21	a	a	DET
aesr-151	72	22	dose	dose	NOUN
aesr-151	72	23	from	from	ADP
aesr-151	72	24	patulin	patulin	NOUN
aesr-151	72	25	(	(	PUNCT
aesr-151	72	26	0.2	0.2	NUM
aesr-151	72	27	mg	mg	PROPN
aesr-151	72	28	/	/	SYM
aesr-151	72	29	kg	kg	PROPN
aesr-151	72	30	b.	b.	PROPN
aesr-151	72	31	w.	w.	PROPN
aesr-151	72	32	)	)	PUNCT
aesr-151	72	33	and	and	CCONJ
aesr-151	72	34	observed	observe	VERB
aesr-151	72	35	over	over	ADP
aesr-151	72	36	a	a	DET
aesr-151	72	37	period	period	NOUN
aesr-151	72	38	of	of	ADP
aesr-151	72	39	two	two	NUM
aesr-151	72	40	weeks	week	NOUN
aesr-151	72	41	(	(	PUNCT
aesr-151	72	42	gi	gi	INTJ
aesr-151	72	43	)	)	PUNCT
aesr-151	72	44	compared	compare	VERB
aesr-151	72	45	to	to	ADP
aesr-151	72	46	the	the	DET
aesr-151	72	47	control	control	NOUN
aesr-151	72	48	group	group	NOUN
aesr-151	72	49	.	.	PUNCT
aesr-151	73	1	gii	gii	PROPN
aesr-151	73	2	treated	treat	VERB
aesr-151	73	3	by	by	ADP
aesr-151	73	4	patulin	patulin	NOUN
aesr-151	73	5	as	as	ADP
aesr-151	73	6	previous	previous	ADJ
aesr-151	73	7	dose	dose	NOUN
aesr-151	73	8	for	for	ADP
aesr-151	73	9	two	two	NUM
aesr-151	73	10	weeks	week	NOUN
aesr-151	73	11	after	after	ADP
aesr-151	73	12	that	that	SCONJ
aesr-151	73	13	they	they	PRON
aesr-151	73	14	were	be	AUX
aesr-151	73	15	injected	inject	VERB
aesr-151	73	16	subcutaneously	subcutaneously	ADV
aesr-151	73	17	with	with	ADP
aesr-151	73	18	goji	goji	NOUN
aesr-151	73	19	extract	extract	NOUN
aesr-151	73	20	2	2	NUM
aesr-151	73	21	ml	ml	NOUN
aesr-151	73	22	/kg	/kg	PUNCT
aesr-151	73	23	/day	/day	PROPN
aesr-151	73	24	for	for	ADP
aesr-151	73	25	two	two	NUM
aesr-151	73	26	weeks	week	NOUN
aesr-151	73	27	.	.	PUNCT
aesr-151	74	1	in	in	ADP
aesr-151	74	2	addition	addition	NOUN
aesr-151	74	3	giii	giii	NOUN
aesr-151	74	4	treated	treat	VERB
aesr-151	74	5	by	by	ADP
aesr-151	74	6	goji	goji	NOUN
aesr-151	74	7	for	for	ADP
aesr-151	74	8	two	two	NUM
aesr-151	74	9	weeks	week	NOUN
aesr-151	74	10	then	then	ADV
aesr-151	74	11	,	,	PUNCT
aesr-151	74	12	they	they	PRON
aesr-151	74	13	were	be	AUX
aesr-151	74	14	injected	inject	VERB
aesr-151	74	15	subcutaneously	subcutaneously	ADV
aesr-151	74	16	with	with	ADP
aesr-151	74	17	the	the	DET
aesr-151	74	18	same	same	ADJ
aesr-151	74	19	toxin	toxin	NOUN
aesr-151	74	20	for	for	ADP
aesr-151	74	21	two	two	NUM
aesr-151	74	22	weeks	week	NOUN
aesr-151	74	23	.	.	PUNCT
aesr-151	75	1	table	table	NOUN
aesr-151	75	2	.	.	PUNCT
aesr-151	76	1	1	1	X
aesr-151	76	2	.	.	X
aesr-151	76	3	and	and	CCONJ
aesr-151	76	4	fig	fig	NOUN
aesr-151	76	5	.	.	PUNCT
aesr-151	77	1	3	3	X
aesr-151	77	2	.	.	X
aesr-151	77	3	represent	represent	VERB
aesr-151	77	4	the	the	DET
aesr-151	77	5	mean	mean	ADJ
aesr-151	77	6	value	value	NOUN
aesr-151	77	7	of	of	ADP
aesr-151	77	8	amylase	amylase	NOUN
aesr-151	77	9	concentration	concentration	NOUN
aesr-151	77	10	(	(	PUNCT
aesr-151	77	11	μkat	μkat	NOUN
aesr-151	77	12	/	/	SYM
aesr-151	77	13	l	l	NOUN
aesr-151	77	14	)	)	PUNCT
aesr-151	77	15	of	of	ADP
aesr-151	77	16	g	g	PROPN
aesr-151	77	17	i	i	PRON
aesr-151	77	18	treated	treat	VERB
aesr-151	77	19	animals	animal	NOUN
aesr-151	77	20	for	for	ADP
aesr-151	77	21	two	two	NUM
aesr-151	77	22	weeks	week	NOUN
aesr-151	77	23	to	to	PART
aesr-151	77	24	be	be	AUX
aesr-151	77	25	(	(	PUNCT
aesr-151	77	26	40.46±0.4	40.46±0.4	NUM
aesr-151	77	27	)	)	PUNCT
aesr-151	77	28	which	which	PRON
aesr-151	77	29	was	be	AUX
aesr-151	77	30	highly	highly	ADV
aesr-151	77	31	significantly	significantly	ADV
aesr-151	77	32	increased	increase	VERB
aesr-151	77	33	from	from	ADP
aesr-151	77	34	normal	normal	ADJ
aesr-151	77	35	value	value	NOUN
aesr-151	77	36	of	of	ADP
aesr-151	77	37	control	control	NOUN
aesr-151	77	38	group	group	NOUN
aesr-151	77	39	(	(	PUNCT
aesr-151	77	40	33.75	33.75	NUM
aesr-151	77	41	±	±	NUM
aesr-151	77	42	0.32	0.32	NUM
aesr-151	77	43	)	)	PUNCT
aesr-151	77	44	,	,	PUNCT
aesr-151	77	45	where	where	SCONJ
aesr-151	77	46	p<0.001	p<0.001	PROPN
aesr-151	77	47	.	.	PUNCT
aesr-151	78	1	on	on	ADP
aesr-151	78	2	the	the	DET
aesr-151	78	3	other	other	ADJ
aesr-151	78	4	hand	hand	NOUN
aesr-151	78	5	,	,	PUNCT
aesr-151	78	6	non	non	ADJ
aesr-151	78	7	-	-	ADJ
aesr-151	78	8	significant	significant	ADJ
aesr-151	78	9	changes	change	NOUN
aesr-151	78	10	in	in	ADP
aesr-151	78	11	the	the	DET
aesr-151	78	12	mean	mean	ADJ
aesr-151	78	13	value	value	NOUN
aesr-151	78	14	of	of	ADP
aesr-151	78	15	amylase	amylase	NOUN
aesr-151	78	16	concentrations	concentration	NOUN
aesr-151	78	17	were	be	AUX
aesr-151	78	18	observed	observe	VERB
aesr-151	78	19	between	between	ADP
aesr-151	78	20	gii	gii	PROPN
aesr-151	78	21	(	(	PUNCT
aesr-151	78	22	32.18	32.18	NUM
aesr-151	78	23	±	±	NUM
aesr-151	78	24	0.4	0.4	NUM
aesr-151	78	25	)	)	PUNCT
aesr-151	78	26	and	and	CCONJ
aesr-151	78	27	giii	giii	NOUN
aesr-151	78	28	(	(	PUNCT
aesr-151	78	29	30.76	30.76	NUM
aesr-151	78	30	±	±	NUM
aesr-151	78	31	0.8	0.8	NUM
aesr-151	78	32	)	)	PUNCT
aesr-151	78	33	compared	compare	VERB
aesr-151	78	34	to	to	ADP
aesr-151	78	35	control.the	control.the	DET
aesr-151	78	36	mean	mean	ADJ
aesr-151	78	37	value	value	NOUN
aesr-151	78	38	of	of	ADP
aesr-151	78	39	lipase	lipase	NOUN
aesr-151	78	40	concentration	concentration	NOUN
aesr-151	78	41	(	(	PUNCT
aesr-151	78	42	μkat	μkat	NOUN
aesr-151	78	43	/	/	SYM
aesr-151	78	44	l	l	NOUN
aesr-151	78	45	)	)	PUNCT
aesr-151	78	46	table.1.and	table.1.and	PROPN
aesr-151	78	47	fig.4	fig.4	PROPN
aesr-151	78	48	.	.	PROPN
aesr-151	78	49	of	of	ADP
aesr-151	78	50	g1	g1	PROPN
aesr-151	78	51	(	(	PUNCT
aesr-151	78	52	0.185	0.185	NUM
aesr-151	78	53	±	±	NUM
aesr-151	78	54	0.007	0.007	NUM
aesr-151	78	55	)	)	PUNCT
aesr-151	78	56	,	,	PUNCT
aesr-151	78	57	g	g	PROPN
aesr-151	78	58	ii	ii	PROPN
aesr-151	78	59	and	and	CCONJ
aesr-151	78	60	g	g	PROPN
aesr-151	78	61	iii	iii	NUM
aesr-151	78	62	showed	show	VERB
aesr-151	78	63	no	no	DET
aesr-151	78	64	significant	significant	ADJ
aesr-151	78	65	change	change	NOUN
aesr-151	78	66	(	(	PUNCT
aesr-151	78	67	p>0.05	p>0.05	NOUN
aesr-151	78	68	)	)	PUNCT
aesr-151	78	69	compared	compare	VERB
aesr-151	78	70	with	with	ADP
aesr-151	78	71	control	control	NOUN
aesr-151	78	72	group	group	NOUN
aesr-151	78	73	.	.	PUNCT
aesr-151	79	1	table.1	table.1	VERB
aesr-151	79	2	.	.	PUNCT
aesr-151	80	1	and	and	CCONJ
aesr-151	80	2	fig.5.represent	fig.5.represent	NOUN
aesr-151	80	3	the	the	DET
aesr-151	80	4	mean	mean	ADJ
aesr-151	80	5	value	value	NOUN
aesr-151	80	6	of	of	ADP
aesr-151	80	7	glucose	glucose	NOUN
aesr-151	80	8	concentration	concentration	NOUN
aesr-151	80	9	(	(	PUNCT
aesr-151	80	10	mmol	mmol	NOUN
aesr-151	80	11	/	/	SYM
aesr-151	80	12	l	l	NOUN
aesr-151	80	13	)	)	PUNCT
aesr-151	80	14	of	of	ADP
aesr-151	80	15	g	g	PROPN
aesr-151	80	16	i	i	PRON
aesr-151	80	17	was	be	AUX
aesr-151	80	18	significantly	significantly	ADV
aesr-151	80	19	elevated	elevate	VERB
aesr-151	80	20	to	to	ADP
aesr-151	80	21	(	(	PUNCT
aesr-151	80	22	10.82±1.33	10.82±1.33	NUM
aesr-151	80	23	)	)	PUNCT
aesr-151	80	24	(	(	PUNCT
aesr-151	80	25	p<0.05)than	p<0.05)than	VERB
aesr-151	80	26	normal	normal	ADJ
aesr-151	80	27	control	control	NOUN
aesr-151	80	28	samples	sample	NOUN
aesr-151	80	29	(	(	PUNCT
aesr-151	80	30	7.604	7.604	NUM
aesr-151	80	31	±0.383	±0.383	NOUN
aesr-151	80	32	)	)	PUNCT
aesr-151	80	33	.	.	PUNCT
aesr-151	81	1	this	this	DET
aesr-151	81	2	level	level	NOUN
aesr-151	81	3	was	be	AUX
aesr-151	81	4	still	still	ADV
aesr-151	81	5	slightly	slightly	ADV
aesr-151	81	6	elevated	elevate	VERB
aesr-151	81	7	to	to	ADP
aesr-151	81	8	8.31±0.77	8.31±0.77	PROPN
aesr-151	81	9	in	in	ADP
aesr-151	81	10	gii	gii	PROPN
aesr-151	81	11	(	(	PUNCT
aesr-151	81	12	p>0.05	p>0.05	PROPN
aesr-151	81	13	)	)	PUNCT
aesr-151	81	14	,	,	PUNCT
aesr-151	81	15	and	and	CCONJ
aesr-151	81	16	9.77±0.64	9.77±0.64	NUM
aesr-151	81	17	in	in	ADP
aesr-151	81	18	giii	giii	NOUN
aesr-151	81	19	(	(	PUNCT
aesr-151	81	20	p<0.05	p<0.05	NOUN
aesr-151	81	21	)	)	PUNCT
aesr-151	81	22	,	,	PUNCT
aesr-151	81	23	but	but	CCONJ
aesr-151	81	24	it	it	PRON
aesr-151	81	25	is	be	AUX
aesr-151	81	26	still	still	ADV
aesr-151	81	27	within	within	ADP
aesr-151	81	28	normal	normal	ADJ
aesr-151	81	29	range	range	NOUN
aesr-151	81	30	with	with	ADP
aesr-151	81	31	control	control	NOUN
aesr-151	81	32	group	group	NOUN
aesr-151	81	33	.	.	PUNCT
aesr-151	82	1	the	the	DET
aesr-151	82	2	mean	mean	ADJ
aesr-151	82	3	value	value	NOUN
aesr-151	82	4	of	of	ADP
aesr-151	82	5	c	c	NOUN
aesr-151	82	6	-	-	PUNCT
aesr-151	82	7	peptide	peptide	NOUN
aesr-151	82	8	concentration	concentration	NOUN
aesr-151	82	9	(	(	PUNCT
aesr-151	82	10	ng	ng	NOUN
aesr-151	82	11	/	/	SYM
aesr-151	82	12	ml	ml	NOUN
aesr-151	82	13	)	)	PUNCT
aesr-151	82	14	in	in	ADP
aesr-151	82	15	table.1	table.1	PROPN
aesr-151	82	16	.	.	PUNCT
aesr-151	83	1	and	and	CCONJ
aesr-151	83	2	fig.6.showed	fig.6.showe	VERB
aesr-151	83	3	significant	significant	ADJ
aesr-151	83	4	decrease	decrease	NOUN
aesr-151	83	5	(	(	PUNCT
aesr-151	83	6	p	p	X
aesr-151	83	7	>	>	X
aesr-151	83	8	0.05	0.05	NUM
aesr-151	83	9	)	)	PUNCT
aesr-151	83	10	compared	compare	VERB
aesr-151	83	11	with	with	ADP
aesr-151	83	12	control	control	NOUN
aesr-151	83	13	.	.	PUNCT
aesr-151	84	1	however	however	ADV
aesr-151	84	2	,	,	PUNCT
aesr-151	84	3	no	no	DET
aesr-151	84	4	significant	significant	ADJ
aesr-151	84	5	changes	change	NOUN
aesr-151	84	6	in	in	ADP
aesr-151	84	7	the	the	DET
aesr-151	84	8	mean	mean	ADJ
aesr-151	84	9	value	value	NOUN
aesr-151	84	10	of	of	ADP
aesr-151	84	11	c	c	NOUN
aesr-151	84	12	-	-	PUNCT
aesr-151	84	13	peptide	peptide	NOUN
aesr-151	84	14	were	be	AUX
aesr-151	84	15	observed	observe	VERB
aesr-151	84	16	between	between	ADP
aesr-151	84	17	gii	gii	NOUN
aesr-151	84	18	and	and	CCONJ
aesr-151	84	19	giii	giii	NOUN
aesr-151	84	20	compared	compare	VERB
aesr-151	84	21	to	to	ADP
aesr-151	84	22	control	control	VERB
aesr-151	84	23	.	.	PUNCT
aesr-151	85	1	the	the	DET
aesr-151	85	2	mean	mean	ADJ
aesr-151	85	3	value	value	NOUN
aesr-151	85	4	of	of	ADP
aesr-151	85	5	insulin	insulin	NOUN
aesr-151	85	6	concentration	concentration	NOUN
aesr-151	85	7	(	(	PUNCT
aesr-151	85	8	μlu	μlu	NOUN
aesr-151	85	9	/	/	SYM
aesr-151	85	10	ml	ml	NOUN
aesr-151	85	11	)	)	PUNCT
aesr-151	85	12	in	in	ADP
aesr-151	85	13	table.1and	table.1and	ADV
aesr-151	85	14	fig.7	fig.7	ADJ
aesr-151	85	15	.	.	PUNCT
aesr-151	85	16	showed	show	VERB
aesr-151	85	17	significant	significant	ADJ
aesr-151	85	18	decrease	decrease	NOUN
aesr-151	85	19	(	(	PUNCT
aesr-151	85	20	p	p	X
aesr-151	85	21	>	>	X
aesr-151	85	22	0.05	0.05	NUM
aesr-151	85	23	)	)	PUNCT
aesr-151	85	24	compared	compare	VERB
aesr-151	85	25	with	with	ADP
aesr-151	85	26	control	control	NOUN
aesr-151	85	27	.	.	PUNCT
aesr-151	86	1	however	however	ADV
aesr-151	86	2	,	,	PUNCT
aesr-151	86	3	this	this	DET
aesr-151	86	4	decrease	decrease	NOUN
aesr-151	86	5	returned	return	VERB
aesr-151	86	6	again	again	ADV
aesr-151	86	7	back	back	ADV
aesr-151	86	8	to	to	ADP
aesr-151	86	9	normal	normal	ADJ
aesr-151	86	10	value	value	NOUN
aesr-151	86	11	in	in	ADP
aesr-151	86	12	gii	gii	NOUN
aesr-151	86	13	and	and	CCONJ
aesr-151	86	14	giii	giii	NOUN
aesr-151	86	15	respectively	respectively	ADV
aesr-151	86	16	with	with	ADP
aesr-151	86	17	non	non	ADJ
aesr-151	86	18	-	-	ADJ
aesr-151	86	19	significant	significant	ADJ
aesr-151	86	20	change	change	NOUN
aesr-151	86	21	compared	compare	VERB
aesr-151	86	22	to	to	ADP
aesr-151	86	23	control	control	PROPN
aesr-151	86	24	group	group	NOUN
aesr-151	86	25	.	.	PUNCT
aesr-151	87	1	table-1	table-1	NUM
aesr-151	87	2	.	.	PUNCT
aesr-151	88	1	effect	effect	NOUN
aesr-151	88	2	of	of	ADP
aesr-151	88	3	patulin	patulin	NOUN
aesr-151	88	4	(	(	PUNCT
aesr-151	88	5	0.2	0.2	NUM
aesr-151	88	6	mg	mg	PROPN
aesr-151	88	7	/	/	SYM
aesr-151	88	8	kg	kg	PROPN
aesr-151	88	9	b.	b.	PROPN
aesr-151	88	10	w.	w.	PROPN
aesr-151	88	11	)	)	PUNCT
aesr-151	88	12	and	and	CCONJ
aesr-151	88	13	goji	goji	NOUN
aesr-151	88	14	extract	extract	NOUN
aesr-151	88	15	(	(	PUNCT
aesr-151	88	16	2	2	NUM
aesr-151	88	17	ml	ml	NOUN
aesr-151	88	18	/	/	SYM
aesr-151	88	19	kg	kg	NOUN
aesr-151	88	20	/day	/day	NUM
aesr-151	88	21	)	)	PUNCT
aesr-151	88	22	on	on	ADP
aesr-151	88	23	some	some	DET
aesr-151	88	24	biochemical	biochemical	ADJ
aesr-151	88	25	parameters	parameter	NOUN
aesr-151	88	26	of	of	ADP
aesr-151	88	27	male	male	ADJ
aesr-151	88	28	rats	rat	NOUN
aesr-151	88	29	:	:	PUNCT
aesr-151	88	30	groups	group	NOUN
aesr-151	88	31	control	control	VERB
aesr-151	88	32	gi	gi	PROPN
aesr-151	88	33	gii	gii	PROPN
aesr-151	88	34	giii	giii	NOUN
aesr-151	88	35	amylase(μkat	amylase(μkat	PROPN
aesr-151	88	36	/	/	SYM
aesr-151	88	37	l	l	NOUN
aesr-151	88	38	)	)	PUNCT
aesr-151	88	39	33.75	33.75	NUM
aesr-151	88	40	±	±	NUM
aesr-151	88	41	0.32	0.32	NUM
aesr-151	88	42	40.46	40.46	NUM
aesr-151	88	43	±	±	NOUN
aesr-151	88	44	0.4	0.4	NUM
aesr-151	88	45	*	*	PUNCT
aesr-151	88	46	*	*	PUNCT
aesr-151	88	47	*	*	X
aesr-151	88	48	32.18	32.18	NUM
aesr-151	88	49	±	±	NUM
aesr-151	88	50	0.4	0.4	NUM
aesr-151	88	51	n.s	n.s	PROPN
aesr-151	88	52	30.76	30.76	NUM
aesr-151	88	53	±	±	NUM
aesr-151	88	54	0.8	0.8	NUM
aesr-151	88	55	n.s	n.s	PROPN
aesr-151	88	56	lipase(μkat	lipase(μkat	PROPN
aesr-151	88	57	/	/	SYM
aesr-151	88	58	l	l	NOUN
aesr-151	88	59	)	)	PUNCT
aesr-151	88	60	0.217±0.04	0.217±0.04	NOUN
aesr-151	88	61	0.189±0.03	0.189±0.03	NUM
aesr-151	89	1	n.s	n.s	PROPN
aesr-151	89	2	0.207±0.01	0.207±0.01	NOUN
aesr-151	89	3	n.s	n.s	PROPN
aesr-151	89	4	0.241±0.007	0.241±0.007	PROPN
aesr-151	89	5	n.s	n.s	PROPN
aesr-151	89	6	glucose(mmol	glucose(mmol	PROPN
aesr-151	89	7	/	/	SYM
aesr-151	89	8	l	l	NOUN
aesr-151	89	9	)	)	PUNCT
aesr-151	89	10	7.604	7.604	NUM
aesr-151	89	11	±0.383	±0.383	NOUN
aesr-151	89	12	10.82±1.33	10.82±1.33	NUM
aesr-151	89	13	*	*	NOUN
aesr-151	89	14	8.31±0.77	8.31±0.77	NUM
aesr-151	90	1	n.s	n.s	PROPN
aesr-151	90	2	9.77±0.64	9.77±0.64	PROPN
aesr-151	90	3	n.s	n.s	PROPN
aesr-151	90	4	c	c	PROPN
aesr-151	90	5	-	-	PUNCT
aesr-151	90	6	peptide(ng	peptide(ng	NOUN
aesr-151	90	7	/	/	SYM
aesr-151	90	8	ml	ml	NOUN
aesr-151	90	9	)	)	PUNCT
aesr-151	90	10	0.341±0.02	0.341±0.02	PROPN
aesr-151	90	11	0.197	0.197	NUM
aesr-151	90	12	±	±	NUM
aesr-151	90	13	0.01	0.01	NUM
aesr-151	90	14	*	*	PUNCT
aesr-151	90	15	0.297	0.297	NUM
aesr-151	90	16	±	±	NUM
aesr-151	90	17	0.01	0.01	NUM
aesr-151	90	18	n.s	n.s	PROPN
aesr-151	90	19	0.338	0.338	NUM
aesr-151	90	20	±	±	NUM
aesr-151	90	21	0.03	0.03	NUM
aesr-151	90	22	n.s	n.s	PROPN
aesr-151	90	23	insulin(μl	insulin(μl	VERB
aesr-151	90	24	u	u	NOUN
aesr-151	90	25	/	/	SYM
aesr-151	90	26	m	m	VERB
aesr-151	90	27	)	)	PUNCT
aesr-151	91	1	0.58±0.101	0.58±0.101	NOUN
aesr-151	91	2	0.383±0.13	0.383±0.13	NUM
aesr-151	91	3	*	*	NOUN
aesr-151	91	4	1.35±0.10	1.35±0.10	NUM
aesr-151	91	5	*	*	PUNCT
aesr-151	91	6	*	*	PUNCT
aesr-151	91	7	*	*	PROPN
aesr-151	91	8	1.54±0.13	1.54±0.13	NUM
aesr-151	91	9	*	*	PUNCT
aesr-151	91	10	*	*	PUNCT
aesr-151	91	11	*	*	PUNCT
aesr-151	91	12	note	note	NOUN
aesr-151	91	13	:	:	PUNCT
aesr-151	91	14	values	value	NOUN
aesr-151	91	15	are	be	AUX
aesr-151	91	16	expressed	express	VERB
aesr-151	91	17	as	as	ADP
aesr-151	91	18	the	the	DET
aesr-151	91	19	mean	mean	NOUN
aesr-151	91	20	±	±	NUM
aesr-151	91	21	se	se	X
aesr-151	91	22	for	for	ADP
aesr-151	91	23	10	10	NUM
aesr-151	91	24	animals	animal	NOUN
aesr-151	91	25	in	in	ADP
aesr-151	91	26	each	each	DET
aesr-151	91	27	group	group	NOUN
aesr-151	91	28	.	.	PUNCT
aesr-151	92	1	gi	gi	NOUN
aesr-151	92	2	=	=	NUM
aesr-151	92	3	treated	treat	VERB
aesr-151	92	4	group	group	NOUN
aesr-151	92	5	with	with	ADP
aesr-151	92	6	patulin	patulin	PROPN
aesr-151	92	7	.	.	PUNCT
aesr-151	93	1	gii	gii	PROPN
aesr-151	93	2	,	,	PUNCT
aesr-151	93	3	giii	giii	NOUN
aesr-151	93	4	=	=	SYM
aesr-151	93	5	treated	treat	VERB
aesr-151	93	6	groups	group	NOUN
aesr-151	93	7	with	with	ADP
aesr-151	93	8	goji	goji	ADJ
aesr-151	93	9	significant	significant	ADJ
aesr-151	93	10	change	change	NOUN
aesr-151	93	11	in	in	ADP
aesr-151	93	12	comparison	comparison	NOUN
aesr-151	93	13	between	between	ADP
aesr-151	93	14	groups	group	NOUN
aesr-151	93	15	:	:	PUNCT
aesr-151	93	16	*	*	PUNCT
aesr-151	93	17	p<0.05	p<0.05	NOUN
aesr-151	93	18	;	;	PUNCT
aesr-151	93	19	*	*	PUNCT
aesr-151	93	20	*	*	PUNCT
aesr-151	93	21	*	*	PUNCT
aesr-151	93	22	p<0.001	p<0.001	X
aesr-151	94	1	n.s	n.s	PROPN
aesr-151	94	2	non	non	ADJ
aesr-151	94	3	significant	significant	ADJ
aesr-151	94	4	(	(	PUNCT
aesr-151	94	5	p	p	X
aesr-151	94	6	>	>	X
aesr-151	94	7	0.05	0.05	NUM
aesr-151	94	8	)	)	PUNCT
aesr-151	94	9	amylase	amylase	NOUN
aesr-151	94	10	contro	contro	PROPN
aesr-151	94	11	l	l	PROPN
aesr-151	94	12	gi	gi	NOUN
aesr-151	94	13	gii	gii	PROPN
aesr-151	94	14	giii	giii	NOUN
aesr-151	94	15	0	0	NUM
aesr-151	94	16	10	10	NUM
aesr-151	94	17	20	20	NUM
aesr-151	94	18	30	30	NUM
aesr-151	94	19	40	40	NUM
aesr-151	94	20	50	50	NUM
aesr-151	94	21	groups	group	NOUN
aesr-151	94	22	co	co	VERB
aesr-151	94	23	nc	nc	PROPN
aesr-151	94	24	.	.	PROPN
aesr-151	94	25			PROPN
aesr-151	94	26	ka	ka	PROPN
aesr-151	94	27	t	t	PROPN
aesr-151	94	28	/	/	SYM
aesr-151	94	29	l	l	NOUN
aesr-151	94	30	fig-3	fig-3	NOUN
aesr-151	94	31	.	.	PUNCT
aesr-151	95	1	α	α	X
aesr-151	95	2	-	-	PUNCT
aesr-151	95	3	amylase	amylase	NOUN
aesr-151	95	4	levels	level	NOUN
aesr-151	95	5	in	in	ADP
aesr-151	95	6	control	control	NOUN
aesr-151	95	7	and	and	CCONJ
aesr-151	95	8	treated	treat	VERB
aesr-151	95	9	groups	group	NOUN
aesr-151	95	10	with	with	ADP
aesr-151	95	11	patulin	patulin	ADJ
aesr-151	95	12	(	(	PUNCT
aesr-151	95	13	2	2	NUM
aesr-151	95	14	mg	mg	PROPN
aesr-151	95	15	/	/	SYM
aesr-151	95	16	kg.b.w	kg.b.w	NOUN
aesr-151	95	17	)	)	PUNCT
aesr-151	95	18	and	and	CCONJ
aesr-151	95	19	goji	goji	NOUN
aesr-151	95	20	extract	extract	NOUN
aesr-151	95	21	(	(	PUNCT
aesr-151	95	22	2	2	NUM
aesr-151	95	23	ml	ml	NOUN
aesr-151	95	24	/	/	SYM
aesr-151	95	25	kg.b.w	kg.b.w	ADJ
aesr-151	95	26	)	)	PUNCT
aesr-151	95	27	agriculture	agriculture	NOUN
aesr-151	95	28	and	and	CCONJ
aesr-151	95	29	food	food	NOUN
aesr-151	95	30	sciences	sciences	PROPN
aesr-151	95	31	research	research	NOUN
aesr-151	95	32	,	,	PUNCT
aesr-151	95	33	2017	2017	NUM
aesr-151	95	34	,	,	PUNCT
aesr-151	95	35	4(1	4(1	NOUN
aesr-151	95	36	):	):	PUNCT
aesr-151	95	37	24	24	NUM
aesr-151	95	38	-	-	SYM
aesr-151	95	39	29	29	NUM
aesr-151	95	40	27	27	NUM
aesr-151	95	41	lipase	lipase	NOUN
aesr-151	95	42	contro	contro	PROPN
aesr-151	95	43	l	l	PROPN
aesr-151	95	44	gi	gi	NOUN
aesr-151	95	45	gii	gii	PROPN
aesr-151	95	46	giii	giii	VERB
aesr-151	95	47	0.0	0.0	NUM
aesr-151	95	48	0.1	0.1	NUM
aesr-151	95	49	0.2	0.2	NUM
aesr-151	95	50	0.3	0.3	NUM
aesr-151	95	51	groups	group	NOUN
aesr-151	95	52	co	co	VERB
aesr-151	95	53	nc	nc	PROPN
aesr-151	95	54	.	.	PROPN
aesr-151	95	55			PROPN
aesr-151	95	56	ka	ka	PROPN
aesr-151	95	57	t	t	PROPN
aesr-151	95	58	/	/	SYM
aesr-151	95	59	l	l	NOUN
aesr-151	95	60	fig-4	fig-4	X
aesr-151	95	61	.	.	PUNCT
aesr-151	96	1	lipase	lipase	NOUN
aesr-151	96	2	levels	level	NOUN
aesr-151	96	3	in	in	ADP
aesr-151	96	4	control	control	NOUN
aesr-151	96	5	and	and	CCONJ
aesr-151	96	6	treated	treat	VERB
aesr-151	96	7	groups	group	NOUN
aesr-151	96	8	with	with	ADP
aesr-151	96	9	patulin	patulin	ADJ
aesr-151	96	10	(	(	PUNCT
aesr-151	96	11	2	2	NUM
aesr-151	96	12	mg	mg	PROPN
aesr-151	96	13	/	/	SYM
aesr-151	96	14	kg.b.w	kg.b.w	NOUN
aesr-151	96	15	)	)	PUNCT
aesr-151	96	16	and	and	CCONJ
aesr-151	96	17	goji	goji	NOUN
aesr-151	96	18	extract	extract	NOUN
aesr-151	96	19	(	(	PUNCT
aesr-151	96	20	2	2	NUM
aesr-151	96	21	ml	ml	NOUN
aesr-151	96	22	/	/	SYM
aesr-151	96	23	kg.b.w	kg.b.w	NOUN
aesr-151	96	24	)	)	PUNCT
aesr-151	96	25	glucose	glucose	NOUN
aesr-151	96	26	contro	contro	PROPN
aesr-151	96	27	l	l	PROPN
aesr-151	96	28	g	g	PROPN
aesr-151	97	1	i	i	PRON
aesr-151	97	2	g	g	PROPN
aesr-151	97	3	ii	ii	PROPN
aesr-151	97	4	g	g	PROPN
aesr-151	97	5	iii	iii	PROPN
aesr-151	97	6	0	0	NUM
aesr-151	97	7	5	5	NUM
aesr-151	97	8	10	10	NUM
aesr-151	97	9	15	15	NUM
aesr-151	97	10	groups	group	NOUN
aesr-151	97	11	co	co	VERB
aesr-151	97	12	nc	nc	PROPN
aesr-151	97	13	.m	.m	PROPN
aesr-151	97	14	m	m	VERB
aesr-151	97	15	ol	ol	ADJ
aesr-151	97	16	/l	/l	PUNCT
aesr-151	98	1	fig-5	fig-5	X
aesr-151	98	2	.	.	PUNCT
aesr-151	99	1	glucose	glucose	NOUN
aesr-151	99	2	levels	level	NOUN
aesr-151	99	3	in	in	ADP
aesr-151	99	4	control	control	NOUN
aesr-151	99	5	and	and	CCONJ
aesr-151	99	6	treated	treat	VERB
aesr-151	99	7	groups	group	NOUN
aesr-151	99	8	with	with	ADP
aesr-151	99	9	patulin	patulin	ADJ
aesr-151	99	10	(	(	PUNCT
aesr-151	99	11	2	2	NUM
aesr-151	99	12	mg	mg	PROPN
aesr-151	99	13	/	/	SYM
aesr-151	99	14	kg.b.w	kg.b.w	NOUN
aesr-151	99	15	)	)	PUNCT
aesr-151	99	16	and	and	CCONJ
aesr-151	99	17	goji	goji	NOUN
aesr-151	99	18	extract	extract	NOUN
aesr-151	99	19	(	(	PUNCT
aesr-151	99	20	2	2	NUM
aesr-151	99	21	ml	ml	NOUN
aesr-151	99	22	/	/	SYM
aesr-151	99	23	kg.b.w	kg.b.w	NOUN
aesr-151	99	24	)	)	PUNCT
aesr-151	99	25	c	c	NOUN
aesr-151	99	26	-	-	PUNCT
aesr-151	99	27	peptide	peptide	NOUN
aesr-151	99	28	contro	contro	PROPN
aesr-151	99	29	l	l	PROPN
aesr-151	99	30	gi	gi	NOUN
aesr-151	99	31	gii	gii	PROPN
aesr-151	99	32	giii	giii	VERB
aesr-151	99	33	0.0	0.0	NUM
aesr-151	99	34	0.1	0.1	NUM
aesr-151	99	35	0.2	0.2	NUM
aesr-151	99	36	0.3	0.3	NUM
aesr-151	99	37	0.4	0.4	NUM
aesr-151	99	38	0.5	0.5	NUM
aesr-151	99	39	groups	group	NOUN
aesr-151	99	40	ng	ng	PROPN
aesr-151	99	41	/m	/m	PUNCT
aesr-151	99	42	l	l	PROPN
aesr-151	99	43	fig-6	fig-6	NUM
aesr-151	99	44	.	.	PUNCT
aesr-151	100	1	c	c	X
aesr-151	100	2	-	-	PUNCT
aesr-151	100	3	peptide	peptide	NOUN
aesr-151	100	4	levels	level	NOUN
aesr-151	100	5	in	in	ADP
aesr-151	100	6	control	control	NOUN
aesr-151	100	7	and	and	CCONJ
aesr-151	100	8	treated	treat	VERB
aesr-151	100	9	groups	group	NOUN
aesr-151	100	10	with	with	ADP
aesr-151	100	11	patulin	patulin	ADJ
aesr-151	100	12	(	(	PUNCT
aesr-151	100	13	2	2	NUM
aesr-151	100	14	mg	mg	PROPN
aesr-151	100	15	/	/	SYM
aesr-151	100	16	kg.b.w	kg.b.w	NOUN
aesr-151	100	17	)	)	PUNCT
aesr-151	100	18	and	and	CCONJ
aesr-151	100	19	goji	goji	NOUN
aesr-151	100	20	extract	extract	NOUN
aesr-151	100	21	(	(	PUNCT
aesr-151	100	22	2	2	NUM
aesr-151	100	23	ml	ml	NOUN
aesr-151	100	24	/	/	SYM
aesr-151	100	25	kg.b.w	kg.b.w	ADJ
aesr-151	100	26	)	)	PUNCT
aesr-151	100	27	insulin	insulin	NOUN
aesr-151	100	28	contro	contro	PROPN
aesr-151	100	29	l	l	PROPN
aesr-151	100	30	g	g	PROPN
aesr-151	101	1	i	i	PRON
aesr-151	101	2	g	g	PROPN
aesr-151	101	3	ii	ii	PROPN
aesr-151	101	4	g	g	PROPN
aesr-151	101	5	iii	iii	PROPN
aesr-151	101	6	0.0	0.0	NUM
aesr-151	101	7	0.5	0.5	NUM
aesr-151	101	8	1.0	1.0	NUM
aesr-151	101	9	1.5	1.5	NUM
aesr-151	101	10	2.0	2.0	NUM
aesr-151	101	11	groups	group	NOUN
aesr-151	101	12	l	l	VERB
aesr-151	101	13	u/	u/	NOUN
aesr-151	101	14	m	m	PROPN
aesr-151	101	15	l	l	NOUN
aesr-151	101	16	fig-7	fig-7	X
aesr-151	101	17	.	.	PUNCT
aesr-151	102	1	insulin	insulin	NOUN
aesr-151	102	2	levels	level	NOUN
aesr-151	102	3	in	in	ADP
aesr-151	102	4	control	control	NOUN
aesr-151	102	5	and	and	CCONJ
aesr-151	102	6	treated	treat	VERB
aesr-151	102	7	groups	group	NOUN
aesr-151	102	8	with	with	ADP
aesr-151	102	9	patulin	patulin	ADJ
aesr-151	102	10	(	(	PUNCT
aesr-151	102	11	2	2	NUM
aesr-151	102	12	mg	mg	PROPN
aesr-151	102	13	/	/	SYM
aesr-151	102	14	kg.b.w	kg.b.w	NOUN
aesr-151	102	15	)	)	PUNCT
aesr-151	102	16	and	and	CCONJ
aesr-151	102	17	goji	goji	NOUN
aesr-151	102	18	extract	extract	NOUN
aesr-151	102	19	(	(	PUNCT
aesr-151	102	20	2	2	NUM
aesr-151	102	21	ml	ml	NOUN
aesr-151	102	22	/	/	SYM
aesr-151	102	23	kg.b.w	kg.b.w	NOUN
aesr-151	102	24	)	)	PUNCT
aesr-151	102	25	4	4	NUM
aesr-151	102	26	.	.	X
aesr-151	102	27	discussion	discussion	NOUN
aesr-151	102	28	the	the	DET
aesr-151	102	29	present	present	ADJ
aesr-151	102	30	study	study	NOUN
aesr-151	102	31	is	be	AUX
aesr-151	102	32	a	a	DET
aesr-151	102	33	biochemical	biochemical	ADJ
aesr-151	102	34	analysis	analysis	NOUN
aesr-151	102	35	on	on	ADP
aesr-151	102	36	the	the	DET
aesr-151	102	37	effect	effect	NOUN
aesr-151	102	38	of	of	ADP
aesr-151	102	39	microbial	microbial	ADJ
aesr-151	102	40	product	product	NOUN
aesr-151	102	41	,	,	PUNCT
aesr-151	102	42	patulin	patulin	ADJ
aesr-151	102	43	on	on	ADP
aesr-151	102	44	ins-1	ins-1	NUM
aesr-151	102	45	pancreatic	pancreatic	ADJ
aesr-151	102	46	beta	beta	NOUN
aesr-151	102	47	cells	cell	NOUN
aesr-151	102	48	(	(	PUNCT
aesr-151	102	49	β	β	NOUN
aesr-151	102	50	-	-	NOUN
aesr-151	102	51	cells	cell	NOUN
aesr-151	102	52	)	)	PUNCT
aesr-151	102	53	and	and	CCONJ
aesr-151	102	54	the	the	DET
aesr-151	102	55	possible	possible	ADJ
aesr-151	102	56	role	role	NOUN
aesr-151	102	57	of	of	ADP
aesr-151	102	58	goji	goji	NOUN
aesr-151	102	59	extract	extract	NOUN
aesr-151	102	60	as	as	ADP
aesr-151	102	61	a	a	DET
aesr-151	102	62	therapy	therapy	NOUN
aesr-151	102	63	on	on	ADP
aesr-151	102	64	pancreas	pancreas	ADJ
aesr-151	102	65	dysfunction	dysfunction	NOUN
aesr-151	102	66	.	.	PUNCT
aesr-151	103	1	the	the	DET
aesr-151	103	2	destruction	destruction	NOUN
aesr-151	103	3	of	of	ADP
aesr-151	103	4	βcells	βcell	NOUN
aesr-151	103	5	and	and	CCONJ
aesr-151	103	6	development	development	NOUN
aesr-151	103	7	of	of	ADP
aesr-151	103	8	type	type	NOUN
aesr-151	103	9	1	1	NUM
aesr-151	103	10	diabetes	diabetes	NOUN
aesr-151	103	11	have	have	AUX
aesr-151	103	12	been	be	AUX
aesr-151	103	13	linked	link	VERB
aesr-151	103	14	with	with	ADP
aesr-151	103	15	exposure	exposure	NOUN
aesr-151	103	16	to	to	ADP
aesr-151	103	17	environmental	environmental	ADJ
aesr-151	103	18	factors	factor	NOUN
aesr-151	103	19	[	[	X
aesr-151	103	20	12	12	NUM
aesr-151	103	21	]	]	PUNCT
aesr-151	103	22	which	which	PRON
aesr-151	103	23	may	may	AUX
aesr-151	103	24	contribute	contribute	VERB
aesr-151	103	25	up	up	ADP
aesr-151	103	26	to	to	PART
aesr-151	103	27	50	50	NUM
aesr-151	103	28	%	%	NOUN
aesr-151	103	29	of	of	ADP
aesr-151	103	30	the	the	DET
aesr-151	103	31	risk	risk	NOUN
aesr-151	103	32	of	of	ADP
aesr-151	103	33	developing	develop	VERB
aesr-151	103	34	this	this	DET
aesr-151	103	35	type	type	NOUN
aesr-151	103	36	of	of	ADP
aesr-151	103	37	diabetes	diabetes	NOUN
aesr-151	103	38	[	[	X
aesr-151	103	39	13	13	NUM
aesr-151	103	40	]	]	PUNCT
aesr-151	103	41	.	.	PUNCT
aesr-151	104	1	the	the	DET
aesr-151	104	2	most	most	ADV
aesr-151	104	3	important	important	ADJ
aesr-151	104	4	environmental	environmental	ADJ
aesr-151	104	5	factors	factor	NOUN
aesr-151	104	6	are	be	AUX
aesr-151	104	7	thought	think	VERB
aesr-151	104	8	to	to	PART
aesr-151	104	9	be	be	AUX
aesr-151	104	10	infection	infection	NOUN
aesr-151	104	11	(	(	PUNCT
aesr-151	104	12	viral	viral	ADJ
aesr-151	104	13	infection	infection	NOUN
aesr-151	104	14	)	)	PUNCT
aesr-151	104	15	,	,	PUNCT
aesr-151	104	16	diet	diet	NOUN
aesr-151	104	17	(	(	PUNCT
aesr-151	104	18	lack	lack	NOUN
aesr-151	104	19	of	of	ADP
aesr-151	104	20	particular	particular	ADJ
aesr-151	104	21	food	food	NOUN
aesr-151	104	22	during	during	ADP
aesr-151	104	23	childhood	childhood	NOUN
aesr-151	104	24	)	)	PUNCT
aesr-151	104	25	and	and	CCONJ
aesr-151	104	26	some	some	DET
aesr-151	104	27	inorganic	inorganic	ADJ
aesr-151	104	28	compounds	compound	NOUN
aesr-151	104	29	(	(	PUNCT
aesr-151	104	30	arsenate	arsenate	NOUN
aesr-151	104	31	ions	ion	NOUN
aesr-151	104	32	)	)	PUNCT
aesr-151	105	1	[	[	X
aesr-151	105	2	14	14	NUM
aesr-151	105	3	,	,	PUNCT
aesr-151	105	4	15	15	NUM
aesr-151	105	5	]	]	PUNCT
aesr-151	105	6	.	.	PUNCT
aesr-151	106	1	to	to	PART
aesr-151	106	2	study	study	VERB
aesr-151	106	3	pancreatic	pancreatic	ADJ
aesr-151	106	4	function	function	NOUN
aesr-151	106	5	of	of	ADP
aesr-151	106	6	rats	rat	NOUN
aesr-151	106	7	treated	treat	VERB
aesr-151	106	8	with	with	ADP
aesr-151	106	9	patulin	patulin	ADJ
aesr-151	106	10	,	,	PUNCT
aesr-151	106	11	α	α	NOUN
aesr-151	106	12	-	-	PUNCT
aesr-151	106	13	amylase	amylase	NOUN
aesr-151	106	14	,	,	PUNCT
aesr-151	106	15	agriculture	agriculture	NOUN
aesr-151	106	16	and	and	CCONJ
aesr-151	106	17	food	food	NOUN
aesr-151	106	18	sciences	sciences	PROPN
aesr-151	106	19	research	research	NOUN
aesr-151	106	20	,	,	PUNCT
aesr-151	106	21	2017	2017	NUM
aesr-151	106	22	,	,	PUNCT
aesr-151	106	23	4(1	4(1	NOUN
aesr-151	106	24	):	):	PUNCT
aesr-151	106	25	24	24	NUM
aesr-151	106	26	-	-	SYM
aesr-151	106	27	29	29	NUM
aesr-151	106	28	28	28	NUM
aesr-151	106	29	lipase	lipase	NOUN
aesr-151	106	30	,	,	PUNCT
aesr-151	106	31	glucose	glucose	NOUN
aesr-151	106	32	,	,	PUNCT
aesr-151	106	33	c	c	NOUN
aesr-151	106	34	-	-	PUNCT
aesr-151	106	35	peptide	peptide	NOUN
aesr-151	106	36	and	and	CCONJ
aesr-151	106	37	insulin	insulin	NOUN
aesr-151	106	38	have	have	AUX
aesr-151	106	39	been	be	AUX
aesr-151	106	40	measured	measure	VERB
aesr-151	106	41	as	as	ADP
aesr-151	106	42	biochemical	biochemical	ADJ
aesr-151	106	43	indicators	indicator	NOUN
aesr-151	106	44	.	.	PUNCT
aesr-151	107	1	alpha	alpha	NOUN
aesr-151	107	2	-	-	PUNCT
aesr-151	107	3	amylase	amylase	NOUN
aesr-151	107	4	catalyzes	catalyze	VERB
aesr-151	107	5	the	the	DET
aesr-151	107	6	hydrolysis	hydrolysis	NOUN
aesr-151	107	7	of	of	ADP
aesr-151	107	8	α[1	α[1	SYM
aesr-151	107	9	,	,	PUNCT
aesr-151	107	10	4]-d	4]-d	NUM
aesr-151	107	11	-	-	PUNCT
aesr-151	107	12	glycosidic	glycosidic	ADJ
aesr-151	107	13	linkages	linkage	NOUN
aesr-151	107	14	of	of	ADP
aesr-151	107	15	starch	starch	NOUN
aesr-151	107	16	and	and	CCONJ
aesr-151	107	17	other	other	ADJ
aesr-151	107	18	glucose	glucose	NOUN
aesr-151	107	19	polymers	polymer	NOUN
aesr-151	107	20	.	.	PUNCT
aesr-151	108	1	inhibitors	inhibitor	NOUN
aesr-151	108	2	of	of	ADP
aesr-151	108	3	this	this	DET
aesr-151	108	4	enzyme	enzyme	NOUN
aesr-151	108	5	could	could	AUX
aesr-151	108	6	be	be	AUX
aesr-151	108	7	of	of	ADP
aesr-151	108	8	use	use	NOUN
aesr-151	108	9	in	in	ADP
aesr-151	108	10	the	the	DET
aesr-151	108	11	treatment	treatment	NOUN
aesr-151	108	12	of	of	ADP
aesr-151	108	13	diabetes	diabetes	NOUN
aesr-151	108	14	,	,	PUNCT
aesr-151	108	15	resulting	result	VERB
aesr-151	108	16	in	in	ADP
aesr-151	108	17	inhibition	inhibition	NOUN
aesr-151	108	18	of	of	ADP
aesr-151	108	19	starch	starch	NOUN
aesr-151	108	20	breaking	breaking	NOUN
aesr-151	108	21	and	and	CCONJ
aesr-151	108	22	decreases	decrease	VERB
aesr-151	108	23	levels	level	NOUN
aesr-151	108	24	of	of	ADP
aesr-151	108	25	blood	blood	NOUN
aesr-151	108	26	glucose	glucose	NOUN
aesr-151	108	27	[	[	X
aesr-151	108	28	16	16	NUM
aesr-151	108	29	]	]	PUNCT
aesr-151	108	30	.	.	PUNCT
aesr-151	109	1	because	because	SCONJ
aesr-151	109	2	of	of	ADP
aesr-151	109	3	the	the	DET
aesr-151	109	4	harmful	harmful	ADJ
aesr-151	109	5	side	side	NOUN
aesr-151	109	6	-	-	PUNCT
aesr-151	109	7	effects	effect	NOUN
aesr-151	109	8	of	of	ADP
aesr-151	109	9	synthetic	synthetic	ADJ
aesr-151	109	10	products	product	NOUN
aesr-151	109	11	and	and	CCONJ
aesr-151	109	12	the	the	DET
aesr-151	109	13	fact	fact	NOUN
aesr-151	109	14	that	that	SCONJ
aesr-151	109	15	plants	plant	NOUN
aesr-151	109	16	are	be	AUX
aesr-151	109	17	easily	easily	ADV
aesr-151	109	18	accessible	accessible	ADJ
aesr-151	109	19	,	,	PUNCT
aesr-151	109	20	interest	interest	NOUN
aesr-151	109	21	in	in	ADP
aesr-151	109	22	drugs	drug	NOUN
aesr-151	109	23	of	of	ADP
aesr-151	109	24	herbal	herbal	ADJ
aesr-151	109	25	origin	origin	NOUN
aesr-151	109	26	has	have	AUX
aesr-151	109	27	significantly	significantly	ADV
aesr-151	109	28	increased	increase	VERB
aesr-151	109	29	.	.	PUNCT
aesr-151	110	1	our	our	PRON
aesr-151	110	2	present	present	ADJ
aesr-151	110	3	biochemical	biochemical	ADJ
aesr-151	110	4	data	datum	NOUN
aesr-151	110	5	in	in	ADP
aesr-151	110	6	the	the	DET
aesr-151	110	7	patulintreated	patulintreate	VERB
aesr-151	110	8	rats	rat	NOUN
aesr-151	110	9	showed	show	VERB
aesr-151	110	10	an	an	DET
aesr-151	110	11	obvious	obvious	ADJ
aesr-151	110	12	increasing	increase	VERB
aesr-151	110	13	(	(	PUNCT
aesr-151	110	14	p<0.001	p<0.001	X
aesr-151	110	15	)	)	PUNCT
aesr-151	110	16	in	in	ADP
aesr-151	110	17	pancreatic	pancreatic	ADJ
aesr-151	110	18	levels	level	NOUN
aesr-151	110	19	of	of	ADP
aesr-151	110	20	amylase	amylase	NOUN
aesr-151	110	21	as	as	SCONJ
aesr-151	110	22	it	it	PRON
aesr-151	110	23	is	be	AUX
aesr-151	110	24	shown	show	VERB
aesr-151	110	25	in	in	ADP
aesr-151	110	26	table	table	NOUN
aesr-151	110	27	.	.	PUNCT
aesr-151	111	1	1	1	NUM
aesr-151	111	2	and	and	CCONJ
aesr-151	111	3	fig.3	fig.3	PROPN
aesr-151	111	4	.	.	PUNCT
aesr-151	112	1	these	these	DET
aesr-151	112	2	elevation	elevation	NOUN
aesr-151	112	3	levels	level	NOUN
aesr-151	112	4	attributed	attribute	VERB
aesr-151	112	5	to	to	ADP
aesr-151	112	6	acute	acute	PROPN
aesr-151	112	7	pancreatitis	pancreatitis	PROPN
aesr-151	112	8	caused	cause	VERB
aesr-151	112	9	by	by	ADP
aesr-151	112	10	patulin	patulin	NOUN
aesr-151	112	11	[	[	X
aesr-151	112	12	17	17	NUM
aesr-151	112	13	]	]	PUNCT
aesr-151	112	14	.	.	PUNCT
aesr-151	113	1	also	also	ADV
aesr-151	113	2	,	,	PUNCT
aesr-151	113	3	many	many	ADJ
aesr-151	113	4	reports	report	NOUN
aesr-151	113	5	have	have	AUX
aesr-151	113	6	dealt	deal	VERB
aesr-151	113	7	with	with	ADP
aesr-151	113	8	the	the	DET
aesr-151	113	9	relationship	relationship	NOUN
aesr-151	113	10	between	between	ADP
aesr-151	113	11	blood	blood	NOUN
aesr-151	113	12	amylase	amylase	NOUN
aesr-151	113	13	and	and	CCONJ
aesr-151	113	14	carbohydrate	carbohydrate	VERB
aesr-151	113	15	metabolism	metabolism	NOUN
aesr-151	113	16	[	[	X
aesr-151	113	17	18	18	NUM
aesr-151	113	18	-	-	PUNCT
aesr-151	113	19	20]or	20]or	NUM
aesr-151	113	20	hormones	hormone	NOUN
aesr-151	113	21	that	that	PRON
aesr-151	113	22	affect	affect	VERB
aesr-151	113	23	carbohydrate	carbohydrate	VERB
aesr-151	113	24	metabolism	metabolism	NOUN
aesr-151	113	25	[	[	X
aesr-151	113	26	20	20	NUM
aesr-151	113	27	-	-	PUNCT
aesr-151	113	28	22].these	22].these	NUM
aesr-151	113	29	studies	study	NOUN
aesr-151	113	30	showed	show	VERB
aesr-151	113	31	that	that	SCONJ
aesr-151	113	32	high	high	ADJ
aesr-151	113	33	levels	level	NOUN
aesr-151	113	34	of	of	ADP
aesr-151	113	35	amylase	amylase	NOUN
aesr-151	113	36	result	result	NOUN
aesr-151	113	37	from	from	ADP
aesr-151	113	38	administration	administration	NOUN
aesr-151	113	39	of	of	ADP
aesr-151	113	40	hormones	hormone	NOUN
aesr-151	113	41	that	that	PRON
aesr-151	113	42	decreases	decrease	VERB
aesr-151	113	43	utilization	utilization	NOUN
aesr-151	113	44	of	of	ADP
aesr-151	113	45	carbohydrate	carbohydrate	NOUN
aesr-151	113	46	or	or	CCONJ
aesr-151	113	47	in	in	ADP
aesr-151	113	48	physiological	physiological	ADJ
aesr-151	113	49	states	state	NOUN
aesr-151	113	50	of	of	ADP
aesr-151	113	51	diminished	diminished	ADJ
aesr-151	113	52	carbohydrate	carbohydrate	NOUN
aesr-151	113	53	utilization	utilization	NOUN
aesr-151	113	54	.	.	PUNCT
aesr-151	114	1	another	another	DET
aesr-151	114	2	parameter	parameter	NOUN
aesr-151	114	3	is	be	AUX
aesr-151	114	4	lipase	lipase	NOUN
aesr-151	114	5	,	,	PUNCT
aesr-151	114	6	which	which	PRON
aesr-151	114	7	is	be	AUX
aesr-151	114	8	triacylglycerol	triacylglycerol	NOUN
aesr-151	114	9	acylhydrolase	acylhydrolase	NOUN
aesr-151	114	10	and	and	CCONJ
aesr-151	114	11	an	an	DET
aesr-151	114	12	omnipresent	omnipresent	NOUN
aesr-151	114	13	enzyme	enzyme	NOUN
aesr-151	114	14	with	with	ADP
aesr-151	114	15	physiological	physiological	ADJ
aesr-151	114	16	significance	significance	NOUN
aesr-151	114	17	and	and	CCONJ
aesr-151	114	18	industrial	industrial	ADJ
aesr-151	114	19	potential	potential	NOUN
aesr-151	114	20	.	.	PUNCT
aesr-151	115	1	it	it	PRON
aesr-151	115	2	catalyzes	catalyze	VERB
aesr-151	115	3	the	the	DET
aesr-151	115	4	hydrolysis	hydrolysis	NOUN
aesr-151	115	5	of	of	ADP
aesr-151	115	6	triglycerides	triglyceride	NOUN
aesr-151	115	7	to	to	PART
aesr-151	115	8	glycerol	glycerol	NOUN
aesr-151	115	9	and	and	CCONJ
aesr-151	115	10	free	free	ADJ
aesr-151	115	11	fatty	fatty	NOUN
aesr-151	115	12	acids	acid	NOUN
aesr-151	115	13	.	.	PUNCT
aesr-151	116	1	it	it	PRON
aesr-151	116	2	is	be	AUX
aesr-151	116	3	soluble	soluble	ADJ
aesr-151	116	4	in	in	ADP
aesr-151	116	5	water	water	NOUN
aesr-151	116	6	and	and	CCONJ
aesr-151	116	7	hydrolyzes	hydrolyze	VERB
aesr-151	116	8	insoluble	insoluble	ADJ
aesr-151	116	9	substrates	substrate	NOUN
aesr-151	116	10	to	to	ADP
aesr-151	116	11	more	more	ADV
aesr-151	116	12	polar	polar	ADJ
aesr-151	116	13	lipolytic	lipolytic	ADJ
aesr-151	116	14	products	product	NOUN
aesr-151	116	15	.	.	PUNCT
aesr-151	117	1	lipase	lipase	NOUN
aesr-151	117	2	is	be	AUX
aesr-151	117	3	released	release	VERB
aesr-151	117	4	from	from	ADP
aesr-151	117	5	pancreatic	pancreatic	ADJ
aesr-151	117	6	acinar	acinar	NOUN
aesr-151	117	7	cells	cell	NOUN
aesr-151	117	8	and	and	CCONJ
aesr-151	117	9	reabsorbed	reabsorb	VERB
aesr-151	117	10	by	by	ADP
aesr-151	117	11	the	the	DET
aesr-151	117	12	kidney	kidney	NOUN
aesr-151	117	13	tubules	tubule	NOUN
aesr-151	117	14	so	so	ADV
aesr-151	117	15	,	,	PUNCT
aesr-151	117	16	it	it	PRON
aesr-151	117	17	remains	remain	VERB
aesr-151	117	18	elevated	elevated	ADJ
aesr-151	117	19	for	for	ADP
aesr-151	117	20	prolonged	prolonged	ADJ
aesr-151	117	21	period	period	NOUN
aesr-151	117	22	which	which	PRON
aesr-151	117	23	may	may	AUX
aesr-151	117	24	be	be	AUX
aesr-151	117	25	helpful	helpful	ADJ
aesr-151	117	26	in	in	ADP
aesr-151	117	27	late	late	ADJ
aesr-151	117	28	presenting	presenting	NOUN
aesr-151	117	29	cases	case	NOUN
aesr-151	118	1	[	[	X
aesr-151	118	2	23	23	NUM
aesr-151	118	3	]	]	PUNCT
aesr-151	118	4	.	.	PUNCT
aesr-151	119	1	in	in	ADP
aesr-151	119	2	this	this	DET
aesr-151	119	3	study	study	NOUN
aesr-151	119	4	,	,	PUNCT
aesr-151	119	5	there	there	PRON
aesr-151	119	6	is	be	VERB
aesr-151	119	7	non	non	ADJ
aesr-151	119	8	-	-	ADJ
aesr-151	119	9	significant	significant	ADJ
aesr-151	119	10	(	(	PUNCT
aesr-151	119	11	p>0.05	p>0.05	NOUN
aesr-151	119	12	)	)	PUNCT
aesr-151	119	13	change	change	NOUN
aesr-151	119	14	between	between	ADP
aesr-151	119	15	patulin	patulin	PROPN
aesr-151	119	16	treated	treat	VERB
aesr-151	119	17	group	group	NOUN
aesr-151	119	18	and	and	CCONJ
aesr-151	119	19	control	control	NOUN
aesr-151	119	20	as	as	SCONJ
aesr-151	119	21	it	it	PRON
aesr-151	119	22	is	be	AUX
aesr-151	119	23	shown	show	VERB
aesr-151	119	24	from	from	ADP
aesr-151	119	25	table	table	NOUN
aesr-151	119	26	.	.	PUNCT
aesr-151	120	1	1	1	X
aesr-151	120	2	.	.	NUM
aesr-151	120	3	and	and	CCONJ
aesr-151	120	4	fig.4	fig.4	PROPN
aesr-151	120	5	.	.	PUNCT
aesr-151	120	6	where	where	SCONJ
aesr-151	120	7	,	,	PUNCT
aesr-151	120	8	many	many	ADJ
aesr-151	120	9	studies	study	NOUN
aesr-151	120	10	have	have	AUX
aesr-151	120	11	reported	report	VERB
aesr-151	120	12	a	a	DET
aesr-151	120	13	negative	negative	ADJ
aesr-151	120	14	predictive	predictive	ADJ
aesr-151	120	15	value	value	NOUN
aesr-151	120	16	of	of	ADP
aesr-151	120	17	serum	serum	NOUN
aesr-151	120	18	lipase	lipase	NOUN
aesr-151	120	19	in	in	ADP
aesr-151	120	20	diagnosing	diagnose	VERB
aesr-151	120	21	acute	acute	PROPN
aesr-151	120	22	pancreatitis	pancreatitis	PROPN
aesr-151	120	23	to	to	PART
aesr-151	120	24	be	be	AUX
aesr-151	120	25	between	between	ADP
aesr-151	120	26	94	94	NUM
aesr-151	120	27	-100	-100	NUM
aesr-151	120	28	%	%	NOUN
aesr-151	120	29	even	even	ADV
aesr-151	120	30	if	if	SCONJ
aesr-151	120	31	amylase	amylase	NOUN
aesr-151	120	32	increases	increase	VERB
aesr-151	120	33	significantly	significantly	ADV
aesr-151	120	34	[	[	X
aesr-151	120	35	24	24	NUM
aesr-151	120	36	,	,	PUNCT
aesr-151	120	37	25	25	NUM
aesr-151	120	38	]	]	PUNCT
aesr-151	120	39	.	.	PUNCT
aesr-151	121	1	the	the	DET
aesr-151	121	2	digestive	digestive	ADJ
aesr-151	121	3	tract	tract	NOUN
aesr-151	121	4	breaks	break	VERB
aesr-151	121	5	down	down	ADP
aesr-151	121	6	carbohydrates	carbohydrate	NOUN
aesr-151	121	7	such	such	ADJ
aesr-151	121	8	as	as	ADP
aesr-151	121	9	,	,	PUNCT
aesr-151	121	10	starch	starch	NOUN
aesr-151	121	11	and	and	CCONJ
aesr-151	121	12	sugars	sugar	NOUN
aesr-151	121	13	found	find	VERB
aesr-151	121	14	in	in	ADP
aesr-151	121	15	many	many	ADJ
aesr-151	121	16	foods	food	NOUN
aesr-151	121	17	to	to	ADP
aesr-151	121	18	glucose	glucose	NOUN
aesr-151	121	19	,	,	PUNCT
aesr-151	121	20	a	a	DET
aesr-151	121	21	form	form	NOUN
aesr-151	121	22	of	of	ADP
aesr-151	121	23	sugar	sugar	NOUN
aesr-151	121	24	that	that	PRON
aesr-151	121	25	enters	enter	VERB
aesr-151	121	26	the	the	DET
aesr-151	121	27	bloodstream	bloodstream	NOUN
aesr-151	121	28	.	.	PUNCT
aesr-151	122	1	with	with	ADP
aesr-151	122	2	the	the	DET
aesr-151	122	3	help	help	NOUN
aesr-151	122	4	of	of	ADP
aesr-151	122	5	the	the	DET
aesr-151	122	6	hormone	hormone	NOUN
aesr-151	122	7	insulin	insulin	NOUN
aesr-151	122	8	,	,	PUNCT
aesr-151	122	9	cells	cell	NOUN
aesr-151	122	10	found	find	VERB
aesr-151	122	11	in	in	ADP
aesr-151	122	12	the	the	DET
aesr-151	122	13	body	body	NOUN
aesr-151	122	14	absorb	absorb	VERB
aesr-151	122	15	glucose	glucose	NOUN
aesr-151	122	16	and	and	CCONJ
aesr-151	122	17	use	use	VERB
aesr-151	122	18	it	it	PRON
aesr-151	122	19	for	for	ADP
aesr-151	122	20	energy	energy	NOUN
aesr-151	122	21	.	.	PUNCT
aesr-151	123	1	when	when	SCONJ
aesr-151	123	2	the	the	DET
aesr-151	123	3	body	body	NOUN
aesr-151	123	4	does	do	AUX
aesr-151	123	5	n't	not	PART
aesr-151	123	6	make	make	VERB
aesr-151	123	7	enough	enough	ADJ
aesr-151	123	8	insulin	insulin	NOUN
aesr-151	123	9	(	(	PUNCT
aesr-151	123	10	pancreas	pancreas	NOUN
aesr-151	123	11	dysfunction	dysfunction	NOUN
aesr-151	123	12	)	)	PUNCT
aesr-151	123	13	leading	lead	VERB
aesr-151	123	14	to	to	ADP
aesr-151	123	15	accumulation	accumulation	NOUN
aesr-151	123	16	of	of	ADP
aesr-151	123	17	sugar	sugar	NOUN
aesr-151	123	18	in	in	ADP
aesr-151	123	19	the	the	DET
aesr-151	123	20	blood	blood	NOUN
aesr-151	123	21	and	and	CCONJ
aesr-151	123	22	diabetes	diabetes	NOUN
aesr-151	123	23	.	.	PUNCT
aesr-151	124	1	in	in	ADP
aesr-151	124	2	our	our	PRON
aesr-151	124	3	study	study	NOUN
aesr-151	124	4	level	level	NOUN
aesr-151	124	5	of	of	ADP
aesr-151	124	6	glucose	glucose	NOUN
aesr-151	124	7	in	in	ADP
aesr-151	124	8	the	the	DET
aesr-151	124	9	blood	blood	NOUN
aesr-151	124	10	was	be	AUX
aesr-151	124	11	measured	measure	VERB
aesr-151	124	12	after	after	ADP
aesr-151	124	13	administration	administration	NOUN
aesr-151	124	14	of	of	ADP
aesr-151	124	15	patulin	patulin	NOUN
aesr-151	124	16	for	for	ADP
aesr-151	124	17	two	two	NUM
aesr-151	124	18	weeks	week	NOUN
aesr-151	124	19	(	(	PUNCT
aesr-151	124	20	g	g	NOUN
aesr-151	124	21	i	i	PROPN
aesr-151	124	22	)	)	PUNCT
aesr-151	124	23	and	and	CCONJ
aesr-151	124	24	it	it	PRON
aesr-151	124	25	shows	show	VERB
aesr-151	124	26	highly	highly	ADV
aesr-151	124	27	significant	significant	ADJ
aesr-151	124	28	increase	increase	NOUN
aesr-151	124	29	(	(	PUNCT
aesr-151	124	30	p<0.05	p<0.05	NOUN
aesr-151	124	31	)	)	PUNCT
aesr-151	124	32	in	in	ADP
aesr-151	124	33	the	the	DET
aesr-151	124	34	mean	mean	ADJ
aesr-151	124	35	value	value	NOUN
aesr-151	124	36	in	in	ADP
aesr-151	124	37	table	table	NOUN
aesr-151	124	38	1	1	NUM
aesr-151	124	39	and	and	CCONJ
aesr-151	124	40	fig	fig	NOUN
aesr-151	124	41	5	5	NUM
aesr-151	124	42	.	.	PUNCT
aesr-151	125	1	this	this	PRON
aesr-151	125	2	leads	lead	VERB
aesr-151	125	3	to	to	ADP
aesr-151	125	4	damaging	damage	VERB
aesr-151	125	5	nerves	nerve	NOUN
aesr-151	125	6	and	and	CCONJ
aesr-151	125	7	blood	blood	NOUN
aesr-151	125	8	vessels	vessel	NOUN
aesr-151	125	9	and	and	CCONJ
aesr-151	125	10	thus	thus	ADV
aesr-151	125	11	complications	complication	NOUN
aesr-151	125	12	such	such	ADJ
aesr-151	125	13	as	as	ADP
aesr-151	125	14	heart	heart	NOUN
aesr-151	125	15	disease	disease	NOUN
aesr-151	125	16	,	,	PUNCT
aesr-151	125	17	stroke	stroke	NOUN
aesr-151	125	18	,	,	PUNCT
aesr-151	125	19	kidney	kidney	NOUN
aesr-151	125	20	disease	disease	NOUN
aesr-151	125	21	,	,	PUNCT
aesr-151	125	22	blindness	blindness	NOUN
aesr-151	125	23	,	,	PUNCT
aesr-151	125	24	dental	dental	ADJ
aesr-151	125	25	disease	disease	NOUN
aesr-151	125	26	,	,	PUNCT
aesr-151	125	27	and	and	CCONJ
aesr-151	125	28	amputations	amputation	NOUN
aesr-151	125	29	.	.	PUNCT
aesr-151	126	1	other	other	ADJ
aesr-151	126	2	complications	complication	NOUN
aesr-151	126	3	of	of	ADP
aesr-151	126	4	diabetes	diabetes	NOUN
aesr-151	126	5	may	may	AUX
aesr-151	126	6	increase	increase	VERB
aesr-151	126	7	susceptibility	susceptibility	NOUN
aesr-151	126	8	to	to	ADP
aesr-151	126	9	other	other	ADJ
aesr-151	126	10	diseases	disease	NOUN
aesr-151	126	11	and	and	CCONJ
aesr-151	126	12	loss	loss	NOUN
aesr-151	126	13	of	of	ADP
aesr-151	126	14	mobility	mobility	NOUN
aesr-151	126	15	with	with	ADP
aesr-151	126	16	aging	age	VERB
aesr-151	126	17	[	[	X
aesr-151	126	18	26	26	NUM
aesr-151	126	19	]	]	PUNCT
aesr-151	126	20	.	.	PUNCT
aesr-151	127	1	in	in	ADP
aesr-151	127	2	addition	addition	NOUN
aesr-151	127	3	,	,	PUNCT
aesr-151	127	4	c	c	NOUN
aesr-151	127	5	-	-	PUNCT
aesr-151	127	6	peptide	peptide	NOUN
aesr-151	127	7	and	and	CCONJ
aesr-151	127	8	insulin	insulin	NOUN
aesr-151	127	9	levels	level	NOUN
aesr-151	127	10	in	in	ADP
aesr-151	127	11	serum	serum	NOUN
aesr-151	127	12	were	be	AUX
aesr-151	127	13	measured	measure	VERB
aesr-151	127	14	.	.	PUNCT
aesr-151	128	1	c	c	X
aesr-151	128	2	-	-	PUNCT
aesr-151	128	3	peptide	peptide	NOUN
aesr-151	128	4	is	be	AUX
aesr-151	128	5	produced	produce	VERB
aesr-151	128	6	in	in	ADP
aesr-151	128	7	equal	equal	ADJ
aesr-151	128	8	amounts	amount	NOUN
aesr-151	128	9	to	to	ADP
aesr-151	128	10	insulin	insulin	NOUN
aesr-151	128	11	and	and	CCONJ
aesr-151	128	12	can	can	AUX
aesr-151	128	13	therefore	therefore	ADV
aesr-151	128	14	be	be	AUX
aesr-151	128	15	used	use	VERB
aesr-151	128	16	to	to	PART
aesr-151	128	17	assess	assess	VERB
aesr-151	128	18	endogenous	endogenous	ADJ
aesr-151	128	19	insulin	insulin	NOUN
aesr-151	128	20	secretion	secretion	NOUN
aesr-151	128	21	in	in	ADP
aesr-151	128	22	type-1	type-1	PROPN
aesr-151	128	23	-	-	PUNCT
aesr-151	128	24	diabetes	diabetes	NOUN
aesr-151	128	25	.	.	PUNCT
aesr-151	129	1	the	the	DET
aesr-151	129	2	physiology	physiology	NOUN
aesr-151	129	3	of	of	ADP
aesr-151	129	4	cpeptide	cpeptide	NOUN
aesr-151	129	5	makes	make	VERB
aesr-151	129	6	it	it	PRON
aesr-151	129	7	appropriate	appropriate	ADJ
aesr-151	129	8	for	for	ADP
aesr-151	129	9	assessing	assess	VERB
aesr-151	129	10	insulin	insulin	NOUN
aesr-151	129	11	secretion	secretion	NOUN
aesr-151	129	12	.	.	PUNCT
aesr-151	130	1	insulin	insulin	NOUN
aesr-151	130	2	is	be	AUX
aesr-151	130	3	produced	produce	VERB
aesr-151	130	4	in	in	ADP
aesr-151	130	5	the	the	DET
aesr-151	130	6	pancreatic	pancreatic	ADJ
aesr-151	130	7	b	b	NOUN
aesr-151	130	8	-	-	PUNCT
aesr-151	130	9	cells	cell	NOUN
aesr-151	130	10	by	by	ADP
aesr-151	130	11	enzymatic	enzymatic	ADJ
aesr-151	130	12	cleavage	cleavage	NOUN
aesr-151	130	13	of	of	ADP
aesr-151	130	14	the	the	DET
aesr-151	130	15	prohormone	prohormone	NOUN
aesr-151	130	16	precursor	precursor	NOUN
aesr-151	130	17	proinsulin	proinsulin	NOUN
aesr-151	130	18	to	to	PART
aesr-151	130	19	produce	produce	VERB
aesr-151	130	20	insulin	insulin	NOUN
aesr-151	130	21	and	and	CCONJ
aesr-151	130	22	c	c	NOUN
aesr-151	130	23	-	-	PUNCT
aesr-151	130	24	peptide	peptide	NOUN
aesr-151	130	25	in	in	ADP
aesr-151	130	26	equimolar	equimolar	ADJ
aesr-151	130	27	amounts	amount	NOUN
aesr-151	130	28	.	.	PUNCT
aesr-151	131	1	its	its	PRON
aesr-151	131	2	half	half	ADJ
aesr-151	131	3	-	-	PUNCT
aesr-151	131	4	life	life	NOUN
aesr-151	131	5	is	be	AUX
aesr-151	131	6	longer	long	ADJ
aesr-151	131	7	than	than	ADP
aesr-151	131	8	insulin	insulin	NOUN
aesr-151	131	9	(	(	PUNCT
aesr-151	131	10	20–30	20–30	NUM
aesr-151	131	11	vs.	vs.	ADP
aesr-151	131	12	3–5	3–5	NUM
aesr-151	131	13	min	min	NOUN
aesr-151	131	14	)	)	PUNCT
aesr-151	131	15	and	and	CCONJ
aesr-151	131	16	it	it	PRON
aesr-151	131	17	therefore	therefore	ADV
aesr-151	131	18	circulates	circulate	VERB
aesr-151	131	19	at	at	ADP
aesr-151	131	20	concentrations	concentration	NOUN
aesr-151	131	21	approximately	approximately	ADV
aesr-151	131	22	five	five	NUM
aesr-151	131	23	times	time	NOUN
aesr-151	131	24	higher	high	ADJ
aesr-151	131	25	in	in	ADP
aesr-151	131	26	the	the	DET
aesr-151	131	27	systemic	systemic	ADJ
aesr-151	131	28	circulation	circulation	NOUN
aesr-151	131	29	[	[	X
aesr-151	131	30	27	27	NUM
aesr-151	131	31	,	,	PUNCT
aesr-151	131	32	28	28	NUM
aesr-151	131	33	]	]	PUNCT
aesr-151	131	34	.	.	PUNCT
aesr-151	132	1	from	from	ADP
aesr-151	132	2	table.1	table.1	PROPN
aesr-151	132	3	and	and	CCONJ
aesr-151	132	4	fig.6	fig.6	VERB
aesr-151	132	5	it	it	PRON
aesr-151	132	6	is	be	AUX
aesr-151	132	7	cleared	clear	VERB
aesr-151	132	8	that	that	PRON
aesr-151	132	9	mean	mean	VERB
aesr-151	132	10	value	value	NOUN
aesr-151	132	11	of	of	ADP
aesr-151	132	12	c	c	NOUN
aesr-151	132	13	-	-	PUNCT
aesr-151	132	14	peptide	peptide	NOUN
aesr-151	132	15	in	in	ADP
aesr-151	132	16	rats	rat	NOUN
aesr-151	132	17	treated	treat	VERB
aesr-151	132	18	with	with	ADP
aesr-151	132	19	patulin	patulin	PROPN
aesr-151	132	20	shows	show	VERB
aesr-151	132	21	significant	significant	ADJ
aesr-151	132	22	decrease	decrease	NOUN
aesr-151	132	23	(	(	PUNCT
aesr-151	132	24	p	p	X
aesr-151	132	25	>	>	X
aesr-151	132	26	0.05	0.05	NUM
aesr-151	132	27	)	)	PUNCT
aesr-151	132	28	compared	compare	VERB
aesr-151	132	29	with	with	ADP
aesr-151	132	30	control	control	NOUN
aesr-151	132	31	.	.	PUNCT
aesr-151	133	1	this	this	DET
aesr-151	133	2	scarce	scarce	ADJ
aesr-151	133	3	value	value	NOUN
aesr-151	133	4	confirms	confirm	VERB
aesr-151	133	5	previous	previous	ADJ
aesr-151	133	6	results	result	NOUN
aesr-151	133	7	obtained	obtain	VERB
aesr-151	133	8	from	from	ADP
aesr-151	133	9	amylase	amylase	NOUN
aesr-151	133	10	and	and	CCONJ
aesr-151	133	11	glucose	glucose	NOUN
aesr-151	133	12	that	that	PRON
aesr-151	133	13	is	be	AUX
aesr-151	133	14	patulin	patulin	ADJ
aesr-151	133	15	induced	induced	ADJ
aesr-151	133	16	type	type	NOUN
aesr-151	133	17	1	1	NUM
aesr-151	133	18	diabetes	diabetes	NOUN
aesr-151	133	19	in	in	ADP
aesr-151	133	20	male	male	ADJ
aesr-151	133	21	rats	rat	NOUN
aesr-151	133	22	after	after	ADP
aesr-151	133	23	subcutaneous	subcutaneous	ADJ
aesr-151	133	24	injection	injection	NOUN
aesr-151	133	25	for	for	ADP
aesr-151	133	26	2	2	NUM
aesr-151	133	27	weeks	week	NOUN
aesr-151	133	28	.	.	PUNCT
aesr-151	134	1	because	because	SCONJ
aesr-151	134	2	dropped	drop	VERB
aesr-151	134	3	levels	level	NOUN
aesr-151	134	4	of	of	ADP
aesr-151	134	5	c	c	NOUN
aesr-151	134	6	-	-	PUNCT
aesr-151	134	7	peptide	peptide	NOUN
aesr-151	134	8	means	mean	VERB
aesr-151	134	9	significant	significant	ADJ
aesr-151	134	10	destruction	destruction	NOUN
aesr-151	134	11	of	of	ADP
aesr-151	134	12	β	β	NOUN
aesr-151	134	13	-	-	NOUN
aesr-151	134	14	cells	cell	NOUN
aesr-151	134	15	and	and	CCONJ
aesr-151	134	16	only	only	ADV
aesr-151	134	17	10	10	NUM
aesr-151	134	18	%	%	NOUN
aesr-151	134	19	of	of	ADP
aesr-151	134	20	normal	normal	ADJ
aesr-151	134	21	cell	cell	NOUN
aesr-151	134	22	mass	mass	NOUN
aesr-151	134	23	remains	remain	VERB
aesr-151	134	24	[	[	X
aesr-151	134	25	29	29	NUM
aesr-151	134	26	]	]	PUNCT
aesr-151	134	27	.	.	PUNCT
aesr-151	135	1	insulin	insulin	NOUN
aesr-151	135	2	is	be	AUX
aesr-151	135	3	known	know	VERB
aesr-151	135	4	to	to	PART
aesr-151	135	5	facilitate	facilitate	VERB
aesr-151	135	6	the	the	DET
aesr-151	135	7	absorption	absorption	NOUN
aesr-151	135	8	of	of	ADP
aesr-151	135	9	glucose	glucose	NOUN
aesr-151	135	10	through	through	ADP
aesr-151	135	11	the	the	DET
aesr-151	135	12	specialized	specialized	ADJ
aesr-151	135	13	membrane	membrane	NOUN
aesr-151	135	14	of	of	ADP
aesr-151	135	15	the	the	DET
aesr-151	135	16	insulin	insulin	NOUN
aesr-151	135	17	sensitive	sensitive	ADJ
aesr-151	135	18	cells	cell	NOUN
aesr-151	135	19	which	which	PRON
aesr-151	135	20	invariably	invariably	ADV
aesr-151	135	21	results	result	VERB
aesr-151	135	22	in	in	ADP
aesr-151	135	23	an	an	DET
aesr-151	135	24	increase	increase	NOUN
aesr-151	135	25	in	in	ADP
aesr-151	135	26	blood	blood	NOUN
aesr-151	135	27	glucose	glucose	NOUN
aesr-151	135	28	level	level	NOUN
aesr-151	135	29	due	due	ADJ
aesr-151	135	30	to	to	ADP
aesr-151	135	31	delayed	delay	VERB
aesr-151	135	32	glucose	glucose	NOUN
aesr-151	135	33	uptake	uptake	ADJ
aesr-151	135	34	[	[	X
aesr-151	135	35	30	30	NUM
aesr-151	135	36	]	]	PUNCT
aesr-151	135	37	.	.	PUNCT
aesr-151	136	1	data	datum	NOUN
aesr-151	136	2	from	from	ADP
aesr-151	136	3	table.1	table.1	PROPN
aesr-151	136	4	and	and	CCONJ
aesr-151	136	5	fig.7	fig.7	ADJ
aesr-151	136	6	.	.	PUNCT
aesr-151	136	7	show	show	VERB
aesr-151	136	8	that	that	SCONJ
aesr-151	136	9	there	there	PRON
aesr-151	136	10	is	be	VERB
aesr-151	136	11	significant	significant	ADJ
aesr-151	136	12	decrease	decrease	NOUN
aesr-151	136	13	in	in	ADP
aesr-151	136	14	the	the	DET
aesr-151	136	15	mean	mean	ADJ
aesr-151	136	16	value	value	NOUN
aesr-151	136	17	(	(	PUNCT
aesr-151	136	18	p	p	X
aesr-151	136	19	>	>	X
aesr-151	136	20	0.05	0.05	NUM
aesr-151	136	21	)	)	PUNCT
aesr-151	136	22	compared	compare	VERB
aesr-151	136	23	with	with	ADP
aesr-151	136	24	control	control	NOUN
aesr-151	136	25	.	.	PUNCT
aesr-151	137	1	insulin	insulin	NOUN
aesr-151	137	2	and	and	CCONJ
aesr-151	137	3	glucagon	glucagon	NOUN
aesr-151	137	4	have	have	VERB
aesr-151	137	5	distinct	distinct	ADJ
aesr-151	137	6	actions	action	NOUN
aesr-151	137	7	in	in	ADP
aesr-151	137	8	diabetes	diabetes	NOUN
aesr-151	137	9	where	where	SCONJ
aesr-151	137	10	,	,	PUNCT
aesr-151	137	11	they	they	PRON
aesr-151	137	12	show	show	VERB
aesr-151	137	13	that	that	SCONJ
aesr-151	137	14	the	the	DET
aesr-151	137	15	impairment	impairment	NOUN
aesr-151	137	16	of	of	ADP
aesr-151	137	17	pancreatic	pancreatic	ADJ
aesr-151	137	18	exocrine	exocrine	NOUN
aesr-151	137	19	functions	function	NOUN
aesr-151	137	20	is	be	AUX
aesr-151	137	21	due	due	ADJ
aesr-151	137	22	to	to	ADP
aesr-151	137	23	insulin	insulin	NOUN
aesr-151	137	24	deficiency	deficiency	NOUN
aesr-151	137	25	and	and	CCONJ
aesr-151	137	26	relative	relative	ADJ
aesr-151	137	27	glucagon	glucagon	NOUN
aesr-151	137	28	predominance	predominance	NOUN
aesr-151	138	1	[	[	X
aesr-151	138	2	31	31	NUM
aesr-151	138	3	]	]	PUNCT
aesr-151	138	4	.	.	PUNCT
aesr-151	139	1	this	this	DET
aesr-151	139	2	reducing	reducing	NOUN
aesr-151	139	3	of	of	ADP
aesr-151	139	4	insulin	insulin	NOUN
aesr-151	139	5	caused	cause	VERB
aesr-151	139	6	by	by	ADP
aesr-151	139	7	patulin	patulin	NOUN
aesr-151	139	8	in	in	ADP
aesr-151	139	9	g	g	PROPN
aesr-151	140	1	i	i	PRON
aesr-151	140	2	affect	affect	VERB
aesr-151	140	3	on	on	ADP
aesr-151	140	4	pancreatic	pancreatic	ADJ
aesr-151	140	5	function	function	NOUN
aesr-151	140	6	resulting	result	VERB
aesr-151	140	7	in	in	ADP
aesr-151	140	8	changes	change	NOUN
aesr-151	140	9	in	in	ADP
aesr-151	140	10	the	the	DET
aesr-151	140	11	composition	composition	NOUN
aesr-151	140	12	and	and	CCONJ
aesr-151	140	13	quality	quality	NOUN
aesr-151	140	14	of	of	ADP
aesr-151	140	15	pancreatic	pancreatic	ADJ
aesr-151	140	16	juice	juice	NOUN
aesr-151	140	17	as	as	ADV
aesr-151	140	18	well	well	ADV
aesr-151	140	19	as	as	ADP
aesr-151	140	20	its	its	PRON
aesr-151	140	21	decreased	decrease	VERB
aesr-151	140	22	production	production	NOUN
aesr-151	140	23	leading	lead	VERB
aesr-151	140	24	to	to	ADP
aesr-151	140	25	accumulation	accumulation	NOUN
aesr-151	140	26	of	of	ADP
aesr-151	140	27	glucose	glucose	NOUN
aesr-151	140	28	in	in	ADP
aesr-151	140	29	the	the	DET
aesr-151	140	30	blood	blood	NOUN
aesr-151	140	31	and	and	CCONJ
aesr-151	140	32	this	this	PRON
aesr-151	140	33	agreed	agree	VERB
aesr-151	140	34	with	with	ADP
aesr-151	140	35	the	the	DET
aesr-151	140	36	increasing	increasing	NOUN
aesr-151	140	37	in	in	ADP
aesr-151	140	38	serum	serum	NOUN
aesr-151	140	39	glucose	glucose	NOUN
aesr-151	140	40	showed	show	VERB
aesr-151	140	41	in	in	ADP
aesr-151	140	42	fig.5	fig.5	PROPN
aesr-151	140	43	.	.	PUNCT
aesr-151	141	1	[	[	X
aesr-151	141	2	32	32	NUM
aesr-151	141	3	]	]	PUNCT
aesr-151	141	4	.	.	PUNCT
aesr-151	142	1	from	from	ADP
aesr-151	142	2	table	table	NOUN
aesr-151	142	3	1	1	NUM
aesr-151	142	4	we	we	PRON
aesr-151	142	5	observe	observe	VERB
aesr-151	142	6	that	that	SCONJ
aesr-151	142	7	levels	level	NOUN
aesr-151	142	8	of	of	ADP
aesr-151	142	9	amylase	amylase	NOUN
aesr-151	142	10	,	,	PUNCT
aesr-151	142	11	glucose	glucose	NOUN
aesr-151	142	12	and	and	CCONJ
aesr-151	142	13	c	c	NOUN
aesr-151	142	14	-	-	PUNCT
aesr-151	142	15	peptide	peptide	NOUN
aesr-151	142	16	return	return	NOUN
aesr-151	142	17	to	to	ADP
aesr-151	142	18	normal	normal	ADJ
aesr-151	142	19	values	value	NOUN
aesr-151	142	20	of	of	ADP
aesr-151	142	21	control	control	NOUN
aesr-151	142	22	in	in	ADP
aesr-151	142	23	group	group	PROPN
aesr-151	142	24	ii	ii	PROPN
aesr-151	142	25	and	and	CCONJ
aesr-151	142	26	group	group	PROPN
aesr-151	142	27	iii	iii	PROPN
aesr-151	142	28	(	(	PUNCT
aesr-151	142	29	treatment	treatment	NOUN
aesr-151	142	30	with	with	ADP
aesr-151	142	31	goji	goji	NOUN
aesr-151	142	32	extract	extract	NOUN
aesr-151	142	33	after	after	ADP
aesr-151	142	34	and	and	CCONJ
aesr-151	142	35	before	before	ADP
aesr-151	142	36	patulin	patulin	NOUN
aesr-151	142	37	respectively	respectively	ADV
aesr-151	142	38	)	)	PUNCT
aesr-151	142	39	and	and	CCONJ
aesr-151	142	40	also	also	ADV
aesr-151	142	41	,	,	PUNCT
aesr-151	142	42	observe	observe	VERB
aesr-151	142	43	that	that	SCONJ
aesr-151	142	44	insulin	insulin	NOUN
aesr-151	142	45	levels	level	NOUN
aesr-151	142	46	show	show	VERB
aesr-151	142	47	highly	highly	ADV
aesr-151	142	48	significant	significant	ADJ
aesr-151	142	49	increase	increase	NOUN
aesr-151	142	50	compared	compare	VERB
aesr-151	142	51	to	to	ADP
aesr-151	142	52	control	control	VERB
aesr-151	142	53	.	.	PUNCT
aesr-151	143	1	the	the	DET
aesr-151	143	2	most	most	ADV
aesr-151	143	3	effective	effective	ADJ
aesr-151	143	4	methods	method	NOUN
aesr-151	143	5	for	for	ADP
aesr-151	143	6	treatment	treatment	NOUN
aesr-151	143	7	of	of	ADP
aesr-151	143	8	diabetes	diabetes	NOUN
aesr-151	143	9	are	be	AUX
aesr-151	143	10	inhibition	inhibition	NOUN
aesr-151	143	11	of	of	ADP
aesr-151	143	12	digestion	digestion	NOUN
aesr-151	143	13	and	and	CCONJ
aesr-151	143	14	absorption	absorption	NOUN
aesr-151	143	15	of	of	ADP
aesr-151	143	16	carbohydrates	carbohydrate	NOUN
aesr-151	143	17	in	in	ADP
aesr-151	143	18	small	small	ADJ
aesr-151	143	19	intestine	intestine	NOUN
aesr-151	143	20	.	.	PUNCT
aesr-151	144	1	that	that	PRON
aesr-151	144	2	is	be	AUX
aesr-151	144	3	happening	happen	VERB
aesr-151	144	4	in	in	ADP
aesr-151	144	5	two	two	NUM
aesr-151	144	6	manners	manner	NOUN
aesr-151	144	7	,	,	PUNCT
aesr-151	144	8	the	the	DET
aesr-151	144	9	first	first	ADJ
aesr-151	144	10	is	be	AUX
aesr-151	144	11	inhibition	inhibition	NOUN
aesr-151	144	12	digestion	digestion	NOUN
aesr-151	144	13	of	of	ADP
aesr-151	144	14	carbohydrates	carbohydrate	NOUN
aesr-151	144	15	with	with	ADP
aesr-151	144	16	inhibition	inhibition	NOUN
aesr-151	144	17	of	of	ADP
aesr-151	144	18	alpha	alpha	ADJ
aesr-151	144	19	amylase	amylase	NOUN
aesr-151	144	20	and	and	CCONJ
aesr-151	144	21	the	the	DET
aesr-151	144	22	second	second	NOUN
aesr-151	144	23	is	be	AUX
aesr-151	144	24	inhibition	inhibition	NOUN
aesr-151	144	25	of	of	ADP
aesr-151	144	26	absorption	absorption	NOUN
aesr-151	144	27	via	via	ADP
aesr-151	144	28	sodium	sodium	NOUN
aesr-151	144	29	/	/	SYM
aesr-151	144	30	glucose	glucose	NOUN
aesr-151	144	31	co	co	NOUN
aesr-151	144	32	-	-	NOUN
aesr-151	144	33	transporters	transporter	NOUN
aesr-151	144	34	[	[	X
aesr-151	144	35	16	16	NUM
aesr-151	144	36	,	,	PUNCT
aesr-151	144	37	33	33	NUM
aesr-151	144	38	]	]	PUNCT
aesr-151	144	39	.	.	PUNCT
aesr-151	145	1	goji	goji	PROPN
aesr-151	145	2	berries	berry	NOUN
aesr-151	145	3	contain	contain	VERB
aesr-151	145	4	many	many	ADJ
aesr-151	145	5	nutrients	nutrient	NOUN
aesr-151	145	6	with	with	ADP
aesr-151	145	7	high	high	ADJ
aesr-151	145	8	biological	biological	ADJ
aesr-151	145	9	activity	activity	NOUN
aesr-151	145	10	,	,	PUNCT
aesr-151	145	11	such	such	ADJ
aesr-151	145	12	as	as	ADP
aesr-151	145	13	polysaccharides	polysaccharide	NOUN
aesr-151	145	14	,	,	PUNCT
aesr-151	145	15	carotenoids	carotenoid	NOUN
aesr-151	145	16	,	,	PUNCT
aesr-151	145	17	phenylpropanoids	phenylpropanoid	NOUN
aesr-151	145	18	and	and	CCONJ
aesr-151	145	19	others	other	NOUN
aesr-151	145	20	.	.	PUNCT
aesr-151	146	1	the	the	DET
aesr-151	146	2	polysaccharide	polysaccharide	NOUN
aesr-151	146	3	complex	complex	NOUN
aesr-151	146	4	is	be	AUX
aesr-151	146	5	the	the	DET
aesr-151	146	6	most	most	ADV
aesr-151	146	7	important	important	ADJ
aesr-151	146	8	and	and	CCONJ
aesr-151	146	9	the	the	DET
aesr-151	146	10	most	most	ADV
aesr-151	146	11	abundant	abundant	ADJ
aesr-151	146	12	group	group	NOUN
aesr-151	146	13	of	of	ADP
aesr-151	146	14	compounds	compound	NOUN
aesr-151	146	15	present	present	ADJ
aesr-151	146	16	in	in	ADP
aesr-151	146	17	goji	goji	NOUN
aesr-151	146	18	fruits	fruit	NOUN
aesr-151	146	19	where	where	SCONJ
aesr-151	146	20	it	it	PRON
aesr-151	146	21	comprises	comprise	VERB
aesr-151	146	22	5	5	NUM
aesr-151	146	23	-	-	SYM
aesr-151	146	24	8	8	NUM
aesr-151	146	25	%	%	NOUN
aesr-151	146	26	of	of	ADP
aesr-151	146	27	dried	dry	VERB
aesr-151	146	28	matter	matter	NOUN
aesr-151	146	29	of	of	ADP
aesr-151	146	30	the	the	DET
aesr-151	146	31	fruits	fruit	NOUN
aesr-151	146	32	.	.	PUNCT
aesr-151	147	1	luo	luo	PROPN
aesr-151	147	2	,	,	PUNCT
aesr-151	147	3	et	et	PROPN
aesr-151	147	4	al	al	PROPN
aesr-151	147	5	.	.	PUNCT
aesr-151	148	1	[	[	X
aesr-151	148	2	34	34	NUM
aesr-151	148	3	]	]	PUNCT
aesr-151	148	4	have	have	AUX
aesr-151	148	5	investigated	investigate	VERB
aesr-151	148	6	the	the	DET
aesr-151	148	7	relation	relation	NOUN
aesr-151	148	8	between	between	ADP
aesr-151	148	9	supplementation	supplementation	NOUN
aesr-151	148	10	with	with	ADP
aesr-151	148	11	different	different	ADJ
aesr-151	148	12	polysaccharide	polysaccharide	NOUN
aesr-151	148	13	fractions	fraction	NOUN
aesr-151	148	14	of	of	ADP
aesr-151	148	15	goji	goji	NOUN
aesr-151	148	16	fruit	fruit	NOUN
aesr-151	148	17	and	and	CCONJ
aesr-151	148	18	the	the	DET
aesr-151	148	19	levels	level	NOUN
aesr-151	148	20	of	of	ADP
aesr-151	148	21	glucose	glucose	NOUN
aesr-151	148	22	in	in	ADP
aesr-151	148	23	blood	blood	NOUN
aesr-151	148	24	.	.	PUNCT
aesr-151	149	1	lowered	lower	VERB
aesr-151	149	2	blood	blood	NOUN
aesr-151	149	3	glucose	glucose	NOUN
aesr-151	149	4	levels	level	NOUN
aesr-151	149	5	were	be	AUX
aesr-151	149	6	recognized	recognize	VERB
aesr-151	149	7	as	as	ADP
aesr-151	149	8	substantial	substantial	ADJ
aesr-151	149	9	hypoglycemic	hypoglycemic	ADJ
aesr-151	149	10	effects	effect	NOUN
aesr-151	149	11	.	.	PUNCT
aesr-151	150	1	it	it	PRON
aesr-151	150	2	was	be	AUX
aesr-151	150	3	found	find	VERB
aesr-151	150	4	that	that	SCONJ
aesr-151	150	5	all	all	DET
aesr-151	150	6	goji	goji	NOUN
aesr-151	150	7	preparations	preparation	NOUN
aesr-151	150	8	resulted	result	VERB
aesr-151	150	9	in	in	ADP
aesr-151	150	10	significantly	significantly	ADV
aesr-151	150	11	decreased	decrease	VERB
aesr-151	150	12	blood	blood	NOUN
aesr-151	150	13	glucose	glucose	NOUN
aesr-151	150	14	levels	level	NOUN
aesr-151	150	15	after	after	ADP
aesr-151	150	16	10	10	NUM
aesr-151	150	17	days	day	NOUN
aesr-151	150	18	of	of	ADP
aesr-151	150	19	treatment	treatment	NOUN
aesr-151	150	20	in	in	ADP
aesr-151	150	21	the	the	DET
aesr-151	150	22	tested	test	VERB
aesr-151	150	23	animals	animal	NOUN
aesr-151	150	24	,	,	PUNCT
aesr-151	150	25	indicating	indicate	VERB
aesr-151	150	26	that	that	SCONJ
aesr-151	150	27	there	there	PRON
aesr-151	150	28	was	be	VERB
aesr-151	150	29	hypoglycemic	hypoglycemic	ADJ
aesr-151	150	30	effect	effect	NOUN
aesr-151	150	31	.	.	PUNCT
aesr-151	151	1	implying	imply	VERB
aesr-151	151	2	that	that	SCONJ
aesr-151	151	3	l.	l.	PROPN
aesr-151	151	4	barbarumpolysaccharides	barbarumpolysaccharides	PROPN
aesr-151	151	5	were	be	AUX
aesr-151	151	6	major	major	ADJ
aesr-151	151	7	bioactive	bioactive	ADJ
aesr-151	151	8	components	component	NOUN
aesr-151	151	9	in	in	ADP
aesr-151	151	10	the	the	DET
aesr-151	151	11	hypoglycemiceffect	hypoglycemiceffect	NOUN
aesr-151	151	12	.	.	PUNCT
aesr-151	152	1	also	also	ADV
aesr-151	152	2	,	,	PUNCT
aesr-151	152	3	antioxidative	antioxidative	ADJ
aesr-151	152	4	protective	protective	ADJ
aesr-151	152	5	mechanisms	mechanism	NOUN
aesr-151	152	6	illustrated	illustrate	VERB
aesr-151	152	7	by	by	ADP
aesr-151	152	8	li	li	PROPN
aesr-151	153	1	[	[	X
aesr-151	153	2	35	35	NUM
aesr-151	153	3	]	]	PUNCT
aesr-151	153	4	who	who	PRON
aesr-151	153	5	said	say	VERB
aesr-151	153	6	that	that	SCONJ
aesr-151	153	7	after	after	ADP
aesr-151	153	8	goji	goji	NOUN
aesr-151	153	9	polysaccharide	polysaccharide	NOUN
aesr-151	153	10	fractions	fraction	NOUN
aesr-151	153	11	treatment	treatment	NOUN
aesr-151	153	12	,	,	PUNCT
aesr-151	153	13	the	the	DET
aesr-151	153	14	antioxidative	antioxidative	ADJ
aesr-151	153	15	activity	activity	NOUN
aesr-151	153	16	of	of	ADP
aesr-151	153	17	superoxide	superoxide	NOUN
aesr-151	153	18	dismutase	dismutase	NOUN
aesr-151	153	19	,	,	PUNCT
aesr-151	153	20	catalase	catalase	NOUN
aesr-151	153	21	and	and	CCONJ
aesr-151	153	22	glutathione	glutathione	NOUN
aesr-151	153	23	was	be	AUX
aesr-151	153	24	significantly	significantly	ADV
aesr-151	153	25	increased	increase	VERB
aesr-151	153	26	.	.	PUNCT
aesr-151	154	1	moreover	moreover	ADV
aesr-151	154	2	,	,	PUNCT
aesr-151	154	3	free	free	ADJ
aesr-151	154	4	radical	radical	ADJ
aesr-151	154	5	scavenging	scavenge	VERB
aesr-151	154	6	activity	activity	NOUN
aesr-151	154	7	was	be	AUX
aesr-151	154	8	also	also	ADV
aesr-151	154	9	elevated	elevate	VERB
aesr-151	154	10	.	.	PUNCT
aesr-151	155	1	in	in	ADP
aesr-151	155	2	conclusion	conclusion	NOUN
aesr-151	155	3	,	,	PUNCT
aesr-151	155	4	this	this	DET
aesr-151	155	5	study	study	NOUN
aesr-151	155	6	illustrates	illustrate	VERB
aesr-151	155	7	that	that	SCONJ
aesr-151	155	8	patulin	patulin	NOUN
aesr-151	155	9	is	be	AUX
aesr-151	155	10	cytotoxic	cytotoxic	ADJ
aesr-151	155	11	to	to	AUX
aesr-151	155	12	ins-1	ins-1	VERB
aesr-151	155	13	cells	cell	NOUN
aesr-151	155	14	,	,	PUNCT
aesr-151	155	15	leading	lead	VERB
aesr-151	155	16	to	to	ADP
aesr-151	155	17	the	the	DET
aesr-151	155	18	possibility	possibility	NOUN
aesr-151	155	19	of	of	ADP
aesr-151	155	20	this	this	DET
aesr-151	155	21	compound	compound	NOUN
aesr-151	155	22	may	may	AUX
aesr-151	155	23	contribute	contribute	VERB
aesr-151	155	24	to	to	ADP
aesr-151	155	25	the	the	DET
aesr-151	155	26	development	development	NOUN
aesr-151	155	27	of	of	ADP
aesr-151	155	28	diabetes	diabetes	NOUN
aesr-151	155	29	,	,	PUNCT
aesr-151	155	30	the	the	DET
aesr-151	155	31	assumption	assumption	NOUN
aesr-151	155	32	being	be	AUX
aesr-151	155	33	that	that	SCONJ
aesr-151	155	34	this	this	DET
aesr-151	155	35	secondary	secondary	ADJ
aesr-151	155	36	product	product	NOUN
aesr-151	155	37	can	can	AUX
aesr-151	155	38	be	be	AUX
aesr-151	155	39	transported	transport	VERB
aesr-151	155	40	to	to	ADP
aesr-151	155	41	the	the	DET
aesr-151	155	42	pancreas	pancrea	NOUN
aesr-151	155	43	via	via	ADP
aesr-151	155	44	the	the	DET
aesr-151	155	45	blood	blood	NOUN
aesr-151	155	46	from	from	ADP
aesr-151	155	47	the	the	DET
aesr-151	155	48	source	source	NOUN
aesr-151	155	49	of	of	ADP
aesr-151	155	50	its	its	PRON
aesr-151	155	51	production	production	NOUN
aesr-151	155	52	.	.	PUNCT
aesr-151	156	1	and	and	CCONJ
aesr-151	156	2	this	this	DET
aesr-151	156	3	study	study	NOUN
aesr-151	156	4	confirmed	confirm	VERB
aesr-151	156	5	hypoglycemic	hypoglycemic	ADJ
aesr-151	156	6	effect	effect	NOUN
aesr-151	156	7	of	of	ADP
aesr-151	156	8	lbp	lbp	PROPN
aesr-151	156	9	found	find	VERB
aesr-151	156	10	in	in	ADP
aesr-151	156	11	goji	goji	NOUN
aesr-151	156	12	berries	berry	NOUN
aesr-151	156	13	.	.	PUNCT
aesr-151	157	1	references	reference	NOUN
aesr-151	157	2	[	[	X
aesr-151	157	3	1	1	NUM
aesr-151	157	4	]	]	PUNCT
aesr-151	157	5	a.	a.	NOUN
aesr-151	157	6	v.	v.	PROPN
aesr-151	157	7	christian	christian	PROPN
aesr-151	157	8	,	,	PUNCT
aesr-151	157	9	v.	v.	PROPN
aesr-151	157	10	s.	s.	PROPN
aesr-151	157	11	bianca	bianca	PROPN
aesr-151	157	12	,	,	PUNCT
aesr-151	157	13	g.	g.	PROPN
aesr-151	157	14	attila	attila	PROPN
aesr-151	157	15	,	,	PUNCT
aesr-151	157	16	k.	k.	PROPN
aesr-151	157	17	helmut	helmut	PROPN
aesr-151	157	18	,	,	PUNCT
aesr-151	157	19	l.	l.	PROPN
aesr-151	157	20	reinhard	reinhard	PROPN
aesr-151	157	21	,	,	PUNCT
aesr-151	157	22	s.	s.	PROPN
aesr-151	157	23	wilhelm	wilhelm	PROPN
aesr-151	157	24	,	,	PUNCT
aesr-151	157	25	and	and	CCONJ
aesr-151	157	26	s.	s.	PROPN
aesr-151	157	27	siegfried	siegfrie	VERB
aesr-151	157	28	,	,	PUNCT
aesr-151	157	29	"	"	PUNCT
aesr-151	157	30	enhanced	enhance	VERB
aesr-151	157	31	mycotoxin	mycotoxin	NOUN
aesr-151	157	32	production	production	NOUN
aesr-151	157	33	of	of	ADP
aesr-151	157	34	a	a	DET
aesr-151	157	35	lipase	lipase	NOUN
aesr-151	157	36	-	-	PUNCT
aesr-151	157	37	deficient	deficient	ADJ
aesr-151	157	38	fusarium	fusarium	NOUN
aesr-151	157	39	graminearum	graminearum	NOUN
aesr-151	157	40	mutant	mutant	NOUN
aesr-151	157	41	correlates	correlate	VERB
aesr-151	157	42	to	to	ADP
aesr-151	157	43	toxin	toxin	NOUN
aesr-151	157	44	-	-	PUNCT
aesr-151	157	45	related	relate	VERB
aesr-151	157	46	gene	gene	NOUN
aesr-151	157	47	expression	expression	NOUN
aesr-151	157	48	,	,	PUNCT
aesr-151	157	49	"	"	PUNCT
aesr-151	157	50	european	european	ADJ
aesr-151	157	51	journal	journal	PROPN
aesr-151	157	52	of	of	ADP
aesr-151	157	53	plant	plant	NOUN
aesr-151	157	54	pathology	pathology	NOUN
aesr-151	157	55	,	,	PUNCT
aesr-151	157	56	vol	vol	NOUN
aesr-151	157	57	.	.	PROPN
aesr-151	157	58	117	117	NUM
aesr-151	157	59	,	,	PUNCT
aesr-151	157	60	pp	pp	PROPN
aesr-151	157	61	.	.	PUNCT
aesr-151	158	1	1–12	1–12	NOUN
aesr-151	158	2	,	,	PUNCT
aesr-151	158	3	2007	2007	NUM
aesr-151	158	4	.	.	PUNCT
aesr-151	159	1	view	view	NOUN
aesr-151	159	2	at	at	ADP
aesr-151	159	3	google	google	PROPN
aesr-151	159	4	scholar	scholar	NOUN
aesr-151	159	5	https://scholar.google.com/scholar?hl=en&q=enhanced%20mycotoxin%20production%20of%20a%20lipase-deficient%20fusarium%20graminearum%20mutant%20correlates%20to%20toxin-related%20gene%20expression	https://scholar.google.com/scholar?hl=en&q=enhanced%20mycotoxin%20production%20of%20a%20lipase-deficient%20fusarium%20graminearum%20mutant%20correlates%20to%20toxin-related%20gene%20expression	NOUN
aesr-151	159	6	agriculture	agriculture	NOUN
aesr-151	159	7	and	and	CCONJ
aesr-151	159	8	food	food	NOUN
aesr-151	159	9	sciences	sciences	PROPN
aesr-151	159	10	research	research	NOUN
aesr-151	159	11	,	,	PUNCT
aesr-151	159	12	2017	2017	NUM
aesr-151	159	13	,	,	PUNCT
aesr-151	159	14	4(1	4(1	NOUN
aesr-151	159	15	):	):	PUNCT
aesr-151	159	16	24	24	NUM
aesr-151	159	17	-	-	SYM
aesr-151	159	18	29	29	NUM
aesr-151	159	19	29	29	NUM
aesr-151	159	20	[	[	X
aesr-151	159	21	2	2	NUM
aesr-151	159	22	]	]	PUNCT
aesr-151	159	23	b.	b.	PROPN
aesr-151	159	24	n.	n.	PROPN
aesr-151	159	25	raid	raid	PROPN
aesr-151	159	26	,	,	PUNCT
aesr-151	159	27	a.	a.	PROPN
aesr-151	159	28	r.	r.	PROPN
aesr-151	159	29	mark	mark	PROPN
aesr-151	159	30	,	,	PUNCT
aesr-151	159	31	c.	c.	PROPN
aesr-151	159	32	abdesslam	abdesslam	PROPN
aesr-151	159	33	,	,	PUNCT
aesr-151	159	34	m.	m.	NOUN
aesr-151	159	35	a.	a.	PROPN
aesr-151	159	36	john	john	PROPN
aesr-151	159	37	,	,	PUNCT
aesr-151	159	38	and	and	CCONJ
aesr-151	159	39	l.	l.	PROPN
aesr-151	159	40	g.	g.	PROPN
aesr-151	159	41	martyn	martyn	PROPN
aesr-151	159	42	,	,	PUNCT
aesr-151	159	43	"	"	PUNCT
aesr-151	159	44	effects	effect	NOUN
aesr-151	159	45	of	of	ADP
aesr-151	159	46	the	the	DET
aesr-151	159	47	microbial	microbial	ADJ
aesr-151	159	48	secondary	secondary	ADJ
aesr-151	159	49	metabolites	metabolite	NOUN
aesr-151	159	50	pyrrolnitrin	pyrrolnitrin	NOUN
aesr-151	159	51	,	,	PUNCT
aesr-151	159	52	phenazine	phenazine	NOUN
aesr-151	159	53	and	and	CCONJ
aesr-151	159	54	patulin	patulin	ADJ
aesr-151	159	55	on	on	ADP
aesr-151	159	56	ins-1	ins-1	NUM
aesr-151	159	57	rat	rat	NOUN
aesr-151	159	58	pancreatic	pancreatic	ADJ
aesr-151	159	59	β	β	NOUN
aesr-151	159	60	-	-	NOUN
aesr-151	159	61	cells	cell	NOUN
aesr-151	159	62	,	,	PUNCT
aesr-151	159	63	"	"	PUNCT
aesr-151	159	64	fems	fems	PROPN
aesr-151	159	65	immunol	immunol	PROPN
aesr-151	159	66	med	med	PROPN
aesr-151	159	67	microbiol	microbiol	PROPN
aesr-151	159	68	,	,	PUNCT
aesr-151	159	69	vol	vol	NOUN
aesr-151	159	70	.	.	PROPN
aesr-151	159	71	63	63	NUM
aesr-151	159	72	,	,	PUNCT
aesr-151	159	73	pp	pp	ADJ
aesr-151	159	74	.	.	PUNCT
aesr-151	160	1	217–227	217–227	NUM
aesr-151	160	2	,	,	PUNCT
aesr-151	160	3	2011	2011	NUM
aesr-151	160	4	.	.	PUNCT
aesr-151	161	1	view	view	NOUN
aesr-151	161	2	at	at	ADP
aesr-151	161	3	google	google	PROPN
aesr-151	161	4	scholar	scholar	NOUN
aesr-151	161	5	|	|	ADV
aesr-151	161	6	view	view	NOUN
aesr-151	161	7	at	at	ADP
aesr-151	161	8	publisher	publisher	NOUN
aesr-151	161	9	[	[	X
aesr-151	161	10	3	3	X
aesr-151	161	11	]	]	PUNCT
aesr-151	161	12	w.	w.	PROPN
aesr-151	161	13	m.	m.	PROPN
aesr-151	161	14	tang	tang	PROPN
aesr-151	161	15	,	,	PUNCT
aesr-151	161	16	e.	e.	PROPN
aesr-151	161	17	chan	chan	PROPN
aesr-151	161	18	,	,	PUNCT
aesr-151	161	19	c.	c.	PROPN
aesr-151	161	20	y.	y.	PROPN
aesr-151	161	21	kwok	kwok	PROPN
aesr-151	161	22	,	,	PUNCT
aesr-151	161	23	y.	y.	PROPN
aesr-151	161	24	k.	k.	PROPN
aesr-151	161	25	lee	lee	PROPN
aesr-151	161	26	,	,	PUNCT
aesr-151	161	27	j.	j.	PROPN
aesr-151	161	28	h.	h.	PROPN
aesr-151	161	29	wu	wu	PROPN
aesr-151	161	30	,	,	PUNCT
aesr-151	161	31	c.	c.	PROPN
aesr-151	161	32	w.	w.	PROPN
aesr-151	161	33	wan	wan	PROPN
aesr-151	161	34	,	,	PUNCT
aesr-151	161	35	r.	r.	PROPN
aesr-151	161	36	y.	y.	PROPN
aesr-151	161	37	chan	chan	PROPN
aesr-151	161	38	,	,	PUNCT
aesr-151	161	39	p.	p.	PROPN
aesr-151	161	40	h.	h.	PROPN
aesr-151	161	41	yu	yu	PROPN
aesr-151	161	42	,	,	PUNCT
aesr-151	161	43	and	and	CCONJ
aesr-151	161	44	s.	s.	PROPN
aesr-151	161	45	w.	w.	PROPN
aesr-151	161	46	chan	chan	PROPN
aesr-151	161	47	,	,	PUNCT
aesr-151	161	48	"	"	PUNCT
aesr-151	161	49	a	a	DET
aesr-151	161	50	review	review	NOUN
aesr-151	161	51	of	of	ADP
aesr-151	161	52	the	the	DET
aesr-151	161	53	anticancer	anticancer	NOUN
aesr-151	161	54	and	and	CCONJ
aesr-151	161	55	immunomodulatory	immunomodulatory	ADJ
aesr-151	161	56	effects	effect	NOUN
aesr-151	161	57	of	of	ADP
aesr-151	161	58	lycium	lycium	NOUN
aesr-151	161	59	barbarum	barbarum	NOUN
aesr-151	161	60	fruit	fruit	NOUN
aesr-151	161	61	,	,	PUNCT
aesr-151	161	62	"	"	PUNCT
aesr-151	161	63	inflammopharmacology	inflammopharmacology	NOUN
aesr-151	161	64	,	,	PUNCT
aesr-151	161	65	vol	vol	NOUN
aesr-151	161	66	.	.	PROPN
aesr-151	161	67	20	20	NUM
aesr-151	161	68	,	,	PUNCT
aesr-151	161	69	pp	pp	ADJ
aesr-151	161	70	.	.	PUNCT
aesr-151	162	1	307–314	307–314	NUM
aesr-151	162	2	,	,	PUNCT
aesr-151	162	3	2012	2012	NUM
aesr-151	162	4	.	.	PUNCT
aesr-151	163	1	view	view	NOUN
aesr-151	163	2	at	at	ADP
aesr-151	163	3	google	google	PROPN
aesr-151	163	4	scholar	scholar	NOUN
aesr-151	163	5	[	[	X
aesr-151	163	6	4	4	NUM
aesr-151	163	7	]	]	X
aesr-151	163	8	c.	c.	PROPN
aesr-151	163	9	jiang	jiang	PROPN
aesr-151	163	10	,	,	PUNCT
aesr-151	163	11	z.	z.	PROPN
aesr-151	163	12	zhi	zhi	PROPN
aesr-151	163	13	-	-	PUNCT
aesr-151	163	14	wei	wei	PROPN
aesr-151	163	15	,	,	PUNCT
aesr-151	163	16	s.	s.	PROPN
aesr-151	163	17	hui	hui	PROPN
aesr-151	163	18	-	-	PUNCT
aesr-151	163	19	ping	ping	PROPN
aesr-151	163	20	,	,	PUNCT
aesr-151	163	21	h.	h.	PROPN
aesr-151	163	22	lan	lan	PROPN
aesr-151	163	23	-	-	PUNCT
aesr-151	163	24	jie	jie	PROPN
aesr-151	163	25	,	,	PUNCT
aesr-151	163	26	f.	f.	PROPN
aesr-151	163	27	xue	xue	PROPN
aesr-151	163	28	-	-	PUNCT
aesr-151	163	29	wen	wen	PROPN
aesr-151	163	30	,	,	PUNCT
aesr-151	163	31	h.	h.	PROPN
aesr-151	163	32	zhi	zhi	PROPN
aesr-151	163	33	-	-	PROPN
aesr-151	163	34	xu	xu	PROPN
aesr-151	163	35	,	,	PUNCT
aesr-151	163	36	s.	s.	PROPN
aesr-151	163	37	tao	tao	PROPN
aesr-151	163	38	,	,	PUNCT
aesr-151	163	39	z.	z.	PROPN
aesr-151	163	40	xueji	xueji	PROPN
aesr-151	163	41	,	,	PUNCT
aesr-151	163	42	j.	j.	PROPN
aesr-151	163	43	z.	z.	PROPN
aesr-151	163	44	ruan	ruan	PROPN
aesr-151	163	45	,	,	PUNCT
aesr-151	163	46	g.	g.	PROPN
aesr-151	163	47	ling	ling	PROPN
aesr-151	163	48	,	,	PUNCT
aesr-151	163	49	c.	c.	PROPN
aesr-151	163	50	chuanhai	chuanhai	PROPN
aesr-151	163	51	,	,	PUNCT
aesr-151	163	52	and	and	CCONJ
aesr-151	163	53	z.	z.	PROPN
aesr-151	163	54	shu	shu	PROPN
aesr-151	163	55	-	-	PUNCT
aesr-151	163	56	feng	feng	PROPN
aesr-151	163	57	,	,	PUNCT
aesr-151	163	58	"	"	PUNCT
aesr-151	163	59	an	an	DET
aesr-151	163	60	evidence	evidence	NOUN
aesr-151	163	61	-	-	PUNCT
aesr-151	163	62	based	base	VERB
aesr-151	163	63	update	update	NOUN
aesr-151	163	64	on	on	ADP
aesr-151	163	65	the	the	DET
aesr-151	163	66	pharmacological	pharmacological	ADJ
aesr-151	163	67	activities	activity	NOUN
aesr-151	163	68	and	and	CCONJ
aesr-151	163	69	possible	possible	ADJ
aesr-151	163	70	molecular	molecular	ADJ
aesr-151	163	71	targets	target	NOUN
aesr-151	163	72	of	of	ADP
aesr-151	163	73	lycium	lycium	NOUN
aesr-151	163	74	barbarum	barbarum	NOUN
aesr-151	163	75	polysaccharides	polysaccharide	NOUN
aesr-151	163	76	,	,	PUNCT
aesr-151	163	77	"	"	PUNCT
aesr-151	163	78	drug	drug	NOUN
aesr-151	163	79	design	design	NOUN
aesr-151	163	80	,	,	PUNCT
aesr-151	163	81	development	development	NOUN
aesr-151	163	82	and	and	CCONJ
aesr-151	163	83	therapy	therapy	NOUN
aesr-151	163	84	,	,	PUNCT
aesr-151	163	85	vol	vol	NOUN
aesr-151	163	86	.	.	PROPN
aesr-151	163	87	9	9	NUM
aesr-151	163	88	,	,	PUNCT
aesr-151	163	89	pp	pp	ADJ
aesr-151	163	90	.	.	PUNCT
aesr-151	164	1	33–78	33–78	NUM
aesr-151	164	2	,	,	PUNCT
aesr-151	164	3	2015	2015	NUM
aesr-151	164	4	.	.	PUNCT
aesr-151	165	1	view	view	NOUN
aesr-151	165	2	at	at	ADP
aesr-151	165	3	google	google	PROPN
aesr-151	165	4	scholar	scholar	NOUN
aesr-151	165	5	|	|	ADV
aesr-151	165	6	view	view	NOUN
aesr-151	165	7	at	at	ADP
aesr-151	165	8	publisher	publisher	NOUN
aesr-151	166	1	[	[	X
aesr-151	166	2	5	5	X
aesr-151	166	3	]	]	PUNCT
aesr-151	166	4	k.	k.	PROPN
aesr-151	166	5	bartosz	bartosz	PROPN
aesr-151	166	6	and	and	CCONJ
aesr-151	166	7	a.	a.	NOUN
aesr-151	166	8	gramza	gramza	NOUN
aesr-151	166	9	-	-	PUNCT
aesr-151	166	10	michałowska	michałowska	ADJ
aesr-151	166	11	,	,	PUNCT
aesr-151	166	12	"	"	PUNCT
aesr-151	166	13	goji	goji	NOUN
aesr-151	166	14	berry	berry	NOUN
aesr-151	166	15	(	(	PUNCT
aesr-151	166	16	lycium	lycium	NOUN
aesr-151	166	17	barbarum	barbarum	NOUN
aesr-151	166	18	):	):	PUNCT
aesr-151	166	19	composition	composition	NOUN
aesr-151	166	20	and	and	CCONJ
aesr-151	166	21	health	health	NOUN
aesr-151	166	22	effects	effect	NOUN
aesr-151	166	23	–	–	PUNCT
aesr-151	166	24	a	a	DET
aesr-151	166	25	review	review	NOUN
aesr-151	166	26	,	,	PUNCT
aesr-151	166	27	"	"	PUNCT
aesr-151	166	28	polish	polish	ADJ
aesr-151	166	29	journal	journal	NOUN
aesr-151	166	30	of	of	ADP
aesr-151	166	31	food	food	NOUN
aesr-151	166	32	and	and	CCONJ
aesr-151	166	33	nutrition	nutrition	NOUN
aesr-151	166	34	sciences	science	NOUN
aesr-151	166	35	,	,	PUNCT
aesr-151	166	36	vol	vol	NOUN
aesr-151	166	37	.	.	PROPN
aesr-151	166	38	66	66	NUM
aesr-151	166	39	,	,	PUNCT
aesr-151	166	40	pp	pp	ADJ
aesr-151	166	41	.	.	PUNCT
aesr-151	167	1	67–75	67–75	NUM
aesr-151	167	2	,	,	PUNCT
aesr-151	167	3	2016	2016	NUM
aesr-151	167	4	.	.	PUNCT
aesr-151	168	1	view	view	NOUN
aesr-151	168	2	at	at	ADP
aesr-151	168	3	google	google	PROPN
aesr-151	168	4	scholar	scholar	NOUN
aesr-151	168	5	[	[	X
aesr-151	168	6	6	6	NUM
aesr-151	168	7	]	]	PUNCT
aesr-151	168	8	q.	q.	PROPN
aesr-151	168	9	y.	y.	PROPN
aesr-151	168	10	li	li	PROPN
aesr-151	168	11	,	,	PUNCT
aesr-151	168	12	healthy	healthy	ADJ
aesr-151	168	13	functions	function	NOUN
aesr-151	168	14	and	and	CCONJ
aesr-151	168	15	medicinal	medicinal	ADJ
aesr-151	168	16	prescriptions	prescription	NOUN
aesr-151	168	17	of	of	ADP
aesr-151	168	18	lycium	lycium	NOUN
aesr-151	168	19	barbarum	barbarum	NOUN
aesr-151	168	20	(	(	PUNCT
aesr-151	168	21	gou	gou	PROPN
aesr-151	168	22	ji	ji	PROPN
aesr-151	168	23	zi	zi	PROPN
aesr-151	168	24	)	)	PUNCT
aesr-151	168	25	.	.	PUNCT
aesr-151	169	1	beijing	beijing	PROPN
aesr-151	169	2	:	:	PUNCT
aesr-151	169	3	jindun	jindun	PROPN
aesr-151	169	4	press	press	PROPN
aesr-151	169	5	.	.	PUNCT
aesr-151	170	1	pp	pp	ADP
aesr-151	170	2	:	:	PUNCT
aesr-151	170	3	1	1	NUM
aesr-151	170	4	-	-	SYM
aesr-151	170	5	16	16	NUM
aesr-151	170	6	,	,	PUNCT
aesr-151	170	7	2001	2001	NUM
aesr-151	170	8	.	.	PUNCT
aesr-151	171	1	[	[	X
aesr-151	171	2	7	7	X
aesr-151	171	3	]	]	PUNCT
aesr-151	171	4	a.	a.	NOUN
aesr-151	171	5	harunobu	harunobu	NOUN
aesr-151	171	6	and	and	CCONJ
aesr-151	171	7	r.	r.	PROPN
aesr-151	171	8	f.	f.	PROPN
aesr-151	171	9	norman	norman	PROPN
aesr-151	171	10	,	,	PUNCT
aesr-151	171	11	"	"	PUNCT
aesr-151	171	12	a	a	DET
aesr-151	171	13	review	review	NOUN
aesr-151	171	14	of	of	ADP
aesr-151	171	15	botanical	botanical	ADJ
aesr-151	171	16	characteristics	characteristic	NOUN
aesr-151	171	17	,	,	PUNCT
aesr-151	171	18	phytochemistry	phytochemistry	NOUN
aesr-151	171	19	,	,	PUNCT
aesr-151	171	20	clinical	clinical	ADJ
aesr-151	171	21	relevance	relevance	NOUN
aesr-151	171	22	in	in	ADP
aesr-151	171	23	efficacy	efficacy	NOUN
aesr-151	171	24	and	and	CCONJ
aesr-151	171	25	safety	safety	NOUN
aesr-151	171	26	of	of	ADP
aesr-151	171	27	lycium	lycium	NOUN
aesr-151	171	28	barbarum	barbarum	NOUN
aesr-151	171	29	fruit	fruit	NOUN
aesr-151	171	30	(	(	PUNCT
aesr-151	171	31	goji	goji	NOUN
aesr-151	171	32	)	)	PUNCT
aesr-151	171	33	,	,	PUNCT
aesr-151	171	34	"	"	PUNCT
aesr-151	171	35	food	food	NOUN
aesr-151	171	36	research	research	NOUN
aesr-151	171	37	international	international	ADJ
aesr-151	171	38	,	,	PUNCT
aesr-151	171	39	vol	vol	NOUN
aesr-151	171	40	.	.	PROPN
aesr-151	171	41	44	44	NUM
aesr-151	171	42	,	,	PUNCT
aesr-151	171	43	pp	pp	ADJ
aesr-151	171	44	.	.	PUNCT
aesr-151	172	1	1702–1717	1702–1717	NUM
aesr-151	172	2	,	,	PUNCT
aesr-151	172	3	2011	2011	NUM
aesr-151	172	4	.	.	PUNCT
aesr-151	173	1	view	view	NOUN
aesr-151	173	2	at	at	ADP
aesr-151	173	3	google	google	PROPN
aesr-151	173	4	scholar	scholar	NOUN
aesr-151	173	5	|	|	ADV
aesr-151	173	6	view	view	NOUN
aesr-151	173	7	at	at	ADP
aesr-151	173	8	publisher	publisher	NOUN
aesr-151	173	9	[	[	X
aesr-151	173	10	8	8	X
aesr-151	173	11	]	]	PUNCT
aesr-151	174	1	s.	s.	PROPN
aesr-151	174	2	yang	yang	PROPN
aesr-151	174	3	and	and	CCONJ
aesr-151	174	4	x.	x.	PROPN
aesr-151	174	5	baojun	baojun	PROPN
aesr-151	174	6	,	,	PUNCT
aesr-151	174	7	"	"	PUNCT
aesr-151	174	8	diffusion	diffusion	NOUN
aesr-151	174	9	profiles	profile	NOUN
aesr-151	174	10	of	of	ADP
aesr-151	174	11	health	health	NOUN
aesr-151	174	12	beneficial	beneficial	ADJ
aesr-151	174	13	components	component	NOUN
aesr-151	174	14	from	from	ADP
aesr-151	174	15	goji	goji	PROPN
aesr-151	174	16	berry	berry	NOUN
aesr-151	174	17	(	(	PUNCT
aesr-151	174	18	lyceum	lyceum	NOUN
aesr-151	174	19	barbarum	barbarum	NOUN
aesr-151	174	20	)	)	PUNCT
aesr-151	174	21	marinated	marinate	VERB
aesr-151	174	22	in	in	ADP
aesr-151	174	23	alcohol	alcohol	NOUN
aesr-151	174	24	and	and	CCONJ
aesr-151	174	25	their	their	PRON
aesr-151	174	26	antioxidant	antioxidant	ADJ
aesr-151	174	27	capacities	capacity	NOUN
aesr-151	174	28	as	as	SCONJ
aesr-151	174	29	affected	affect	VERB
aesr-151	174	30	by	by	ADP
aesr-151	174	31	alcohol	alcohol	NOUN
aesr-151	174	32	concentration	concentration	NOUN
aesr-151	174	33	and	and	CCONJ
aesr-151	174	34	steeping	steeping	NOUN
aesr-151	174	35	time	time	NOUN
aesr-151	174	36	,	,	PUNCT
aesr-151	174	37	"	"	PUNCT
aesr-151	174	38	foods	food	NOUN
aesr-151	174	39	,	,	PUNCT
aesr-151	174	40	vol	vol	NOUN
aesr-151	174	41	.	.	PROPN
aesr-151	175	1	2	2	NUM
aesr-151	175	2	,	,	PUNCT
aesr-151	175	3	pp	pp	ADJ
aesr-151	175	4	.	.	PUNCT
aesr-151	176	1	32	32	NUM
aesr-151	176	2	-	-	SYM
aesr-151	176	3	42	42	NUM
aesr-151	176	4	,	,	PUNCT
aesr-151	176	5	2013	2013	NUM
aesr-151	176	6	.	.	PUNCT
aesr-151	177	1	view	view	NOUN
aesr-151	177	2	at	at	ADP
aesr-151	177	3	google	google	PROPN
aesr-151	177	4	scholar	scholar	NOUN
aesr-151	177	5	|	|	ADV
aesr-151	177	6	view	view	NOUN
aesr-151	177	7	at	at	ADP
aesr-151	177	8	publisher	publisher	NOUN
aesr-151	177	9	[	[	X
aesr-151	177	10	9	9	X
aesr-151	177	11	]	]	X
aesr-151	177	12	j.	j.	PROPN
aesr-151	177	13	ranson	ranson	PROPN
aesr-151	177	14	,	,	PUNCT
aesr-151	177	15	"	"	PUNCT
aesr-151	177	16	curr	curr	PROPN
aesr-151	177	17	prob	prob	PROPN
aesr-151	177	18	surg	surg	PROPN
aesr-151	177	19	1979	1979	NUM
aesr-151	177	20	;	;	PUNCT
aesr-151	177	21	16:1	16:1	NUM
aesr-151	177	22	.	.	PROPN
aesr-151	177	23	salt	salt	PROPN
aesr-151	177	24	wb	wb	PROPN
aesr-151	177	25	ii	ii	PROPN
aesr-151	177	26	,	,	PUNCT
aesr-151	177	27	schnker	schnker	PROPN
aesr-151	177	28	s.	s.	PROPN
aesr-151	177	29	medicine	medicine	PROPN
aesr-151	177	30	1976	1976	NUM
aesr-151	177	31	;	;	PUNCT
aesr-151	178	1	55:269	55:269	NUM
aesr-151	178	2	.	.	PUNCT
aesr-151	178	3	stefanini	stefanini	PROPN
aesr-151	178	4	p	p	PROPN
aesr-151	178	5	,	,	PUNCT
aesr-151	178	6	ermini	ermini	PROPN
aesr-151	178	7	m	m	PROPN
aesr-151	178	8	,	,	PUNCT
aesr-151	178	9	j	j	PROPN
aesr-151	178	10	am	be	AUX
aesr-151	178	11	surg	surg	NOUN
aesr-151	178	12	1965	1965	NUM
aesr-151	178	13	;	;	PUNCT
aesr-151	178	14	110:866	110:866	PROPN
aesr-151	178	15	henry	henry	PROPN
aesr-151	178	16	rj	rj	PROPN
aesr-151	178	17	,	,	PUNCT
aesr-151	178	18	chiamori	chiamori	PROPN
aesr-151	178	19	n.	n.	PROPN
aesr-151	178	20	clin	clin	PROPN
aesr-151	178	21	chem	chem	NOUN
aesr-151	178	22	19610	19610	NUM
aesr-151	178	23	;	;	PUNCT
aesr-151	178	24	6:434	6:434	NUM
aesr-151	178	25	.	.	PUNCT
aesr-151	179	1	kaufman	kaufman	PROPN
aesr-151	179	2	ra	ra	PROPN
aesr-151	179	3	,	,	PUNCT
aesr-151	179	4	tietz	tietz	PROPN
aesr-151	179	5	nw	nw	PROPN
aesr-151	179	6	,	,	PUNCT
aesr-151	179	7	"	"	PUNCT
aesr-151	179	8	clinical	clinical	ADJ
aesr-151	179	9	chemistry	chemistry	NOUN
aesr-151	179	10	,	,	PUNCT
aesr-151	179	11	vol	vol	NOUN
aesr-151	179	12	.	.	PROPN
aesr-151	179	13	26	26	NUM
aesr-151	179	14	,	,	PUNCT
aesr-151	179	15	p.	p.	NOUN
aesr-151	179	16	486	486	NUM
aesr-151	179	17	,	,	PUNCT
aesr-151	179	18	1980	1980	NUM
aesr-151	179	19	.	.	PUNCT
aesr-151	180	1	[	[	X
aesr-151	180	2	10	10	NUM
aesr-151	180	3	]	]	X
aesr-151	180	4	w.	w.	PROPN
aesr-151	180	5	rick	rick	PROPN
aesr-151	180	6	,	,	PUNCT
aesr-151	180	7	"	"	PUNCT
aesr-151	180	8	zeittschrift	zeittschrift	NOUN
aesr-151	180	9	clinical	clinical	ADJ
aesr-151	180	10	chemistry	chemistry	NOUN
aesr-151	180	11	,	,	PUNCT
aesr-151	180	12	"	"	PUNCT
aesr-151	180	13	clinical	clinical	ADJ
aesr-151	180	14	biochemistry	biochemistry	NOUN
aesr-151	180	15	,	,	PUNCT
aesr-151	180	16	vol	vol	NOUN
aesr-151	180	17	.	.	PROPN
aesr-151	180	18	7	7	NUM
aesr-151	180	19	,	,	PUNCT
aesr-151	180	20	pp	pp	ADJ
aesr-151	180	21	.	.	PUNCT
aesr-151	181	1	530	530	NUM
aesr-151	181	2	–	–	PUNCT
aesr-151	181	3	536	536	NUM
aesr-151	181	4	,	,	PUNCT
aesr-151	181	5	1969	1969	NUM
aesr-151	181	6	.	.	PUNCT
aesr-151	182	1	[	[	X
aesr-151	182	2	11	11	NUM
aesr-151	182	3	]	]	PUNCT
aesr-151	182	4	p.	p.	NOUN
aesr-151	182	5	trinder	trinder	NOUN
aesr-151	182	6	,	,	PUNCT
aesr-151	182	7	"	"	PUNCT
aesr-151	182	8	determination	determination	NOUN
aesr-151	182	9	of	of	ADP
aesr-151	182	10	glucose	glucose	NOUN
aesr-151	182	11	in	in	ADP
aesr-151	182	12	blood	blood	NOUN
aesr-151	182	13	using	use	VERB
aesr-151	182	14	glucose	glucose	NOUN
aesr-151	182	15	oxidase	oxidase	NOUN
aesr-151	182	16	with	with	ADP
aesr-151	182	17	an	an	DET
aesr-151	182	18	alternative	alternative	ADJ
aesr-151	182	19	oxygen	oxygen	NOUN
aesr-151	182	20	receptor	receptor	NOUN
aesr-151	182	21	,	,	PUNCT
aesr-151	182	22	"	"	PUNCT
aesr-151	182	23	annals	annal	NOUN
aesr-151	182	24	of	of	ADP
aesr-151	182	25	clinical	clinical	ADJ
aesr-151	182	26	biochemistry	biochemistry	NOUN
aesr-151	182	27	,	,	PUNCT
aesr-151	182	28	vol	vol	NOUN
aesr-151	182	29	.	.	PROPN
aesr-151	183	1	6	6	NUM
aesr-151	183	2	,	,	PUNCT
aesr-151	183	3	pp	pp	ADJ
aesr-151	183	4	.	.	PUNCT
aesr-151	184	1	24	24	NUM
aesr-151	184	2	-	-	SYM
aesr-151	184	3	27	27	NUM
aesr-151	184	4	,	,	PUNCT
aesr-151	184	5	1969	1969	NUM
aesr-151	184	6	.	.	PUNCT
aesr-151	185	1	view	view	NOUN
aesr-151	185	2	at	at	ADP
aesr-151	185	3	publisher	publisher	NOUN
aesr-151	185	4	[	[	X
aesr-151	185	5	12	12	NUM
aesr-151	185	6	]	]	PUNCT
aesr-151	186	1	k.	k.	PROPN
aesr-151	186	2	a.	a.	PROPN
aesr-151	186	3	hans	hans	PROPN
aesr-151	186	4	,	,	PUNCT
aesr-151	186	5	v.	v.	PROPN
aesr-151	186	6	outi	outi	PROPN
aesr-151	186	7	,	,	PUNCT
aesr-151	186	8	h.	h.	PROPN
aesr-151	186	9	heikki	heikki	PROPN
aesr-151	186	10	,	,	PUNCT
aesr-151	186	11	i.	i.	PROPN
aesr-151	186	12	jorma	jorma	PROPN
aesr-151	186	13	,	,	PUNCT
aesr-151	186	14	and	and	CCONJ
aesr-151	186	15	k.	k.	PROPN
aesr-151	186	16	mikael	mikael	PROPN
aesr-151	186	17	,	,	PUNCT
aesr-151	186	18	"	"	PUNCT
aesr-151	186	19	environmental	environmental	ADJ
aesr-151	186	20	factors	factor	NOUN
aesr-151	186	21	in	in	ADP
aesr-151	186	22	the	the	DET
aesr-151	186	23	etiology	etiology	NOUN
aesr-151	186	24	of	of	ADP
aesr-151	186	25	type	type	NOUN
aesr-151	186	26	1	1	NUM
aesr-151	186	27	diabetes	diabete	NOUN
aesr-151	186	28	,	,	PUNCT
aesr-151	186	29	"	"	PUNCT
aesr-151	186	30	american	american	ADJ
aesr-151	186	31	journal	journal	PROPN
aesr-151	186	32	of	of	ADP
aesr-151	186	33	medical	medical	ADJ
aesr-151	186	34	genetics	genetic	NOUN
aesr-151	186	35	,	,	PUNCT
aesr-151	186	36	vol	vol	NOUN
aesr-151	186	37	.	.	PROPN
aesr-151	186	38	115	115	NUM
aesr-151	186	39	,	,	PUNCT
aesr-151	186	40	pp	pp	ADJ
aesr-151	186	41	.	.	PUNCT
aesr-151	186	42	18–29	18–29	NUM
aesr-151	186	43	,	,	PUNCT
aesr-151	186	44	2002	2002	NUM
aesr-151	186	45	.	.	PUNCT
aesr-151	187	1	view	view	NOUN
aesr-151	187	2	at	at	ADP
aesr-151	187	3	google	google	PROPN
aesr-151	187	4	scholar	scholar	NOUN
aesr-151	187	5	[	[	X
aesr-151	187	6	13	13	NUM
aesr-151	187	7	]	]	PUNCT
aesr-151	187	8	m.	m.	NOUN
aesr-151	187	9	a.	a.	PROPN
aesr-151	187	10	myers	myers	PROPN
aesr-151	187	11	,	,	PUNCT
aesr-151	187	12	k.	k.	PROPN
aesr-151	187	13	d.	d.	PROPN
aesr-151	187	14	hettiarachchi	hettiarachchi	PROPN
aesr-151	187	15	,	,	PUNCT
aesr-151	187	16	j.	j.	PROPN
aesr-151	187	17	ludeman	ludeman	PROPN
aesr-151	187	18	,	,	PUNCT
aesr-151	187	19	a.	a.	PROPN
aesr-151	187	20	wilson	wilson	PROPN
aesr-151	187	21	,	,	PUNCT
aesr-151	187	22	c.	c.	PROPN
aesr-151	187	23	wilson	wilson	PROPN
aesr-151	187	24	,	,	PUNCT
aesr-151	187	25	and	and	CCONJ
aesr-151	187	26	p.	p.	NOUN
aesr-151	187	27	zimmet	zimmet	NOUN
aesr-151	187	28	,	,	PUNCT
aesr-151	187	29	"	"	PUNCT
aesr-151	187	30	dietary	dietary	ADJ
aesr-151	187	31	microbial	microbial	ADJ
aesr-151	187	32	toxins	toxin	NOUN
aesr-151	187	33	and	and	CCONJ
aesr-151	187	34	type	type	NOUN
aesr-151	187	35	1	1	NUM
aesr-151	187	36	diabetes	diabetes	NOUN
aesr-151	187	37	,	,	PUNCT
aesr-151	187	38	"	"	PUNCT
aesr-151	187	39	annals	annal	NOUN
aesr-151	187	40	of	of	ADP
aesr-151	187	41	the	the	DET
aesr-151	187	42	new	new	PROPN
aesr-151	187	43	york	york	PROPN
aesr-151	187	44	academy	academy	PROPN
aesr-151	187	45	of	of	ADP
aesr-151	187	46	sciences	sciences	PROPN
aesr-151	187	47	,	,	PUNCT
aesr-151	187	48	vol	vol	NOUN
aesr-151	187	49	.	.	PUNCT
aesr-151	187	50	1005	1005	NUM
aesr-151	187	51	,	,	PUNCT
aesr-151	187	52	pp	pp	ADV
aesr-151	187	53	.	.	PUNCT
aesr-151	188	1	418–422	418–422	NUM
aesr-151	188	2	,	,	PUNCT
aesr-151	188	3	2003	2003	NUM
aesr-151	188	4	.	.	PUNCT
aesr-151	189	1	view	view	NOUN
aesr-151	189	2	at	at	ADP
aesr-151	189	3	google	google	PROPN
aesr-151	189	4	scholar	scholar	NOUN
aesr-151	189	5	[	[	X
aesr-151	189	6	14	14	NUM
aesr-151	189	7	]	]	X
aesr-151	189	8	h.	h.	PROPN
aesr-151	189	9	w.	w.	PROPN
aesr-151	189	10	peng	peng	PROPN
aesr-151	189	11	,	,	PUNCT
aesr-151	189	12	"	"	PUNCT
aesr-151	189	13	environmental	environmental	ADJ
aesr-151	189	14	factors	factor	NOUN
aesr-151	189	15	in	in	ADP
aesr-151	189	16	the	the	DET
aesr-151	189	17	development	development	NOUN
aesr-151	189	18	of	of	ADP
aesr-151	189	19	type	type	NOUN
aesr-151	189	20	1	1	NUM
aesr-151	189	21	diabetes	diabete	NOUN
aesr-151	189	22	,	,	PUNCT
aesr-151	189	23	"	"	PUNCT
aesr-151	189	24	reviews	review	NOUN
aesr-151	189	25	in	in	ADP
aesr-151	189	26	endocrine	endocrine	PROPN
aesr-151	189	27	&	&	CCONJ
aesr-151	189	28	metabolic	metabolic	NOUN
aesr-151	189	29	disorders	disorder	NOUN
aesr-151	189	30	,	,	PUNCT
aesr-151	189	31	vol	vol	NOUN
aesr-151	189	32	.	.	PROPN
aesr-151	189	33	7	7	NUM
aesr-151	189	34	,	,	PUNCT
aesr-151	189	35	pp	pp	ADJ
aesr-151	189	36	.	.	PUNCT
aesr-151	190	1	149–162	149–162	NUM
aesr-151	190	2	,	,	PUNCT
aesr-151	190	3	2006	2006	NUM
aesr-151	190	4	.	.	PUNCT
aesr-151	191	1	[	[	X
aesr-151	191	2	15	15	NUM
aesr-151	191	3	]	]	X
aesr-151	191	4	m.	m.	NOUN
aesr-151	191	5	j.	j.	PROPN
aesr-151	191	6	richer	richer	PROPN
aesr-151	191	7	and	and	CCONJ
aesr-151	191	8	m.	m.	PROPN
aesr-151	191	9	s.	s.	PROPN
aesr-151	191	10	horwitz	horwitz	PROPN
aesr-151	191	11	,	,	PUNCT
aesr-151	191	12	"	"	PUNCT
aesr-151	191	13	coxsackievirus	coxsackievirus	NOUN
aesr-151	191	14	infection	infection	NOUN
aesr-151	191	15	as	as	ADP
aesr-151	191	16	an	an	DET
aesr-151	191	17	environmental	environmental	ADJ
aesr-151	191	18	factor	factor	NOUN
aesr-151	191	19	in	in	ADP
aesr-151	191	20	the	the	DET
aesr-151	191	21	etiology	etiology	NOUN
aesr-151	191	22	of	of	ADP
aesr-151	191	23	type	type	NOUN
aesr-151	191	24	1	1	NUM
aesr-151	191	25	diabetes	diabete	NOUN
aesr-151	191	26	,	,	PUNCT
aesr-151	191	27	"	"	PUNCT
aesr-151	191	28	autoimmunity	autoimmunity	NOUN
aesr-151	191	29	reviews	review	NOUN
aesr-151	191	30	,	,	PUNCT
aesr-151	191	31	vol	vol	NOUN
aesr-151	191	32	.	.	PROPN
aesr-151	191	33	8	8	NUM
aesr-151	191	34	,	,	PUNCT
aesr-151	191	35	pp	pp	ADJ
aesr-151	191	36	.	.	PUNCT
aesr-151	192	1	611–615	611–615	NUM
aesr-151	192	2	,	,	PUNCT
aesr-151	192	3	2009	2009	NUM
aesr-151	192	4	.	.	PUNCT
aesr-151	193	1	view	view	NOUN
aesr-151	193	2	at	at	ADP
aesr-151	193	3	google	google	PROPN
aesr-151	193	4	scholar	scholar	NOUN
aesr-151	193	5	|	|	ADV
aesr-151	193	6	view	view	NOUN
aesr-151	193	7	at	at	ADP
aesr-151	193	8	publisher	publisher	NOUN
aesr-151	193	9	[	[	X
aesr-151	193	10	16	16	NUM
aesr-151	193	11	]	]	X
aesr-151	193	12	m.	m.	NOUN
aesr-151	193	13	najafian	najafian	PROPN
aesr-151	193	14	,	,	PUNCT
aesr-151	193	15	m.	m.	NOUN
aesr-151	193	16	z.	z.	PROPN
aesr-151	193	17	jahromi	jahromi	PROPN
aesr-151	193	18	,	,	PUNCT
aesr-151	193	19	and	and	CCONJ
aesr-151	193	20	m.	m.	PROPN
aesr-151	193	21	j.	j.	PROPN
aesr-151	193	22	nowroznejhad	nowroznejhad	PROPN
aesr-151	193	23	,	,	PUNCT
aesr-151	193	24	"	"	PUNCT
aesr-151	193	25	phloridzin	phloridzin	NOUN
aesr-151	193	26	reduces	reduce	VERB
aesr-151	193	27	blood	blood	NOUN
aesr-151	193	28	glucose	glucose	NOUN
aesr-151	193	29	levels	level	NOUN
aesr-151	193	30	and	and	CCONJ
aesr-151	193	31	improves	improve	VERB
aesr-151	193	32	lipids	lipids	ADJ
aesr-151	193	33	metabolism	metabolism	NOUN
aesr-151	193	34	in	in	ADP
aesr-151	193	35	streptozotocin	streptozotocin	NOUN
aesr-151	193	36	-	-	PUNCT
aesr-151	193	37	induced	induce	VERB
aesr-151	193	38	diabetic	diabetic	ADJ
aesr-151	193	39	rats	rat	NOUN
aesr-151	193	40	,	,	PUNCT
aesr-151	193	41	"	"	PUNCT
aesr-151	193	42	molecular	molecular	ADJ
aesr-151	193	43	biology	biology	NOUN
aesr-151	193	44	reports	report	NOUN
aesr-151	193	45	,	,	PUNCT
aesr-151	193	46	vol	vol	NOUN
aesr-151	193	47	.	.	PROPN
aesr-151	194	1	1	1	NUM
aesr-151	194	2	,	,	PUNCT
aesr-151	194	3	pp	pp	ADJ
aesr-151	194	4	.	.	PUNCT
aesr-151	195	1	1	1	NUM
aesr-151	195	2	-	-	SYM
aesr-151	195	3	8	8	NUM
aesr-151	195	4	,	,	PUNCT
aesr-151	195	5	2011	2011	NUM
aesr-151	195	6	.	.	PUNCT
aesr-151	196	1	[	[	X
aesr-151	196	2	17	17	NUM
aesr-151	196	3	]	]	PUNCT
aesr-151	196	4	k.	k.	PROPN
aesr-151	196	5	j.	j.	PROPN
aesr-151	196	6	carroll	carroll	PROPN
aesr-151	196	7	,	,	PUNCT
aesr-151	196	8	b.	b.	PROPN
aesr-151	196	9	herrick	herrick	PROPN
aesr-151	196	10	,	,	PUNCT
aesr-151	196	11	t.	t.	PROPN
aesr-151	196	12	gipson	gipson	PROPN
aesr-151	196	13	,	,	PUNCT
aesr-151	196	14	and	and	CCONJ
aesr-151	196	15	p.	p.	PROPN
aesr-151	196	16	l.	l.	PROPN
aesr-151	196	17	suzanne	suzanne	PROPN
aesr-151	196	18	,	,	PUNCT
aesr-151	196	19	"	"	PUNCT
aesr-151	196	20	acute	acute	ADJ
aesr-151	196	21	pancreatitis	pancreatitis	NOUN
aesr-151	196	22	:	:	PUNCT
aesr-151	196	23	diagnosis	diagnosis	NOUN
aesr-151	196	24	,	,	PUNCT
aesr-151	196	25	prognosis	prognosis	NOUN
aesr-151	196	26	,	,	PUNCT
aesr-151	196	27	and	and	CCONJ
aesr-151	196	28	treatment	treatment	NOUN
aesr-151	196	29	,	,	PUNCT
aesr-151	196	30	"	"	PUNCT
aesr-151	196	31	american	american	ADJ
aesr-151	196	32	family	family	NOUN
aesr-151	196	33	physician	physician	NOUN
aesr-151	196	34	,	,	PUNCT
aesr-151	196	35	vol	vol	NOUN
aesr-151	196	36	.	.	PROPN
aesr-151	196	37	75	75	NUM
aesr-151	196	38	,	,	PUNCT
aesr-151	196	39	pp	pp	ADJ
aesr-151	196	40	.	.	PUNCT
aesr-151	197	1	1513	1513	NUM
aesr-151	197	2	-	-	SYM
aesr-151	197	3	1520	1520	NUM
aesr-151	197	4	,	,	PUNCT
aesr-151	197	5	2007	2007	NUM
aesr-151	197	6	.	.	PUNCT
aesr-151	198	1	view	view	NOUN
aesr-151	198	2	at	at	ADP
aesr-151	198	3	google	google	PROPN
aesr-151	198	4	scholar	scholar	NOUN
aesr-151	198	5	[	[	X
aesr-151	198	6	18	18	NUM
aesr-151	198	7	]	]	X
aesr-151	198	8	d.	d.	PROPN
aesr-151	198	9	a.	a.	PROPN
aesr-151	198	10	dreiling	dreiling	PROPN
aesr-151	198	11	,	,	PUNCT
aesr-151	198	12	h.	h.	PROPN
aesr-151	198	13	d.	d.	PROPN
aesr-151	198	14	janowitz	janowitz	PROPN
aesr-151	198	15	,	,	PUNCT
aesr-151	198	16	d.	d.	PROPN
aesr-151	198	17	marshall	marshall	PROPN
aesr-151	198	18	,	,	PUNCT
aesr-151	198	19	and	and	CCONJ
aesr-151	198	20	p.	p.	PROPN
aesr-151	198	21	haemmerli	haemmerli	PROPN
aesr-151	198	22	,	,	PUNCT
aesr-151	198	23	"	"	PUNCT
aesr-151	198	24	relationship	relationship	NOUN
aesr-151	198	25	between	between	ADP
aesr-151	198	26	blood	blood	NOUN
aesr-151	198	27	amylase	amylase	NOUN
aesr-151	198	28	and	and	CCONJ
aesr-151	198	29	factors	factor	NOUN
aesr-151	198	30	affecting	affect	VERB
aesr-151	198	31	carbohydrate	carbohydrate	ADJ
aesr-151	198	32	metabolism	metabolism	NOUN
aesr-151	198	33	.	.	PUNCT
aesr-151	199	1	i.	i.	NOUN
aesr-151	199	2	the	the	DET
aesr-151	199	3	regulation	regulation	NOUN
aesr-151	199	4	of	of	ADP
aesr-151	199	5	blood	blood	NOUN
aesr-151	199	6	amylase	amylase	NOUN
aesr-151	199	7	levels	level	NOUN
aesr-151	199	8	in	in	ADP
aesr-151	199	9	subjects	subject	NOUN
aesr-151	199	10	without	without	ADP
aesr-151	199	11	pancreatic	pancreatic	ADJ
aesr-151	199	12	disease	disease	NOUN
aesr-151	199	13	,	,	PUNCT
aesr-151	199	14	"	"	PUNCT
aesr-151	199	15	american	american	ADJ
aesr-151	199	16	journal	journal	NOUN
aesr-151	199	17	of	of	ADP
aesr-151	199	18	digestive	digestive	ADJ
aesr-151	199	19	diseases	disease	NOUN
aesr-151	199	20	,	,	PUNCT
aesr-151	199	21	vol	vol	NOUN
aesr-151	199	22	.	.	PROPN
aesr-151	200	1	3	3	NUM
aesr-151	200	2	,	,	PUNCT
aesr-151	200	3	pp	pp	ADJ
aesr-151	200	4	.	.	PUNCT
aesr-151	201	1	214	214	NUM
aesr-151	201	2	–	–	SYM
aesr-151	201	3	219	219	NUM
aesr-151	201	4	,	,	PUNCT
aesr-151	201	5	1958	1958	NUM
aesr-151	201	6	.	.	PUNCT
aesr-151	202	1	view	view	NOUN
aesr-151	202	2	at	at	ADP
aesr-151	202	3	google	google	PROPN
aesr-151	202	4	scholar	scholar	NOUN
aesr-151	202	5	|	|	ADV
aesr-151	202	6	view	view	NOUN
aesr-151	202	7	at	at	ADP
aesr-151	202	8	publisher	publisher	NOUN
aesr-151	202	9	[	[	X
aesr-151	202	10	19	19	NUM
aesr-151	202	11	]	]	X
aesr-151	202	12	d.	d.	PROPN
aesr-151	202	13	a.	a.	PROPN
aesr-151	202	14	dreiling	dreiling	PROPN
aesr-151	202	15	and	and	CCONJ
aesr-151	202	16	e.	e.	PROPN
aesr-151	202	17	l.	l.	PROPN
aesr-151	202	18	bierman	bierman	PROPN
aesr-151	202	19	,	,	PUNCT
aesr-151	202	20	"	"	PUNCT
aesr-151	202	21	correlation	correlation	NOUN
aesr-151	202	22	between	between	ADP
aesr-151	202	23	plasma	plasma	NOUN
aesr-151	202	24	amylase	amylase	NOUN
aesr-151	202	25	activity	activity	NOUN
aesr-151	202	26	and	and	CCONJ
aesr-151	202	27	concentration	concentration	NOUN
aesr-151	202	28	of	of	ADP
aesr-151	202	29	plasma	plasma	NOUN
aesr-151	202	30	non	non	ADJ
aesr-151	202	31	-	-	ADJ
aesr-151	202	32	esterifled	esterifled	ADJ
aesr-151	202	33	fatty	fatty	NOUN
aesr-151	202	34	acids	acid	NOUN
aesr-151	202	35	(	(	PUNCT
aesr-151	202	36	nefa	nefa	NOUN
aesr-151	202	37	)	)	PUNCT
aesr-151	202	38	,	,	PUNCT
aesr-151	202	39	"	"	PUNCT
aesr-151	202	40	proceedings	proceeding	NOUN
aesr-151	202	41	of	of	ADP
aesr-151	202	42	the	the	DET
aesr-151	202	43	society	society	NOUN
aesr-151	202	44	for	for	ADP
aesr-151	202	45	experimental	experimental	ADJ
aesr-151	202	46	biology	biology	NOUN
aesr-151	202	47	and	and	CCONJ
aesr-151	202	48	medicine	medicine	NOUN
aesr-151	202	49	,	,	PUNCT
aesr-151	202	50	vol	vol	NOUN
aesr-151	202	51	.	.	PROPN
aesr-151	202	52	95	95	NUM
aesr-151	202	53	,	,	PUNCT
aesr-151	202	54	pp	pp	ADJ
aesr-151	202	55	.	.	PUNCT
aesr-151	203	1	496	496	NUM
aesr-151	203	2	-	-	SYM
aesr-151	203	3	497	497	NUM
aesr-151	203	4	,	,	PUNCT
aesr-151	203	5	1957	1957	NUM
aesr-151	203	6	.	.	PUNCT
aesr-151	204	1	view	view	NOUN
aesr-151	204	2	at	at	ADP
aesr-151	204	3	google	google	PROPN
aesr-151	204	4	scholar	scholar	NOUN
aesr-151	204	5	|	|	ADV
aesr-151	204	6	view	view	NOUN
aesr-151	204	7	at	at	ADP
aesr-151	204	8	publisher	publisher	NOUN
aesr-151	204	9	[	[	X
aesr-151	204	10	20	20	NUM
aesr-151	204	11	]	]	PUNCT
aesr-151	204	12	d.	d.	PROPN
aesr-151	204	13	a.	a.	PROPN
aesr-151	204	14	dreiling	dreiling	PROPN
aesr-151	204	15	,	,	PUNCT
aesr-151	204	16	w.	w.	PROPN
aesr-151	204	17	k.	k.	PROPN
aesr-151	204	18	rosenthal	rosenthal	PROPN
aesr-151	204	19	,	,	PUNCT
aesr-151	204	20	m.	m.	NOUN
aesr-151	204	21	kass	kass	PROPN
aesr-151	204	22	,	,	PUNCT
aesr-151	204	23	and	and	CCONJ
aesr-151	204	24	h.	h.	PROPN
aesr-151	204	25	d.	d.	PROPN
aesr-151	204	26	janowitz	janowitz	PROPN
aesr-151	204	27	,	,	PUNCT
aesr-151	204	28	"	"	PUNCT
aesr-151	204	29	relationship	relationship	NOUN
aesr-151	204	30	between	between	ADP
aesr-151	204	31	blood	blood	NOUN
aesr-151	204	32	amylase	amylase	NOUN
aesr-151	204	33	and	and	CCONJ
aesr-151	204	34	factors	factor	NOUN
aesr-151	204	35	affecting	affect	VERB
aesr-151	204	36	carbohydrate	carbohydrate	NOUN
aesr-151	204	37	metabolism	metabolism	NOUN
aesr-151	204	38	,	,	PUNCT
aesr-151	204	39	"	"	PUNCT
aesr-151	204	40	american	american	ADJ
aesr-151	204	41	journal	journal	NOUN
aesr-151	204	42	of	of	ADP
aesr-151	204	43	digestive	digestive	ADJ
aesr-151	204	44	diseases	disease	NOUN
aesr-151	204	45	,	,	PUNCT
aesr-151	204	46	vol	vol	NOUN
aesr-151	204	47	.	.	PROPN
aesr-151	205	1	4	4	NUM
aesr-151	205	2	,	,	PUNCT
aesr-151	205	3	pp	pp	ADJ
aesr-151	205	4	.	.	PUNCT
aesr-151	206	1	731736	731736	NUM
aesr-151	206	2	,	,	PUNCT
aesr-151	206	3	1959	1959	NUM
aesr-151	206	4	.	.	PUNCT
aesr-151	207	1	view	view	NOUN
aesr-151	207	2	at	at	ADP
aesr-151	207	3	google	google	PROPN
aesr-151	207	4	scholar	scholar	NOUN
aesr-151	207	5	|	|	ADV
aesr-151	207	6	view	view	NOUN
aesr-151	207	7	at	at	ADP
aesr-151	207	8	publisher	publisher	NOUN
aesr-151	207	9	[	[	X
aesr-151	207	10	21	21	NUM
aesr-151	207	11	]	]	X
aesr-151	207	12	h.	h.	PROPN
aesr-151	207	13	a.	a.	NOUN
aesr-151	207	14	cope	cope	VERB
aesr-151	207	15	and	and	CCONJ
aesr-151	207	16	m.	m.	PROPN
aesr-151	207	17	blatt	blatt	PROPN
aesr-151	207	18	,	,	PUNCT
aesr-151	207	19	"	"	PUNCT
aesr-151	207	20	the	the	DET
aesr-151	207	21	activity	activity	NOUN
aesr-151	207	22	of	of	ADP
aesr-151	207	23	the	the	DET
aesr-151	207	24	blood	blood	NOUN
aesr-151	207	25	serum	serum	NOUN
aesr-151	207	26	amylase	amylase	NOUN
aesr-151	207	27	in	in	ADP
aesr-151	207	28	the	the	DET
aesr-151	207	29	hypophysectomized	hypophysectomized	ADJ
aesr-151	207	30	dog	dog	NOUN
aesr-151	207	31	,	,	PUNCT
aesr-151	207	32	"	"	PUNCT
aesr-151	207	33	american	american	ADJ
aesr-151	207	34	journal	journal	PROPN
aesr-151	207	35	of	of	ADP
aesr-151	207	36	physiology	physiology	NOUN
aesr-151	207	37	,	,	PUNCT
aesr-151	207	38	vol	vol	NOUN
aesr-151	207	39	.	.	PROPN
aesr-151	207	40	182	182	NUM
aesr-151	207	41	,	,	PUNCT
aesr-151	207	42	pp	pp	ADJ
aesr-151	207	43	.	.	PUNCT
aesr-151	208	1	428	428	NUM
aesr-151	208	2	434	434	NUM
aesr-151	208	3	,	,	PUNCT
aesr-151	208	4	1938	1938	NUM
aesr-151	208	5	.	.	PUNCT
aesr-151	209	1	[	[	X
aesr-151	209	2	22	22	NUM
aesr-151	209	3	]	]	PUNCT
aesr-151	209	4	r.	r.	PROPN
aesr-151	209	5	e.	e.	PROPN
aesr-151	209	6	pfeffer	pfeffer	PROPN
aesr-151	209	7	and	and	CCONJ
aesr-151	209	8	j.	j.	PROPN
aesr-151	209	9	w.	w.	PROPN
aesr-151	209	10	hinton	hinton	PROPN
aesr-151	209	11	,	,	PUNCT
aesr-151	209	12	"	"	PUNCT
aesr-151	209	13	some	some	DET
aesr-151	209	14	relationships	relationship	NOUN
aesr-151	209	15	between	between	ADP
aesr-151	209	16	adrenal	adrenal	ADJ
aesr-151	209	17	medullary	medullary	NOUN
aesr-151	209	18	and	and	CCONJ
aesr-151	209	19	cortical	cortical	ADJ
aesr-151	209	20	substances	substance	NOUN
aesr-151	209	21	and	and	CCONJ
aesr-151	209	22	exocrine	exocrine	NOUN
aesr-151	209	23	secretion	secretion	NOUN
aesr-151	209	24	of	of	ADP
aesr-151	209	25	the	the	DET
aesr-151	209	26	pancreas	pancrea	NOUN
aesr-151	209	27	,	,	PUNCT
aesr-151	209	28	"	"	PUNCT
aesr-151	209	29	gastroenterology	gastroenterology	NOUN
aesr-151	209	30	,	,	PUNCT
aesr-151	209	31	vol	vol	NOUN
aesr-151	209	32	.	.	PROPN
aesr-151	209	33	31	31	NUM
aesr-151	209	34	,	,	PUNCT
aesr-151	209	35	pp	pp	ADJ
aesr-151	209	36	.	.	PUNCT
aesr-151	210	1	746	746	NUM
aesr-151	210	2	750	750	NUM
aesr-151	210	3	,	,	PUNCT
aesr-151	210	4	1957	1957	NUM
aesr-151	210	5	.	.	PUNCT
aesr-151	211	1	view	view	NOUN
aesr-151	211	2	at	at	ADP
aesr-151	211	3	google	google	PROPN
aesr-151	211	4	scholar	scholar	NOUN
aesr-151	211	5	[	[	X
aesr-151	211	6	23	23	NUM
aesr-151	211	7	]	]	PUNCT
aesr-151	211	8	t.	t.	NOUN
aesr-151	211	9	cartier	cartier	NOUN
aesr-151	211	10	,	,	PUNCT
aesr-151	211	11	p.	p.	NOUN
aesr-151	211	12	sogni	sogni	PROPN
aesr-151	211	13	,	,	PUNCT
aesr-151	211	14	f.	f.	PROPN
aesr-151	211	15	perruche	perruche	PROPN
aesr-151	211	16	,	,	PUNCT
aesr-151	211	17	o.	o.	PROPN
aesr-151	211	18	meyniard	meyniard	NOUN
aesr-151	211	19	,	,	PUNCT
aesr-151	211	20	y.	y.	PROPN
aesr-151	211	21	e.	e.	PROPN
aesr-151	211	22	claessens	claessens	PROPN
aesr-151	211	23	,	,	PUNCT
aesr-151	211	24	j.	j.	PROPN
aesr-151	211	25	f.	f.	PROPN
aesr-151	211	26	dhainaut	dhainaut	PROPN
aesr-151	211	27	,	,	PUNCT
aesr-151	211	28	and	and	CCONJ
aesr-151	211	29	g.	g.	PROPN
aesr-151	211	30	der	der	PROPN
aesr-151	211	31	sahakian	sahakian	PROPN
aesr-151	211	32	,	,	PUNCT
aesr-151	211	33	"	"	PUNCT
aesr-151	211	34	normal	normal	ADJ
aesr-151	211	35	lipase	lipase	NOUN
aesr-151	211	36	serum	serum	NOUN
aesr-151	211	37	level	level	NOUN
aesr-151	211	38	in	in	ADP
aesr-151	211	39	acute	acute	ADJ
aesr-151	211	40	pancreatitis	pancreatitis	PROPN
aesr-151	211	41	:	:	PUNCT
aesr-151	211	42	a	a	DET
aesr-151	211	43	case	case	NOUN
aesr-151	211	44	report	report	NOUN
aesr-151	211	45	,	,	PUNCT
aesr-151	211	46	"	"	PUNCT
aesr-151	211	47	emergency	emergency	NOUN
aesr-151	211	48	medicine	medicine	NOUN
aesr-151	211	49	journal	journal	NOUN
aesr-151	211	50	,	,	PUNCT
aesr-151	211	51	vol	vol	NOUN
aesr-151	211	52	.	.	PROPN
aesr-151	211	53	23	23	NUM
aesr-151	211	54	,	,	PUNCT
aesr-151	211	55	pp	pp	ADJ
aesr-151	211	56	.	.	PUNCT
aesr-151	212	1	701	701	NUM
aesr-151	212	2	-	-	SYM
aesr-151	212	3	702	702	NUM
aesr-151	212	4	,	,	PUNCT
aesr-151	212	5	2006	2006	NUM
aesr-151	212	6	.	.	PUNCT
aesr-151	213	1	view	view	NOUN
aesr-151	213	2	at	at	ADP
aesr-151	213	3	google	google	PROPN
aesr-151	213	4	scholar	scholar	NOUN
aesr-151	213	5	|	|	ADV
aesr-151	213	6	view	view	NOUN
aesr-151	213	7	at	at	ADP
aesr-151	213	8	publisher	publisher	NOUN
aesr-151	213	9	[	[	X
aesr-151	213	10	24	24	NUM
aesr-151	213	11	]	]	PUNCT
aesr-151	213	12	a.	a.	NOUN
aesr-151	213	13	z.	z.	PROPN
aesr-151	213	14	al	al	PROPN
aesr-151	213	15	-	-	PUNCT
aesr-151	213	16	bahrani	bahrani	PROPN
aesr-151	213	17	and	and	CCONJ
aesr-151	213	18	b.	b.	PROPN
aesr-151	213	19	j.	j.	PROPN
aesr-151	213	20	ammori	ammori	PROPN
aesr-151	213	21	,	,	PUNCT
aesr-151	213	22	"	"	PUNCT
aesr-151	213	23	clinical	clinical	ADJ
aesr-151	213	24	laboratory	laboratory	NOUN
aesr-151	213	25	assessment	assessment	NOUN
aesr-151	213	26	of	of	ADP
aesr-151	213	27	acute	acute	PROPN
aesr-151	213	28	pancreatitis	pancreatitis	NOUN
aesr-151	213	29	,	,	PUNCT
aesr-151	213	30	"	"	PUNCT
aesr-151	213	31	clinica	clinica	PROPN
aesr-151	213	32	chimica	chimica	PROPN
aesr-151	213	33	acta	acta	PROPN
aesr-151	213	34	,	,	PUNCT
aesr-151	213	35	vol	vol	NOUN
aesr-151	213	36	.	.	PROPN
aesr-151	214	1	362	362	NUM
aesr-151	214	2	,	,	PUNCT
aesr-151	214	3	pp	pp	ADJ
aesr-151	214	4	.	.	PUNCT
aesr-151	215	1	26	26	NUM
aesr-151	215	2	-	-	SYM
aesr-151	215	3	48	48	NUM
aesr-151	215	4	,	,	PUNCT
aesr-151	215	5	2005	2005	NUM
aesr-151	215	6	.	.	PUNCT
aesr-151	216	1	view	view	NOUN
aesr-151	216	2	at	at	ADP
aesr-151	216	3	google	google	PROPN
aesr-151	216	4	scholar	scholar	NOUN
aesr-151	216	5	|	|	ADV
aesr-151	216	6	view	view	NOUN
aesr-151	216	7	at	at	ADP
aesr-151	216	8	publisher	publisher	NOUN
aesr-151	216	9	[	[	X
aesr-151	217	1	25	25	NUM
aesr-151	217	2	]	]	PUNCT
aesr-151	217	3	b.	b.	PROPN
aesr-151	217	4	sternby	sternby	PROPN
aesr-151	217	5	,	,	PUNCT
aesr-151	217	6	j.	j.	PROPN
aesr-151	217	7	f.	f.	PROPN
aesr-151	217	8	o'brien	o'brien	PROPN
aesr-151	217	9	,	,	PUNCT
aesr-151	217	10	a.	a.	PROPN
aesr-151	217	11	r.	r.	PROPN
aesr-151	217	12	zinsmeister	zinsmeister	PROPN
aesr-151	217	13	,	,	PUNCT
aesr-151	217	14	and	and	CCONJ
aesr-151	217	15	e.	e.	PROPN
aesr-151	217	16	p.	p.	PROPN
aesr-151	217	17	dimagno	dimagno	NOUN
aesr-151	217	18	,	,	PUNCT
aesr-151	217	19	"	"	PUNCT
aesr-151	217	20	what	what	PRON
aesr-151	217	21	is	be	AUX
aesr-151	217	22	the	the	DET
aesr-151	217	23	best	good	ADJ
aesr-151	217	24	biochemical	biochemical	ADJ
aesr-151	217	25	test	test	NOUN
aesr-151	217	26	to	to	PART
aesr-151	217	27	diagnose	diagnose	VERB
aesr-151	217	28	acute	acute	NOUN
aesr-151	217	29	pancreatitis	pancreatitis	PROPN
aesr-151	217	30	?	?	PUNCT
aesr-151	218	1	a	a	DET
aesr-151	218	2	prospective	prospective	ADJ
aesr-151	218	3	clinical	clinical	ADJ
aesr-151	218	4	study	study	NOUN
aesr-151	218	5	,	,	PUNCT
aesr-151	218	6	"	"	PUNCT
aesr-151	218	7	mayo	mayo	NOUN
aesr-151	218	8	clinic	clinic	NOUN
aesr-151	218	9	proceedings	proceeding	NOUN
aesr-151	218	10	,	,	PUNCT
aesr-151	218	11	vol	vol	NOUN
aesr-151	218	12	.	.	PROPN
aesr-151	218	13	71	71	NUM
aesr-151	218	14	,	,	PUNCT
aesr-151	218	15	pp	pp	ADJ
aesr-151	218	16	.	.	PUNCT
aesr-151	218	17	1138	1138	NUM
aesr-151	218	18	-	-	SYM
aesr-151	218	19	1144	1144	NUM
aesr-151	218	20	,	,	PUNCT
aesr-151	218	21	1996	1996	NUM
aesr-151	218	22	.	.	PUNCT
aesr-151	219	1	view	view	NOUN
aesr-151	219	2	at	at	ADP
aesr-151	219	3	google	google	PROPN
aesr-151	219	4	scholar	scholar	NOUN
aesr-151	219	5	|	|	ADV
aesr-151	219	6	view	view	NOUN
aesr-151	219	7	at	at	ADP
aesr-151	219	8	publisher	publisher	NOUN
aesr-151	219	9	[	[	X
aesr-151	219	10	26	26	NUM
aesr-151	219	11	]	]	PUNCT
aesr-151	219	12	a.	a.	NOUN
aesr-151	219	13	shuldiner	shuldiner	PROPN
aesr-151	219	14	,	,	PUNCT
aesr-151	219	15	"	"	PUNCT
aesr-151	219	16	national	national	ADJ
aesr-151	219	17	institutes	institute	NOUN
aesr-151	219	18	of	of	ADP
aesr-151	219	19	diabetes	diabetes	NOUN
aesr-151	219	20	and	and	CCONJ
aesr-151	219	21	digestive	digestive	ADJ
aesr-151	219	22	and	and	CCONJ
aesr-151	219	23	kidney	kidney	NOUN
aesr-151	219	24	diseases	disease	NOUN
aesr-151	219	25	,	,	PUNCT
aesr-151	220	1	nih	nih	PROPN
aesr-151	220	2	publication	publication	PROPN
aesr-151	220	3	no	no	INTJ
aesr-151	221	1	.	.	PUNCT
aesr-151	221	2	14–5164	14–5164	NOUN
aesr-151	221	3	,	,	PUNCT
aesr-151	221	4	"	"	PUNCT
aesr-151	221	5	2014	2014	NUM
aesr-151	221	6	.	.	PUNCT
aesr-151	222	1	[	[	X
aesr-151	222	2	27	27	NUM
aesr-151	222	3	]	]	PUNCT
aesr-151	222	4	k.	k.	PROPN
aesr-151	222	5	s.	s.	PROPN
aesr-151	222	6	polonsky	polonsky	PROPN
aesr-151	222	7	,	,	PUNCT
aesr-151	222	8	j.	j.	PROPN
aesr-151	222	9	licinio	licinio	PROPN
aesr-151	222	10	-	-	PUNCT
aesr-151	222	11	paixao	paixao	PROPN
aesr-151	222	12	,	,	PUNCT
aesr-151	222	13	b.	b.	PROPN
aesr-151	222	14	given	give	VERB
aesr-151	222	15	,	,	PUNCT
aesr-151	222	16	w.	w.	PROPN
aesr-151	222	17	pugh	pugh	PROPN
aesr-151	222	18	,	,	PUNCT
aesr-151	222	19	p.	p.	PROPN
aesr-151	222	20	rue	rue	PROPN
aesr-151	222	21	,	,	PUNCT
aesr-151	222	22	and	and	CCONJ
aesr-151	222	23	j.	j.	PROPN
aesr-151	222	24	galloway	galloway	PROPN
aesr-151	222	25	,	,	PUNCT
aesr-151	222	26	"	"	PUNCT
aesr-151	222	27	use	use	NOUN
aesr-151	222	28	of	of	ADP
aesr-151	222	29	biosynthetic	biosynthetic	ADJ
aesr-151	222	30	human	human	ADJ
aesr-151	222	31	c	c	NOUN
aesr-151	222	32	-	-	PUNCT
aesr-151	222	33	peptide	peptide	NOUN
aesr-151	222	34	in	in	ADP
aesr-151	222	35	the	the	DET
aesr-151	222	36	measurement	measurement	NOUN
aesr-151	222	37	of	of	ADP
aesr-151	222	38	insulin	insulin	NOUN
aesr-151	222	39	secretion	secretion	NOUN
aesr-151	222	40	rates	rate	NOUN
aesr-151	222	41	in	in	ADP
aesr-151	222	42	normal	normal	ADJ
aesr-151	222	43	volunteers	volunteer	NOUN
aesr-151	222	44	and	and	CCONJ
aesr-151	222	45	type	type	NOUN
aesr-151	222	46	i	i	PRON
aesr-151	222	47	diabetic	diabetic	ADJ
aesr-151	222	48	patients	patient	NOUN
aesr-151	222	49	,	,	PUNCT
aesr-151	222	50	"	"	PUNCT
aesr-151	222	51	journal	journal	NOUN
aesr-151	222	52	of	of	ADP
aesr-151	222	53	clinical	clinical	ADJ
aesr-151	222	54	investigation	investigation	NOUN
aesr-151	222	55	,	,	PUNCT
aesr-151	222	56	vol	vol	NOUN
aesr-151	222	57	.	.	PROPN
aesr-151	223	1	77	77	NUM
aesr-151	223	2	,	,	PUNCT
aesr-151	223	3	pp	pp	ADJ
aesr-151	223	4	.	.	PUNCT
aesr-151	224	1	98–105	98–105	NUM
aesr-151	224	2	,	,	PUNCT
aesr-151	224	3	1986	1986	NUM
aesr-151	224	4	.	.	PUNCT
aesr-151	225	1	view	view	NOUN
aesr-151	225	2	at	at	ADP
aesr-151	225	3	google	google	PROPN
aesr-151	225	4	scholar	scholar	NOUN
aesr-151	225	5	|	|	ADV
aesr-151	225	6	view	view	NOUN
aesr-151	225	7	at	at	ADP
aesr-151	225	8	publisher	publisher	NOUN
aesr-151	225	9	[	[	X
aesr-151	225	10	28	28	NUM
aesr-151	225	11	]	]	X
aesr-151	225	12	j.	j.	PROPN
aesr-151	225	13	licinio	licinio	PROPN
aesr-151	225	14	-	-	PUNCT
aesr-151	225	15	paixao	paixao	PROPN
aesr-151	225	16	,	,	PUNCT
aesr-151	225	17	k.	k.	PROPN
aesr-151	225	18	s.	s.	PROPN
aesr-151	225	19	polonsky	polonsky	PROPN
aesr-151	225	20	,	,	PUNCT
aesr-151	225	21	b.	b.	PROPN
aesr-151	225	22	d.	d.	PROPN
aesr-151	225	23	given	give	VERB
aesr-151	225	24	,	,	PUNCT
aesr-151	225	25	w.	w.	PROPN
aesr-151	225	26	pugh	pugh	PROPN
aesr-151	225	27	,	,	PUNCT
aesr-151	225	28	d.	d.	PROPN
aesr-151	225	29	ostrega	ostrega	PROPN
aesr-151	225	30	,	,	PUNCT
aesr-151	225	31	and	and	CCONJ
aesr-151	225	32	b.	b.	PROPN
aesr-151	225	33	f.	f.	PROPN
aesr-151	225	34	frank	frank	PROPN
aesr-151	225	35	,	,	PUNCT
aesr-151	225	36	"	"	PUNCT
aesr-151	225	37	ingestion	ingestion	NOUN
aesr-151	225	38	of	of	ADP
aesr-151	225	39	a	a	DET
aesr-151	225	40	mixed	mixed	ADJ
aesr-151	225	41	meal	meal	NOUN
aesr-151	225	42	does	do	AUX
aesr-151	225	43	not	not	PART
aesr-151	225	44	affect	affect	VERB
aesr-151	225	45	the	the	DET
aesr-151	225	46	metabolic	metabolic	NOUN
aesr-151	225	47	clearance	clearance	NOUN
aesr-151	225	48	rate	rate	NOUN
aesr-151	225	49	of	of	ADP
aesr-151	225	50	biosynthetic	biosynthetic	ADJ
aesr-151	225	51	human	human	ADJ
aesr-151	225	52	c	c	NOUN
aesr-151	225	53	-	-	PUNCT
aesr-151	225	54	peptide	peptide	NOUN
aesr-151	225	55	,	,	PUNCT
aesr-151	225	56	"	"	PUNCT
aesr-151	225	57	journal	journal	NOUN
aesr-151	225	58	of	of	ADP
aesr-151	225	59	clinical	clinical	ADJ
aesr-151	225	60	endocrinology	endocrinology	NOUN
aesr-151	225	61	and	and	CCONJ
aesr-151	225	62	metabolism	metabolism	NOUN
aesr-151	225	63	,	,	PUNCT
aesr-151	225	64	vol	vol	NOUN
aesr-151	225	65	.	.	PROPN
aesr-151	225	66	63	63	NUM
aesr-151	225	67	,	,	PUNCT
aesr-151	225	68	pp	pp	ADJ
aesr-151	225	69	.	.	PUNCT
aesr-151	226	1	401	401	NUM
aesr-151	226	2	–	–	PUNCT
aesr-151	226	3	403	403	NUM
aesr-151	226	4	,	,	PUNCT
aesr-151	226	5	1986	1986	NUM
aesr-151	226	6	.	.	PUNCT
aesr-151	227	1	view	view	NOUN
aesr-151	227	2	at	at	ADP
aesr-151	227	3	google	google	PROPN
aesr-151	227	4	scholar	scholar	NOUN
aesr-151	227	5	|	|	ADV
aesr-151	227	6	view	view	NOUN
aesr-151	227	7	at	at	ADP
aesr-151	227	8	publisher	publisher	NOUN
aesr-151	227	9	[	[	X
aesr-151	227	10	29	29	NUM
aesr-151	227	11	]	]	PUNCT
aesr-151	227	12	s.	s.	PROPN
aesr-151	227	13	madsbad	madsbad	PROPN
aesr-151	227	14	,	,	PUNCT
aesr-151	227	15	t.	t.	NOUN
aesr-151	227	16	krarup	krarup	PROPN
aesr-151	227	17	,	,	PUNCT
aesr-151	227	18	l.	l.	PROPN
aesr-151	227	19	regeur	regeur	PROPN
aesr-151	227	20	,	,	PUNCT
aesr-151	227	21	o.	o.	PROPN
aesr-151	227	22	k.	k.	PROPN
aesr-151	227	23	faber	faber	PROPN
aesr-151	227	24	,	,	PUNCT
aesr-151	227	25	and	and	CCONJ
aesr-151	227	26	c.	c.	PROPN
aesr-151	227	27	binder	binder	NOUN
aesr-151	227	28	,	,	PUNCT
aesr-151	227	29	"	"	PUNCT
aesr-151	227	30	insulin	insulin	NOUN
aesr-151	227	31	secretory	secretory	NOUN
aesr-151	227	32	reserve	reserve	NOUN
aesr-151	227	33	in	in	ADP
aesr-151	227	34	insulin	insulin	NOUN
aesr-151	227	35	dependent	dependent	ADJ
aesr-151	227	36	patients	patient	NOUN
aesr-151	227	37	at	at	ADP
aesr-151	227	38	time	time	NOUN
aesr-151	227	39	of	of	ADP
aesr-151	227	40	diagnosis	diagnosis	NOUN
aesr-151	227	41	and	and	CCONJ
aesr-151	227	42	the	the	DET
aesr-151	227	43	first	first	ADJ
aesr-151	227	44	180	180	NUM
aesr-151	227	45	days	day	NOUN
aesr-151	227	46	of	of	ADP
aesr-151	227	47	insulin	insulin	NOUN
aesr-151	227	48	treatment	treatment	NOUN
aesr-151	227	49	,	,	PUNCT
aesr-151	227	50	"	"	PUNCT
aesr-151	227	51	acta	acta	PROPN
aesr-151	227	52	endocrinol	endocrinol	NOUN
aesr-151	227	53	(	(	PUNCT
aesr-151	227	54	copenh	copenh	ADJ
aesr-151	227	55	)	)	PUNCT
aesr-151	227	56	,	,	PUNCT
aesr-151	227	57	vol	vol	NOUN
aesr-151	227	58	.	.	PROPN
aesr-151	227	59	95	95	NUM
aesr-151	227	60	,	,	PUNCT
aesr-151	227	61	pp	pp	ADJ
aesr-151	227	62	.	.	PUNCT
aesr-151	228	1	359–363	359–363	NUM
aesr-151	228	2	,	,	PUNCT
aesr-151	228	3	1980	1980	NUM
aesr-151	228	4	.	.	PUNCT
aesr-151	229	1	view	view	NOUN
aesr-151	229	2	at	at	ADP
aesr-151	229	3	google	google	PROPN
aesr-151	229	4	scholar	scholar	NOUN
aesr-151	229	5	[	[	X
aesr-151	229	6	30	30	NUM
aesr-151	229	7	]	]	PUNCT
aesr-151	229	8	j.	j.	PROPN
aesr-151	229	9	cardenas	cardenas	PROPN
aesr-151	229	10	,	,	PUNCT
aesr-151	229	11	e.	e.	PROPN
aesr-151	229	12	alvarez	alvarez	PROPN
aesr-151	229	13	,	,	PUNCT
aesr-151	229	14	a.	a.	PROPN
aesr-151	229	15	m.	m.	PROPN
aesr-151	229	16	s.	s.	PROPN
aesr-151	229	17	decastro	decastro	PROPN
aesr-151	229	18	,	,	PUNCT
aesr-151	229	19	j.	j.	PROPN
aesr-151	229	20	m.	m.	PROPN
aesr-151	229	21	sanchez	sanchez	PROPN
aesr-151	229	22	,	,	PUNCT
aesr-151	229	23	m.	m.	NOUN
aesr-151	229	24	valmaseda	valmaseda	PROPN
aesr-151	229	25	,	,	PUNCT
aesr-151	229	26	s.	s.	PROPN
aesr-151	229	27	w.	w.	PROPN
aesr-151	229	28	elson	elson	PROPN
aesr-151	229	29	,	,	PUNCT
aesr-151	229	30	and	and	CCONJ
aesr-151	229	31	j.	j.	PROPN
aesr-151	229	32	v.	v.	PROPN
aesr-151	229	33	sinisterra	sinisterra	PROPN
aesr-151	229	34	,	,	PUNCT
aesr-151	229	35	"	"	PUNCT
aesr-151	229	36	screening	screening	NOUN
aesr-151	229	37	and	and	CCONJ
aesr-151	229	38	catalytic	catalytic	ADJ
aesr-151	229	39	activity	activity	NOUN
aesr-151	229	40	in	in	ADP
aesr-151	229	41	organic	organic	ADJ
aesr-151	229	42	synthesis	synthesis	NOUN
aesr-151	229	43	of	of	ADP
aesr-151	229	44	novel	novel	ADJ
aesr-151	229	45	fungal	fungal	ADJ
aesr-151	229	46	and	and	CCONJ
aesr-151	229	47	yeast	yeast	NOUN
aesr-151	229	48	lipases	lipase	NOUN
aesr-151	229	49	,	,	PUNCT
aesr-151	229	50	"	"	PUNCT
aesr-151	229	51	journal	journal	NOUN
aesr-151	229	52	of	of	ADP
aesr-151	229	53	molecular	molecular	ADJ
aesr-151	229	54	catalysis	catalysis	NOUN
aesr-151	229	55	b	b	NOUN
aesr-151	229	56	:	:	PUNCT
aesr-151	229	57	enzymatic	enzymatic	ADJ
aesr-151	229	58	,	,	PUNCT
aesr-151	229	59	vol	vol	NOUN
aesr-151	229	60	.	.	PROPN
aesr-151	229	61	14	14	NUM
aesr-151	229	62	,	,	PUNCT
aesr-151	229	63	pp	pp	ADJ
aesr-151	229	64	.	.	PUNCT
aesr-151	230	1	111	111	NUM
aesr-151	230	2	-	-	SYM
aesr-151	230	3	123	123	NUM
aesr-151	230	4	,	,	PUNCT
aesr-151	230	5	2001	2001	NUM
aesr-151	230	6	.	.	PUNCT
aesr-151	231	1	view	view	NOUN
aesr-151	231	2	at	at	ADP
aesr-151	231	3	google	google	PROPN
aesr-151	231	4	scholar	scholar	NOUN
aesr-151	231	5	|	|	ADV
aesr-151	231	6	view	view	NOUN
aesr-151	231	7	at	at	ADP
aesr-151	231	8	publisher	publisher	NOUN
aesr-151	231	9	[	[	X
aesr-151	231	10	31	31	NUM
aesr-151	231	11	]	]	PUNCT
aesr-151	232	1	h.	h.	PROPN
aesr-151	232	2	p.	p.	PROPN
aesr-151	232	3	harding	harding	PROPN
aesr-151	232	4	,	,	PUNCT
aesr-151	232	5	h.	h.	PROPN
aesr-151	232	6	zeng	zeng	PROPN
aesr-151	232	7	,	,	PUNCT
aesr-151	232	8	y.	y.	PROPN
aesr-151	232	9	zhang	zhang	PROPN
aesr-151	232	10	,	,	PUNCT
aesr-151	232	11	r.	r.	PROPN
aesr-151	232	12	jungries	jungries	PROPN
aesr-151	232	13	,	,	PUNCT
aesr-151	232	14	p.	p.	PROPN
aesr-151	232	15	chung	chung	PROPN
aesr-151	232	16	,	,	PUNCT
aesr-151	232	17	h.	h.	PROPN
aesr-151	232	18	plesken	plesken	PROPN
aesr-151	232	19	,	,	PUNCT
aesr-151	232	20	d.	d.	PROPN
aesr-151	232	21	d.	d.	PROPN
aesr-151	232	22	sabatini	sabatini	PROPN
aesr-151	232	23	,	,	PUNCT
aesr-151	232	24	and	and	CCONJ
aesr-151	232	25	r.	r.	PROPN
aesr-151	232	26	d.	d.	PROPN
aesr-151	232	27	,	,	PUNCT
aesr-151	232	28	"	"	PUNCT
aesr-151	232	29	diabetes	diabetes	NOUN
aesr-151	232	30	mellitus	mellitus	NOUN
aesr-151	232	31	and	and	CCONJ
aesr-151	232	32	exocrine	exocrine	VERB
aesr-151	232	33	pancreatic	pancreatic	ADJ
aesr-151	232	34	dysfunction	dysfunction	NOUN
aesr-151	232	35	in	in	ADP
aesr-151	232	36	perk	perk	NOUN
aesr-151	232	37	/	/	SYM
aesr-151	232	38	mice	mouse	NOUN
aesr-151	232	39	reveals	reveal	VERB
aesr-151	232	40	a	a	DET
aesr-151	232	41	role	role	NOUN
aesr-151	232	42	for	for	ADP
aesr-151	232	43	translational	translational	ADJ
aesr-151	232	44	control	control	NOUN
aesr-151	232	45	in	in	ADP
aesr-151	232	46	secretory	secretory	ADJ
aesr-151	232	47	cell	cell	NOUN
aesr-151	232	48	survival	survival	NOUN
aesr-151	232	49	,	,	PUNCT
aesr-151	232	50	"	"	PUNCT
aesr-151	232	51	molecular	molecular	ADJ
aesr-151	232	52	cell	cell	NOUN
aesr-151	232	53	,	,	PUNCT
aesr-151	232	54	vol	vol	NOUN
aesr-151	232	55	.	.	PROPN
aesr-151	233	1	7	7	NUM
aesr-151	233	2	,	,	PUNCT
aesr-151	233	3	pp	pp	ADJ
aesr-151	233	4	.	.	PUNCT
aesr-151	233	5	1153–1163	1153–1163	NUM
aesr-151	233	6	,	,	PUNCT
aesr-151	233	7	2001	2001	NUM
aesr-151	233	8	.	.	PUNCT
aesr-151	234	1	view	view	NOUN
aesr-151	234	2	at	at	ADP
aesr-151	234	3	google	google	PROPN
aesr-151	234	4	scholar	scholar	NOUN
aesr-151	234	5	|	|	ADV
aesr-151	234	6	view	view	NOUN
aesr-151	234	7	at	at	ADP
aesr-151	234	8	publisher	publisher	NOUN
aesr-151	234	9	[	[	X
aesr-151	234	10	32	32	NUM
aesr-151	234	11	]	]	PUNCT
aesr-151	235	1	k.	k.	PROPN
aesr-151	235	2	h.	h.	PROPN
aesr-151	235	3	kim	kim	PROPN
aesr-151	235	4	,	,	PUNCT
aesr-151	235	5	h.	h.	PROPN
aesr-151	235	6	s.	s.	PROPN
aesr-151	235	7	lee	lee	PROPN
aesr-151	235	8	,	,	PUNCT
aesr-151	235	9	c.	c.	PROPN
aesr-151	235	10	d.	d.	PROPN
aesr-151	235	11	kim	kim	PROPN
aesr-151	235	12	,	,	PUNCT
aesr-151	235	13	h.	h.	PROPN
aesr-151	235	14	j.	j.	PROPN
aesr-151	235	15	chun	chun	PROPN
aesr-151	235	16	,	,	PUNCT
aesr-151	235	17	c.	c.	PROPN
aesr-151	235	18	w.	w.	PROPN
aesr-151	235	19	song	song	PROPN
aesr-151	235	20	,	,	PUNCT
aesr-151	235	21	s.	s.	PROPN
aesr-151	235	22	h.	h.	PROPN
aesr-151	235	23	um	um	INTJ
aesr-151	235	24	,	,	PUNCT
aesr-151	235	25	h.	h.	PROPN
aesr-151	235	26	s.	s.	PROPN
aesr-151	235	27	ryu	ryu	PROPN
aesr-151	235	28	,	,	PUNCT
aesr-151	235	29	and	and	CCONJ
aesr-151	235	30	j.	j.	PROPN
aesr-151	235	31	h.	h.	PROPN
aesr-151	235	32	hyun	hyun	PROPN
aesr-151	235	33	,	,	PUNCT
aesr-151	235	34	"	"	PUNCT
aesr-151	235	35	evaluation	evaluation	NOUN
aesr-151	235	36	of	of	ADP
aesr-151	235	37	pancreatic	pancreatic	ADJ
aesr-151	235	38	exocrine	exocrine	NOUN
aesr-151	235	39	function	function	NOUN
aesr-151	235	40	using	use	VERB
aesr-151	235	41	pure	pure	ADJ
aesr-151	235	42	pancreatic	pancreatic	ADJ
aesr-151	235	43	juice	juice	NOUN
aesr-151	235	44	in	in	ADP
aesr-151	235	45	noninsulin	noninsulin	PROPN
aesr-151	235	46	-	-	PUNCT
aesr-151	235	47	dependent	dependent	ADJ
aesr-151	235	48	diabetes	diabetes	NOUN
aesr-151	235	49	mellitus	mellitus	NOUN
aesr-151	235	50	,	,	PUNCT
aesr-151	235	51	"	"	PUNCT
aesr-151	235	52	journal	journal	NOUN
aesr-151	235	53	of	of	ADP
aesr-151	235	54	clinical	clinical	ADJ
aesr-151	235	55	gastroenterology	gastroenterology	NOUN
aesr-151	235	56	,	,	PUNCT
aesr-151	235	57	vol	vol	NOUN
aesr-151	235	58	.	.	PROPN
aesr-151	235	59	31	31	NUM
aesr-151	235	60	,	,	PUNCT
aesr-151	235	61	pp	pp	ADJ
aesr-151	235	62	.	.	PUNCT
aesr-151	236	1	51	51	NUM
aesr-151	236	2	–	–	PUNCT
aesr-151	236	3	54	54	NUM
aesr-151	236	4	,	,	PUNCT
aesr-151	236	5	2000	2000	NUM
aesr-151	236	6	.	.	PUNCT
aesr-151	237	1	view	view	NOUN
aesr-151	237	2	at	at	ADP
aesr-151	237	3	google	google	PROPN
aesr-151	237	4	scholar	scholar	NOUN
aesr-151	237	5	|	|	ADV
aesr-151	237	6	view	view	NOUN
aesr-151	237	7	at	at	ADP
aesr-151	237	8	publisher	publisher	NOUN
aesr-151	237	9	[	[	X
aesr-151	237	10	33	33	NUM
aesr-151	237	11	]	]	PUNCT
aesr-151	237	12	m.	m.	NOUN
aesr-151	237	13	najafian	najafian	PROPN
aesr-151	237	14	,	,	PUNCT
aesr-151	237	15	a.	a.	PROPN
aesr-151	237	16	ebrahim	ebrahim	PROPN
aesr-151	237	17	-	-	PUNCT
aesr-151	237	18	habibi	habibi	PROPN
aesr-151	237	19	,	,	PUNCT
aesr-151	237	20	and	and	CCONJ
aesr-151	237	21	p.	p.	PROPN
aesr-151	237	22	yaghmaei	yaghmaei	PROPN
aesr-151	237	23	,	,	PUNCT
aesr-151	237	24	"	"	PUNCT
aesr-151	237	25	core	core	ADJ
aesr-151	237	26	structure	structure	NOUN
aesr-151	237	27	of	of	ADP
aesr-151	237	28	flavonoids	flavonoid	NOUN
aesr-151	237	29	precursor	precursor	NOUN
aesr-151	237	30	as	as	ADP
aesr-151	237	31	an	an	DET
aesr-151	237	32	antihyperglycemic	antihyperglycemic	ADJ
aesr-151	237	33	and	and	CCONJ
aesr-151	237	34	antihyperlipidemic	antihyperlipidemic	ADJ
aesr-151	237	35	agent	agent	NOUN
aesr-151	237	36	:	:	PUNCT
aesr-151	237	37	an	an	DET
aesr-151	237	38	in	in	ADP
aesr-151	237	39	vivo	vivo	NOUN
aesr-151	237	40	study	study	NOUN
aesr-151	237	41	in	in	ADP
aesr-151	237	42	rats	rat	NOUN
aesr-151	237	43	,	,	PUNCT
aesr-151	237	44	"	"	PUNCT
aesr-151	237	45	acta	acta	PROPN
aesr-151	237	46	biochimica	biochimica	PROPN
aesr-151	237	47	polonica	polonica	PROPN
aesr-151	237	48	,	,	PUNCT
aesr-151	237	49	vol	vol	NOUN
aesr-151	237	50	.	.	PROPN
aesr-151	237	51	57	57	NUM
aesr-151	237	52	,	,	PUNCT
aesr-151	237	53	pp	pp	ADJ
aesr-151	237	54	.	.	PUNCT
aesr-151	238	1	553	553	NUM
aesr-151	238	2	-	-	SYM
aesr-151	238	3	560	560	NUM
aesr-151	238	4	,	,	PUNCT
aesr-151	238	5	2010	2010	NUM
aesr-151	238	6	.	.	PUNCT
aesr-151	239	1	view	view	NOUN
aesr-151	239	2	at	at	ADP
aesr-151	239	3	google	google	PROPN
aesr-151	239	4	scholar	scholar	NOUN
aesr-151	239	5	[	[	X
aesr-151	239	6	34	34	NUM
aesr-151	239	7	]	]	X
aesr-151	239	8	q.	q.	PROPN
aesr-151	239	9	luo	luo	PROPN
aesr-151	239	10	,	,	PUNCT
aesr-151	239	11	y.	y.	PROPN
aesr-151	239	12	cai	cai	PROPN
aesr-151	239	13	,	,	PUNCT
aesr-151	239	14	j.	j.	PROPN
aesr-151	239	15	yan	yan	PROPN
aesr-151	239	16	,	,	PUNCT
aesr-151	239	17	m.	m.	NOUN
aesr-151	239	18	sun	sun	PROPN
aesr-151	239	19	,	,	PUNCT
aesr-151	239	20	and	and	CCONJ
aesr-151	239	21	h.	h.	PROPN
aesr-151	239	22	corke	corke	PROPN
aesr-151	239	23	,	,	PUNCT
aesr-151	239	24	"	"	PUNCT
aesr-151	239	25	hypoglycemic	hypoglycemic	ADJ
aesr-151	239	26	and	and	CCONJ
aesr-151	239	27	hypolipidemic	hypolipidemic	ADJ
aesr-151	239	28	effects	effect	NOUN
aesr-151	239	29	and	and	CCONJ
aesr-151	239	30	antioxidant	antioxidant	ADJ
aesr-151	239	31	activity	activity	NOUN
aesr-151	239	32	of	of	ADP
aesr-151	239	33	fruit	fruit	NOUN
aesr-151	239	34	extracts	extract	NOUN
aesr-151	239	35	from	from	ADP
aesr-151	239	36	lycium	lycium	NOUN
aesr-151	239	37	barbarum	barbarum	NOUN
aesr-151	239	38	,	,	PUNCT
aesr-151	239	39	"	"	PUNCT
aesr-151	239	40	life	life	NOUN
aesr-151	239	41	sciences	science	NOUN
aesr-151	239	42	,	,	PUNCT
aesr-151	239	43	vol	vol	NOUN
aesr-151	239	44	.	.	PROPN
aesr-151	240	1	76	76	NUM
aesr-151	240	2	,	,	PUNCT
aesr-151	240	3	pp	pp	ADJ
aesr-151	240	4	.	.	PUNCT
aesr-151	241	1	137–149	137–149	NUM
aesr-151	241	2	,	,	PUNCT
aesr-151	241	3	2004	2004	NUM
aesr-151	241	4	.	.	PUNCT
aesr-151	242	1	view	view	NOUN
aesr-151	242	2	at	at	ADP
aesr-151	242	3	google	google	PROPN
aesr-151	242	4	scholar	scholar	NOUN
aesr-151	242	5	|	|	ADV
aesr-151	242	6	view	view	NOUN
aesr-151	242	7	at	at	ADP
aesr-151	242	8	publisher	publisher	NOUN
aesr-151	242	9	[	[	X
aesr-151	242	10	35	35	NUM
aesr-151	242	11	]	]	PUNCT
aesr-151	242	12	x.	x.	NOUN
aesr-151	242	13	m.	m.	PROPN
aesr-151	242	14	li	li	PROPN
aesr-151	242	15	,	,	PUNCT
aesr-151	242	16	"	"	PUNCT
aesr-151	242	17	protective	protective	ADJ
aesr-151	242	18	effect	effect	NOUN
aesr-151	242	19	of	of	ADP
aesr-151	242	20	lycium	lycium	NOUN
aesr-151	242	21	barbarum	barbarum	NOUN
aesr-151	242	22	polysaccharides	polysaccharide	NOUN
aesr-151	242	23	on	on	ADP
aesr-151	242	24	streptozotocin	streptozotocin	NOUN
aesr-151	242	25	-	-	PUNCT
aesr-151	242	26	induced	induce	VERB
aesr-151	242	27	oxidative	oxidative	ADJ
aesr-151	242	28	stress	stress	NOUN
aesr-151	242	29	in	in	ADP
aesr-151	242	30	rats	rat	NOUN
aesr-151	242	31	,	,	PUNCT
aesr-151	242	32	"	"	PUNCT
aesr-151	242	33	international	international	ADJ
aesr-151	242	34	journal	journal	NOUN
aesr-151	242	35	of	of	ADP
aesr-151	242	36	biological	biological	ADJ
aesr-151	242	37	macromolecules	macromolecule	NOUN
aesr-151	242	38	,	,	PUNCT
aesr-151	242	39	vol	vol	NOUN
aesr-151	242	40	.	.	PROPN
aesr-151	242	41	40	40	NUM
aesr-151	242	42	,	,	PUNCT
aesr-151	242	43	pp	pp	ADJ
aesr-151	242	44	.	.	PUNCT
aesr-151	243	1	461–465	461–465	NUM
aesr-151	243	2	,	,	PUNCT
aesr-151	243	3	2007	2007	NUM
aesr-151	243	4	.	.	PUNCT
aesr-151	244	1	view	view	NOUN
aesr-151	244	2	at	at	ADP
aesr-151	244	3	google	google	PROPN
aesr-151	244	4	scholar	scholar	NOUN
aesr-151	244	5	|	|	ADV
aesr-151	244	6	view	view	NOUN
aesr-151	244	7	at	at	ADP
aesr-151	244	8	publisher	publisher	NOUN
aesr-151	244	9	asian	asian	PROPN
aesr-151	244	10	online	online	PROPN
aesr-151	244	11	journal	journal	PROPN
aesr-151	244	12	publishing	publishing	NOUN
aesr-151	244	13	group	group	NOUN
aesr-151	244	14	is	be	AUX
aesr-151	244	15	not	not	PART
aesr-151	244	16	responsible	responsible	ADJ
aesr-151	244	17	or	or	CCONJ
aesr-151	244	18	answerable	answerable	ADJ
aesr-151	244	19	for	for	ADP
aesr-151	244	20	any	any	DET
aesr-151	244	21	loss	loss	NOUN
aesr-151	244	22	,	,	PUNCT
aesr-151	244	23	damage	damage	NOUN
aesr-151	244	24	or	or	CCONJ
aesr-151	244	25	liability	liability	NOUN
aesr-151	244	26	,	,	PUNCT
aesr-151	244	27	etc	etc	X
aesr-151	244	28	.	.	X
aesr-151	244	29	caused	cause	VERB
aesr-151	244	30	in	in	ADP
aesr-151	244	31	relation	relation	NOUN
aesr-151	244	32	to	to	PART
aesr-151	244	33	/	/	PUNCT
aesr-151	244	34	arising	arise	VERB
aesr-151	244	35	out	out	ADP
aesr-151	244	36	of	of	ADP
aesr-151	244	37	the	the	DET
aesr-151	244	38	use	use	NOUN
aesr-151	244	39	of	of	ADP
aesr-151	244	40	the	the	DET
aesr-151	244	41	content	content	NOUN
aesr-151	244	42	.	.	PUNCT
aesr-151	245	1	any	any	DET
aesr-151	245	2	queries	query	NOUN
aesr-151	245	3	should	should	AUX
aesr-151	245	4	be	be	AUX
aesr-151	245	5	directed	direct	VERB
aesr-151	245	6	to	to	ADP
aesr-151	245	7	the	the	DET
aesr-151	245	8	corresponding	corresponding	ADJ
aesr-151	245	9	author	author	NOUN
aesr-151	245	10	of	of	ADP
aesr-151	245	11	the	the	DET
aesr-151	245	12	article	article	NOUN
aesr-151	245	13	.	.	PUNCT
aesr-151	246	1	https://scholar.google.com/scholar?hl=en&q=effects%20of%20the%20microbial%20secondary%20metabolites%20pyrrolnitrin,%20phenazine%20and%20patulin%20on%20ins-1%20rat%20pancreatic%20β-cells	https://scholar.google.com/scholar?hl=en&q=effects%20of%20the%20microbial%20secondary%20metabolites%20pyrrolnitrin,%20phenazine%20and%20patulin%20on%20ins-1%20rat%20pancreatic%20β-cell	NOUN
aesr-151	246	2	https://scholar.google.com/scholar?hl=en&q=effects%20of%20the%20microbial%20secondary%20metabolites%20pyrrolnitrin,%20phenazine%20and%20patulin%20on%20ins-1%20rat%20pancreatic%20β-cells	https://scholar.google.com/scholar?hl=en&q=effects%20of%20the%20microbial%20secondary%20metabolites%20pyrrolnitrin,%20phenazine%20and%20patulin%20on%20ins-1%20rat%20pancreatic%20β-cell	NOUN
aesr-151	246	3	http://dx.doi.org/10.1111/j.1574-695x.2011.00844.x	http://dx.doi.org/10.1111/j.1574-695x.2011.00844.x	X
aesr-151	246	4	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20the%20anticancer%20and%20immunomodulatory%20effects%20of%20lycium%20barbarum%20fruit	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20the%20anticancer%20and%20immunomodulatory%20effects%20of%20lycium%20barbarum%20fruit	NOUN
aesr-151	246	5	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20the%20anticancer%20and%20immunomodulatory%20effects%20of%20lycium%20barbarum%20fruit	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20the%20anticancer%20and%20immunomodulatory%20effects%20of%20lycium%20barbarum%20fruit	NOUN
aesr-151	246	6	https://scholar.google.com/scholar?hl=en&q=an%20evidence-based%20update%20on%20the%20pharmacological%20activities%20and%20possible%20molecular%20targets%20of%20lycium%20barbarum%20polysaccharides	https://scholar.google.com/scholar?hl=en&q=an%20evidence-based%20update%20on%20the%20pharmacological%20activities%20and%20possible%20molecular%20targets%20of%20lycium%20barbarum%20polysaccharide	VERB
aesr-151	246	7	http://dx.doi.org/10.2147/dddt.s72892	http://dx.doi.org/10.2147/dddt.s72892	PROPN
aesr-151	246	8	https://scholar.google.com/scholar?hl=en&q=goji%20berry%20(lycium%20barbarum):%20composition%20and%20health%20effects%20–%20a%20review	https://scholar.google.com/scholar?hl=en&q=goji%20berry%20(lycium%20barbarum):%20composition%20and%20health%20effects%20–%20a%20review	PROPN
aesr-151	246	9	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20botanical%20characteristics,%20phytochemistry,%20clinical%20relevance%20in%20efficacy%20and%20safety%20of%20lycium%20barbarum%20fruit%20(goji	https://scholar.google.com/scholar?hl=en&q=a%20review%20of%20botanical%20characteristics,%20phytochemistry,%20clinical%20relevance%20in%20efficacy%20and%20safety%20of%20lycium%20barbarum%20fruit%20(goji	PROPN
aesr-151	246	10	)	)	PUNCT
aesr-151	246	11	http://dx.doi.org/10.1016/j.foodres.2011.03.027	http://dx.doi.org/10.1016/j.foodres.2011.03.027	PROPN
aesr-151	246	12	https://scholar.google.com/scholar?hl=en&q=diffusion%20profiles%20of%20health%20beneficial%20components%20from%20goji%20berry%20(lyceum%20barbarum)%20marinated%20in%20alcohol%20and%20their%20antioxidant%20capacities%20as%20affected%20by%20alcohol%20concentration%20and%20steeping%20time	https://scholar.google.com/scholar?hl=en&q=diffusion%20profiles%20of%20health%20beneficial%20components%20from%20goji%20berry%20(lyceum%20barbarum)%20marinated%20in%20alcohol%20and%20their%20antioxidant%20capacities%20as%20affected%20by%20alcohol%20concentration%20and%20steeping%20time	PROPN
aesr-151	246	13	https://scholar.google.com/scholar?hl=en&q=diffusion%20profiles%20of%20health%20beneficial%20components%20from%20goji%20berry%20(lyceum%20barbarum)%20marinated%20in%20alcohol%20and%20their%20antioxidant%20capacities%20as%20affected%20by%20alcohol%20concentration%20and%20steeping%20time	https://scholar.google.com/scholar?hl=en&q=diffusion%20profiles%20of%20health%20beneficial%20components%20from%20goji%20berry%20(lyceum%20barbarum)%20marinated%20in%20alcohol%20and%20their%20antioxidant%20capacities%20as%20affected%20by%20alcohol%20concentration%20and%20steeping%20time	X
aesr-151	246	14	http://dx.doi.org/10.3390/foods2010032	http://dx.doi.org/10.3390/foods2010032	PROPN
aesr-151	246	15	http://dx.doi.org/10.1177/000456326900600108	http://dx.doi.org/10.1177/000456326900600108	VERB
aesr-151	246	16	https://scholar.google.com/scholar?hl=en&q=environmental%20factors%20in%20the%20etiology%20of%20type%201%20diabetes	https://scholar.google.com/scholar?hl=en&q=environmental%20factors%20in%20the%20etiology%20of%20type%201%20diabete	VERB
aesr-151	246	17	https://scholar.google.com/scholar?hl=en&q=dietary%20microbial%20toxins%20and%20type%201%20diabetes	https://scholar.google.com/scholar?hl=en&q=dietary%20microbial%20toxins%20and%20type%201%20diabete	NOUN
aesr-151	246	18	https://scholar.google.com/scholar?hl=en&q=coxsackievirus%20infection%20as%20an%20environmental%20factor%20in%20the%20etiology%20of%20type%201%20diabetes	https://scholar.google.com/scholar?hl=en&q=coxsackievirus%20infection%20as%20an%20environmental%20factor%20in%20the%20etiology%20of%20type%201%20diabete	VERB
aesr-151	246	19	http://dx.doi.org/10.1016/j.autrev.2009.02.006	http://dx.doi.org/10.1016/j.autrev.2009.02.006	PROPN
aesr-151	246	20	https://scholar.google.com/scholar?hl=en&q=acute%20pancreatitis:%20diagnosis,%20prognosis,%20and%20treatment	https://scholar.google.com/scholar?hl=en&q=acute%20pancreatitis:%20diagnosis,%20prognosis,%20and%20treatment	ADJ
aesr-151	246	21	https://scholar.google.com/scholar?hl=en&q=relationship%20between%20blood%20amylase%20and%20factors%20affecting%20carbohydrate%20metabolism.%20i.%20the%20regulation%20of%20blood%20amylase%20levels%20in%20subjects%20without%20pancreatic%20disease	https://scholar.google.com/scholar?hl=en&q=relationship%20between%20blood%20amylase%20and%20factors%20affecting%20carbohydrate%20metabolism.%20i.%20the%20regulation%20of%20blood%20amylase%20levels%20in%20subjects%20without%20pancreatic%20disease	NOUN
aesr-151	246	22	http://dx.doi.org/10.1007/bf02231268	http://dx.doi.org/10.1007/bf02231268	PROPN
aesr-151	246	23	https://scholar.google.com/scholar?hl=en&q=correlation%20between%20plasma%20amylase%20activity%20and%20concentration%20of%20plasma%20non-esterifled%20fatty%20acids%20(nefa	https://scholar.google.com/scholar?hl=en&q=correlation%20between%20plasma%20amylase%20activity%20and%20concentration%20of%20plasma%20non-esterifled%20fatty%20acids%20(nefa	PROPN
aesr-151	246	24	)	)	PUNCT
aesr-151	246	25	http://dx.doi.org/10.3181/00379727-95-23264	http://dx.doi.org/10.3181/00379727-95-23264	SCONJ
aesr-151	246	26	http://dx.doi.org/10.3181/00379727-95-23264	http://dx.doi.org/10.3181/00379727-95-23264	ADJ
aesr-151	246	27	https://scholar.google.com/scholar?hl=en&q=relationship%20between%20blood%20amylase%20and%20factors%20affecting%20carbohydrate%20metabolism	https://scholar.google.com/scholar?hl=en&q=relationship%20between%20blood%20amylase%20and%20factors%20affecting%20carbohydrate%20metabolism	NOUN
aesr-151	246	28	http://dx.doi.org/10.1007/bf02232179	http://dx.doi.org/10.1007/bf02232179	NOUN
aesr-151	246	29	https://scholar.google.com/scholar?hl=en&q=some%20relationships%20between%20adrenal%20medullary%20and%20cortical%20substances%20and%20exocrine%20secretion%20of%20the%20pancreas	https://scholar.google.com/scholar?hl=en&q=some%20relationships%20between%20adrenal%20medullary%20and%20cortical%20substances%20and%20exocrine%20secretion%20of%20the%20pancrea	NOUN
aesr-151	246	30	https://scholar.google.com/scholar?hl=en&q=normal%20lipase%20serum%20level%20in%20acute%20pancreatitis:%20a%20case%20report	https://scholar.google.com/scholar?hl=en&q=normal%20lipase%20serum%20level%20in%20acute%20pancreatitis:%20a%20case%20report	VERB
aesr-151	246	31	http://dx.doi.org/10.1136/emj.2006.037655	http://dx.doi.org/10.1136/emj.2006.037655	NOUN
aesr-151	246	32	https://scholar.google.com/scholar?hl=en&q=clinical%20laboratory%20assessment%20of%20acute%20pancreatitis	https://scholar.google.com/scholar?hl=en&q=clinical%20laboratory%20assessment%20of%20acute%20pancreatitis	NOUN
aesr-151	246	33	http://dx.doi.org/10.1016/j.cccn.2005.06.008	http://dx.doi.org/10.1016/j.cccn.2005.06.008	NOUN
aesr-151	246	34	https://scholar.google.com/scholar?hl=en&q=what%20is%20the%20best%20biochemical%20test%20to%20diagnose%20acute%20pancreatitis?%20a%20prospective%20clinical%20study	https://scholar.google.com/scholar?hl=en&q=what%20is%20the%20best%20biochemical%20test%20to%20diagnose%20acute%20pancreatitis?%20a%20prospective%20clinical%20study	PROPN
aesr-151	246	35	http://dx.doi.org/10.4065/71.12.1138	http://dx.doi.org/10.4065/71.12.1138	PROPN
aesr-151	246	36	https://scholar.google.com/scholar?hl=en&q=use%20of%20biosynthetic%20human%20c-peptide%20in%20the%20measurement%20of%20insulin%20secretion%20rates%20in%20normal%20volunteers%20and%20type%20i%20diabetic%20patients	https://scholar.google.com/scholar?hl=en&q=use%20of%20biosynthetic%20human%20c-peptide%20in%20the%20measurement%20of%20insulin%20secretion%20rates%20in%20normal%20volunteers%20and%20type%20i%20diabetic%20patient	NOUN
aesr-151	246	37	http://dx.doi.org/10.1172/jci112308	http://dx.doi.org/10.1172/jci112308	ADP
aesr-151	246	38	https://scholar.google.com/scholar?hl=en&q=ingestion%20of%20a%20mixed%20meal%20does%20not%20affect%20the%20metabolic%20clearance%20rate%20of%20biosynthetic%20human%20c-peptide	https://scholar.google.com/scholar?hl=en&q=ingestion%20of%20a%20mixed%20meal%20does%20not%20affect%20the%20metabolic%20clearance%20rate%20of%20biosynthetic%20human%20c-peptide	NOUN
aesr-151	246	39	http://dx.doi.org/10.1210/jcem-63-2-401	http://dx.doi.org/10.1210/jcem-63-2-401	PROPN
aesr-151	246	40	https://scholar.google.com/scholar?hl=en&q=insulin%20secretory%20reserve%20in%20insulin%20dependent%20patients%20at%20time%20of%20diagnosis%20and%20the%20first%20180%20days%20of%20insulin%20treatment	https://scholar.google.com/scholar?hl=en&q=insulin%20secretory%20reserve%20in%20insulin%20dependent%20patients%20at%20time%20of%20diagnosis%20and%20the%20first%20180%20days%20of%20insulin%20treatment	NOUN
aesr-151	246	41	https://scholar.google.com/scholar?hl=en&q=screening%20and%20catalytic%20activity%20in%20organic%20synthesis%20of%20novel%20fungal%20and%20yeast%20lipases	https://scholar.google.com/scholar?hl=en&q=screening%20and%20catalytic%20activity%20in%20organic%20synthesis%20of%20novel%20fungal%20and%20yeast%20lipase	VERB
aesr-151	246	42	http://dx.doi.org/10.1016/s1381-1177(00)00244-7	http://dx.doi.org/10.1016/s1381-1177(00)00244-7	NOUN
aesr-151	246	43	https://scholar.google.com/scholar?hl=en&q=diabetes%20mellitus%20and%20exocrine%20pancreatic%20dysfunction%20in%20perk-%20/-%20mice%20reveals%20a%20role%20for%20translational%20control%20in%20secretory%20cell%20survival	https://scholar.google.com/scholar?hl=en&q=diabetes%20mellitus%20and%20exocrine%20pancreatic%20dysfunction%20in%20perk-%20/-%20mice%20reveals%20a%20role%20for%20translational%20control%20in%20secretory%20cell%20survival	NOUN
aesr-151	246	44	http://dx.doi.org/10.1016/s1097-2765(01)00264-7	http://dx.doi.org/10.1016/s1097-2765(01)00264-7	PRON
aesr-151	246	45	https://scholar.google.com/scholar?hl=en&q=evaluation%20of%20pancreatic%20exocrine%20function%20using%20pure%20pancreatic%20juice%20in%20noninsulin-dependent%20diabetes%20mellitus	https://scholar.google.com/scholar?hl=en&q=evaluation%20of%20pancreatic%20exocrine%20function%20using%20pure%20pancreatic%20juice%20in%20noninsulin-dependent%20diabetes%20mellitus	PROPN
aesr-151	247	1	http://dx.doi.org/10.1097/00004836-200007000-00012	http://dx.doi.org/10.1097/00004836-200007000-00012	PROPN
aesr-151	247	2	https://scholar.google.com/scholar?hl=en&q=core%20structure%20of%20flavonoids%20precursor%20as%20an%20antihyperglycemic%20and%20antihyperlipidemic%20agent:%20an%20in%20vivo%20study%20in%20rats	https://scholar.google.com/scholar?hl=en&q=core%20structure%20of%20flavonoids%20precursor%20as%20an%20antihyperglycemic%20and%20antihyperlipidemic%20agent:%20an%20in%20vivo%20study%20in%20rats	AUX
aesr-151	247	3	https://scholar.google.com/scholar?hl=en&q=hypoglycemic%20and%20hypolipidemic%20effects%20and%20antioxidant%20activity%20of%20fruit%20extracts%20from%20lycium%20barbarum	https://scholar.google.com/scholar?hl=en&q=hypoglycemic%20and%20hypolipidemic%20effects%20and%20antioxidant%20activity%20of%20fruit%20extracts%20from%20lycium%20barbarum	VERB
aesr-151	247	4	http://dx.doi.org/10.1016/j.lfs.2004.04.056	http://dx.doi.org/10.1016/j.lfs.2004.04.056	PROPN
aesr-151	247	5	https://scholar.google.com/scholar?hl=en&q=protective%20effect%20of%20lycium%20barbarum%20polysaccharides%20on%20streptozotocin-induced%20oxidative%20stress%20in%20rats	https://scholar.google.com/scholar?hl=en&q=protective%20effect%20of%20lycium%20barbarum%20polysaccharides%20on%20streptozotocin-induced%20oxidative%20stress%20in%20rat	VERB
aesr-151	248	1	http://dx.doi.org/10.1016/j.ijbiomac.2006.11.002	http://dx.doi.org/10.1016/j.ijbiomac.2006.11.002	PROPN